BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;61:e78-e140. [PMID: 23256914 DOI: 10.1016/j.jacc.2012.11.019] [Cited by in Crossref: 1741] [Cited by in F6Publishing: 1463] [Article Influence: 174.1] [Reference Citation Analysis]
Number Citing Articles
1 Brokmeier H, Kido K. Off-label Use for Direct Oral Anticoagulants: Valvular Atrial Fibrillation, Heart Failure, Left Ventricular Thrombus, Superficial Vein Thrombosis, Pulmonary Hypertension-a Systematic Review. Ann Pharmacother 2021;55:995-1009. [PMID: 33148014 DOI: 10.1177/1060028020970618] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Liu B, Guo R, Zhou S, Xie S, Wang K, Xu Y. Effects of obstructive sleep apnea on cardiac function and clinical outcomes in Chinese patients with ST-elevation myocardial infarction. ScientificWorldJournal 2014;2014:908582. [PMID: 24701193 DOI: 10.1155/2014/908582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
3 Levy BR, Slade MD, Lampert R. Idealization of youthfulness predicts worse recovery among older individuals. Psychol Aging 2019;34:202-7. [PMID: 30730160 DOI: 10.1037/pag0000330] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Kochar A, Summers MB, Benziger CP, Marquis-Gravel G, DeWalt DA, Pepine CJ, Gupta K, Bradley SM, Dodson JA, Lampert BC, Robertson H, Polonsky TS, Jones WS, Effron MB. Clinician engagement in the ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness) trial. Clin Trials 2021;18:449-56. [PMID: 33541120 DOI: 10.1177/1740774520988838] [Reference Citation Analysis]
5 Usta C, Bedel A. Update on pharmacological treatment of acute coronary syndrome without persistent ST segment elevation myocardial infarction in the elderly. J Geriatr Cardiol 2017;14:457-64. [PMID: 28868074 DOI: 10.11909/j.issn.1671-5411.2017.07.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Liu Y, Tan N, Huo Y, Chen S, Liu J, Chen YD, Wu K, Wu G, Chen K, Ye J, Liang Y, Feng X, Dong S, Wu Q, Ye X, Zeng H, Zhang M, Dai M, Duan CY, Sun G, He Y, Song F, Guo Z, Chen PY, Ge J, Xian Y, Chen J. Hydration for prevention of kidney injury after primary coronary intervention for acute myocardial infarction: a randomised clinical trial. Heart 2021:heartjnl-2021-319716. [PMID: 34509996 DOI: 10.1136/heartjnl-2021-319716] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bijay Y, Miriyala V, Pant S, Chander R, Nosheen J, Turcotte KD, Rizk S, Mucciardi N, Randy K, Cao S. Lung carcinoma paraneoplastic reactive regional pericarditis mimicking ST elevation myocardial infarct. J Community Hosp Intern Med Perspect 2021;11:859-62. [PMID: 34804407 DOI: 10.1080/20009666.2021.1973218] [Reference Citation Analysis]
8 Hebbal VP, Setty HS, Sathvik CM, Patil V, Sahoo S, Manjunath CN. Acute ST-segment elevation myocardial infarction: The prognostic importance of lead augmented vector right and leads V7-V9. J Nat Sci Biol Med 2017;8:104-9. [PMID: 28250684 DOI: 10.4103/0976-9668.198364] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Hirota Y, Sawano M, Numasawa Y, Ueda I, Noma S, Suzuki M, Hayashida K, Yuasa S, Maekawa Y, Kohsaka S, Fukuda K. Characteristics and in-hospital outcomes in young patients presenting with acute coronary syndrome treated by percutaneous coronary intervention. Cardiovasc Interv and Ther 2018;33:154-62. [DOI: 10.1007/s12928-017-0471-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
10 Gaglia MA, Shavelle DM, Tun H, Bhatt J, Mehra A, Matthews RV, Clavijo L. African-American patients are less likely to receive drug-eluting stents during percutaneous coronary intervention. Cardiovascular Revascularization Medicine 2014;15:214-8. [DOI: 10.1016/j.carrev.2014.04.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
11 Zhang Y, Zheng W, Sun J, Li G, Chi B. Electrocardiogram score for the selection of reperfusion strategy in early latecomers with ST-segment elevation myocardial infarction. Journal of Electrocardiology 2015;48:260-7. [DOI: 10.1016/j.jelectrocard.2015.01.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Rogers KC, Oliphant CS, Finks SW. Clinical efficacy and safety of cilostazol: a critical review of the literature. Drugs 2015;75:377-95. [PMID: 25758742 DOI: 10.1007/s40265-015-0364-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
13 Adebayo O, Rogers RL. Hypertensive Emergencies in the Emergency Department. Emerg Med Clin North Am 2015;33:539-51. [PMID: 26226865 DOI: 10.1016/j.emc.2015.04.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
14 Dehmer GJ, Badhwar V, Bermudez EA, Cleveland JC, Cohen MG, D’agostino RS, Ferguson TB, Hendel RC, Isler ML, Jacobs JP, Jneid H, Katz AS, Maddox TM, Shahian DM. 2020 AHA/ACC Key Data Elements and Definitions for Coronary Revascularization. Journal of the American College of Cardiology 2020;75:1975-2088. [DOI: 10.1016/j.jacc.2020.02.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
15 Huang B, Xu C, Liu H, Deng W, Yang Z, Wan J, Yan H, Cao G, Chen J, Jiang H. In-Hospital Management and Outcomes of Acute Myocardial Infarction Before and During the Coronavirus Disease 2019 Pandemic. J Cardiovasc Pharmacol 2020;76:540-8. [PMID: 33170591 DOI: 10.1097/FJC.0000000000000909] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
16 Cabello JB, Burls A, Emparanza JI, Bayliss SE, Quinn T. Oxygen therapy for acute myocardial infarction. Cochrane Database Syst Rev 2016;12:CD007160. [PMID: 27991651 DOI: 10.1002/14651858.CD007160.pub4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
17 Choi Y, Lee YJ, Shin SD, Song KJ, Lee K, Lee EJ, Kim YJ, Ahn KO, Hong KJ, Ro YS. The impact of recommended percutaneous coronary intervention care on hospital outcomes for interhospital-transferred STEMI patients. Am J Emerg Med 2017;35:7-12. [PMID: 27771225 DOI: 10.1016/j.ajem.2016.09.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Rossello X, Yellon DM. A critical review on the translational journey of cardioprotective therapies! International Journal of Cardiology 2016;220:176-84. [DOI: 10.1016/j.ijcard.2016.06.131] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
19 Franchi F, Angiolillo DJ. Novel antiplatelet agents in acute coronary syndrome. Nat Rev Cardiol 2015;12:30-47. [DOI: 10.1038/nrcardio.2014.156] [Cited by in Crossref: 220] [Cited by in F6Publishing: 191] [Article Influence: 27.5] [Reference Citation Analysis]
20 Lemor A, Basir MB, Patel K, Kolski B, Kaki A, Kapur NK, Riley R, Finley J, Goldsweig A, Aronow HD, Belford PM, Tehrani B, Truesdell AG, Lasorda D, Bharadwaj A, Hanson I, Lalonde T, Gorgis S, O'neill W, Lemor A, Basir MB, O'neill WW, Patel K, Kolski B, Schreiber T, Kaki A, Tehrani B, Truesdell AG, Lasorda D, Bharadwaj A, Hanson I, Almany S, Timmis S, Dixon S, Lalonde T, Attallah A, Todd J, Marso S, Wilkins C, Patel N, Senter S, Mcrae T, Rahman A, Gelormini J, Kapur N, Singh IM, Riley R, O'neill B, Overly T, Sharma R, Dupont A, Green M, Lim M, Khuddus M, Caputo C, Larkin T, Askari R, Marso S, Nsair A, Akhtar Y, Hanson I, Lin L, Mcallister D, Finley J, Goldsweig A, Park J, Gorwara S, Nazir R, Martin S, Foster M, Smith C, Rangaswamy C, Zuberi O, Federici R, Baker J, Cawich I, Korpas D, Srivastava N, Aronow HD, Schaeffer M, Wohns D, Belford PM, Mehra A, Blank N, Alraies MC, Ashbrook M, Abdel-hafez O, Khandelwal A, Alaswad K, Gorgis S, Johnson T, Hacala M. Multivessel Versus Culprit-Vessel Percutaneous Coronary Intervention in Cardiogenic Shock. JACC: Cardiovascular Interventions 2020;13:1171-8. [DOI: 10.1016/j.jcin.2020.03.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
21 Liu L, Wang D. A rare transitory change of the De Winter ST/T-wave complex in a patient with cardiac arrest: A case report. Medicine (Baltimore) 2020;99:e20133. [PMID: 32384494 DOI: 10.1097/MD.0000000000020133] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Seropian IM, Toldo S, Van Tassell BW, Abbate A. Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction. J Am Coll Cardiol 2014;63:1593-603. [PMID: 24530674 DOI: 10.1016/j.jacc.2014.01.014] [Cited by in Crossref: 160] [Cited by in F6Publishing: 152] [Article Influence: 20.0] [Reference Citation Analysis]
23 Storey RF, Angiolillo DJ, Bonaca MP, Thomas MR, Judge HM, Rollini F, Franchi F, Ahsan AJ, Bhatt DL, Kuder JF, Steg PG, Cohen M, Muthusamy R, Braunwald E, Sabatine MS. Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial. Journal of the American College of Cardiology 2016;67:1145-54. [DOI: 10.1016/j.jacc.2015.12.062] [Cited by in Crossref: 74] [Cited by in F6Publishing: 69] [Article Influence: 12.3] [Reference Citation Analysis]
24 Tisminetzky M, Gurwitz J, Chen HY, Erskine N, Yarzebski J, Gore J, Lessard D, Goldberg R. Identification and Characteristics of Low-Risk Survivors of an Acute Myocardial Infarction. Am J Cardiol 2016;117:1552-7. [PMID: 27013386 DOI: 10.1016/j.amjcard.2016.02.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
25 Cabello JB, Burls A, Emparanza JI, Bayliss S, Quinn T, Cabello JB. Oxygen therapy for acute myocardial infarction. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd007160.pub3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
26 Vora AN, Peterson ED, Hellkamp AS, Sutton NR, Panacek E, Thomas L, de Lemos JA, Wang TY. Care Transitions After Acute Myocardial Infarction for Transferred-In Versus Direct-Arrival Patients. Circ Cardiovasc Qual Outcomes 2016;9:109-16. [DOI: 10.1161/circoutcomes.115.002108] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]
27 Akpek M, Sahin O, Sarli B, Baktir AO, Saglam H, Urkmez S, Ergin A, Oguzhan A, Arinc H, Kaya MG. Acute Effects of Intracoronary Tirofiban on No-Reflow Phenomena in Patients With ST-Segment Elevated Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Angiology 2015;66:560-7. [DOI: 10.1177/0003319714545780] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Fan P, Gao Y, Zheng M, Xu T, Schoenhagen P, Jin Z. Recent progress and market analysis of anticoagulant drugs. J Thorac Dis 2018;10:2011-25. [PMID: 29707358 DOI: 10.21037/jtd.2018.03.95] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
29 Palamalai V, Murakami MM, Apple FS. Diagnostic performance of four point of care cardiac troponin I assays to rule in and rule out acute myocardial infarction. Clin Biochem 2013;46:1631-5. [PMID: 23850852 DOI: 10.1016/j.clinbiochem.2013.06.026] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
30 Patel A, Prabhakaran D, Berendsen M, Mohanan PP, Huffman MD. Pre-hospital policies for the care of patients with acute coronary syndromes in India: A policy document analysis. Indian Heart J 2017;69 Suppl 1:S12-9. [PMID: 28400033 DOI: 10.1016/j.ihj.2016.06.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
31 Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm 2018;15:e190-252. [PMID: 29097320 DOI: 10.1016/j.hrthm.2017.10.035] [Cited by in Crossref: 209] [Cited by in F6Publishing: 157] [Article Influence: 41.8] [Reference Citation Analysis]
32 Zahran S, Figueiredo VP, Graham MM, Schulz R, Hwang PM. Proteolytic Digestion of Serum Cardiac Troponin I as Marker of Ischemic Severity. J Appl Lab Med 2018;3:450-5. [PMID: 33636927 DOI: 10.1373/jalm.2017.025254] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
33 Cao B, Wang H, Zhang C, Xia M, Yang X. Remote Ischemic Postconditioning (RIPC) of the Upper Arm Results in Protection from Cardiac Ischemia-Reperfusion Injury Following Primary Percutaneous Coronary Intervention (PCI) for Acute ST-Segment Elevation Myocardial Infarction (STEMI). Med Sci Monit 2018;24:1017-26. [PMID: 29456238 DOI: 10.12659/msm.908247] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
34 Shahzad A, Kemp I, Mars C, Wilson K, Roome C, Cooper R, Andron M, Appleby C, Fisher M, Khand A, Kunadian B, Mills JD, Morris JL, Morrison WL, Munir S, Palmer ND, Perry RA, Ramsdale DR, Velavan P, Stables RH; HEAT-PPCI trial investigators. Unfractionated heparin vs bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial. Lancet. 2014;384:1849-1858. [PMID: 25002178 DOI: 10.1016/s0140-6736(14)60924-7] [Cited by in Crossref: 359] [Cited by in F6Publishing: 53] [Article Influence: 44.9] [Reference Citation Analysis]
35 Mccann GP, Khan JN, Greenwood JP, Nazir SA, Dalby M, Curzen N, Hetherington S, Kelly DJ, Blackman DJ, Ring A, Peebles C, Wong J, Sasikaran T, Flather M, Swanton H, Gershlick AH. The randomised Complete versus Lesion-only PRimary percutaneous coronary Intervention Trial: Cardiovascular Magnetic Resonance imaging substudy (CvLPRIT-CMR). Efficacy Mech Eval 2016;3:1-72. [DOI: 10.3310/eme03010] [Reference Citation Analysis]
36 Yu B, Akushevich I, Yashkin AP, Kravchenko J. Epidemiology of Geographic Disparities of Myocardial Infarction Among Older Adults in the United States: Analysis of 2000-2017 Medicare Data. Front Cardiovasc Med 2021;8:707102. [PMID: 34568451 DOI: 10.3389/fcvm.2021.707102] [Reference Citation Analysis]
37 Rao Z, Zheng H, Wang F, Wang A, Liu L, Dong K, Zhao X, Cao Y, Wang Y. High On-Treatment Platelet Reactivity to Adenosine Diphosphate Predicts Ischemic Events of Minor Stroke and Transient Ischemic Attack. J Stroke Cerebrovasc Dis 2017;26:2074-81. [PMID: 28736132 DOI: 10.1016/j.jstrokecerebrovasdis.2017.04.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
38 Das D, Savu A, Bainey KR, Welsh RC, Kaul P. Temporal Trends in in-Hospital Bleeding and Transfusion in a Contemporary Canadian ST-Elevation Myocardial Infarction Patient Population. CJC Open 2021;3:479-87. [PMID: 34027351 DOI: 10.1016/j.cjco.2020.12.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Chen SJ, Liu W, Huang BT, Tsauo JY, Pu XB, Peng Y, Chen M, Huang DJ. The impact of optimal medical therapy at discharge on mortality in patients with coronary artery disease. J Geriatr Cardiol 2017;14:100-7. [PMID: 28491084 DOI: 10.11909/j.issn.1671-5411.2017.02.004] [Reference Citation Analysis]
40 Harhash AA, May T, Hsu CH, Seder DB, Dankiewicz J, Agarwal S, Patel N, McPherson J, Riker R, Soreide E, Hirsch KG, Stammet P, Dupont A, Forsberg S, Rubertsson S, Friberg H, Nielsen N, Mooney MR, Kern KB. Incidence of cardiac interventions and associated cardiac arrest outcomes in patients with nonshockable initial rhythms and no ST elevation post resuscitation. Resuscitation 2021;167:188-97. [PMID: 34437992 DOI: 10.1016/j.resuscitation.2021.08.026] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Her AY, Shin ES, Kim YH, Garg S, Jeong MH. The contribution of gender and age on early and late mortality following ST-segment elevation myocardial infarction: results from the Korean Acute Myocardial Infarction National Registry with Registries. J Geriatr Cardiol 2018;15:205-14. [PMID: 29720999 DOI: 10.11909/j.issn.1671-5411.2018.03.001] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
42 Polito CC, Isakov A, Yancey AH 2nd, Wilson DK, Anderson BA, Bloom I, Martin GS, Sevransky JE. Prehospital recognition of severe sepsis: development and validation of a novel EMS screening tool. Am J Emerg Med 2015;33:1119-25. [PMID: 26070235 DOI: 10.1016/j.ajem.2015.04.024] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
43 Wegmann C, Pfister R, Scholz S, Markhof A, Wanke S, Kuhr K, Rudolph T, Baldus S, Reuter H. Diagnostische Wertigkeit des Linksschenkelblocks bei Patienten mit akutem Myokardinfarkt: Eine prospektive Analyse. Herz 2015;40:1107-14. [DOI: 10.1007/s00059-015-4326-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
44 Li PWC, Yu DSF. Testing a Model to Reveal the Predictive Mechanism of Care-Seeking Decisions Among Patients With Acute Myocardial Infarction. J Cardiovasc Nurs 2017;32:393-400. [PMID: 27281057 DOI: 10.1097/JCN.0000000000000355] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
45 Awerbach JD, Krasuski RA, Camitta MG. Coronary Disease and Modifying Cardiovascular Risk in Adult Congenital Heart Disease Patients: Should General Guidelines Apply? Progress in Cardiovascular Diseases 2018;61:300-7. [DOI: 10.1016/j.pcad.2018.07.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
46 Ladwig K, Fang X, Wolf K, Hoschar S, Albarqouni L, Ronel J, Meinertz T, Spieler D, Laugwitz K, Schunkert H. Comparison of Delay Times Between Symptom Onset of an Acute ST-elevation Myocardial Infarction and Hospital Arrival in Men and Women <65 Years Versus ≥65 Years of Age. The American Journal of Cardiology 2017;120:2128-34. [DOI: 10.1016/j.amjcard.2017.09.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
47 Yin Y, Fang C, Jiang S, Wang J, Wang Y, Guo J, Lei F, Sun S, Pei X, Jia R, Li L, Wang Y, Yu H, Dai J, Yu B. In vivo evidence of atherosclerotic plaque erosion and healing in patients with acute coronary syndrome using serial optical coherence tomography imaging. Am Heart J 2022;243:66-76. [PMID: 34582778 DOI: 10.1016/j.ahj.2021.09.007] [Reference Citation Analysis]
48 Dégano IR, Subirana I, Fusco D, Tavazzi L, Kirchberger I, Farmakis D, Ferrières J, Azevedo A, Torre M, Garel P, Brosa M, Davoli M, Meisinger C, Bongard V, Araújo C, Lekakis J, Francès A, Castell C, Elosua R, Marrugat J. Percutaneous coronary intervention reduces mortality in myocardial infarction patients with comorbidities: Implications for elderly patients with diabetes or kidney disease. International Journal of Cardiology 2017;249:83-9. [DOI: 10.1016/j.ijcard.2017.07.054] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
49 Bahiru E, Temu T, Mwanga J, Ndede K, Vusha S, Gitura B, Farquhar C, Bukachi F, Huffman MD. Facilitators, context of and barriers to acute coronary syndrome care at Kenyatta National Hospital, Nairobi, Kenya: a qualitative analysis. Cardiovasc J Afr 2018;29:177-82. [PMID: 29750227 DOI: 10.5830/CVJA-2018-013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
50 Hao Y, Liu J, Liu J, Smith SC, Huo Y, Fonarow GC, Ma C, Ge J, Taubert KA, Morgan L, Guo Y, Zhang Q, Wang W, Zhao D. Rationale and design of the Improving Care for Cardiovascular Disease in China (CCC) project: A national effort to prompt quality enhancement for acute coronary syndrome. American Heart Journal 2016;179:107-15. [DOI: 10.1016/j.ahj.2016.06.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
51 Shavadia JS, Youngson E, Bainey KR, Bakal J, Welsh RC. Outcomes and Prognostic Impact of Prophylactic Oral Anticoagulation in Anterior ST-Segment Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction. J Am Heart Assoc 2017;6:e006054. [PMID: 28673899 DOI: 10.1161/JAHA.117.006054] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 2.6] [Reference Citation Analysis]
52 Ko BS, Drakos SG, Welt FGP, Shah RU. Controversies and Challenges in the Management of ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock. Interv Cardiol Clin 2016;5:541-9. [PMID: 28582002 DOI: 10.1016/j.iccl.2016.06.010] [Reference Citation Analysis]
53 Yiadom MY, Baugh CW, McWade CM, Liu X, Song KJ, Patterson BW, Jenkins CA, Tanski M, Mills AM, Salazar G, Wang TJ, Dittus RS, Liu D, Storrow AB. Performance of Emergency Department Screening Criteria for an Early ECG to Identify ST-Segment Elevation Myocardial Infarction. J Am Heart Assoc 2017;6:e003528. [PMID: 28232323 DOI: 10.1161/JAHA.116.003528] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
54 Chowdhury IZ, Amin MN, Chowdhury MZ, Rahman SM, Ahmed M, Cader FA. Pre hospital delay and its associated factors in acute myocardial infarction in a developing country. PLoS One 2021;16:e0259979. [PMID: 34818360 DOI: 10.1371/journal.pone.0259979] [Reference Citation Analysis]
55 Abou R, Prihadi EA, Goedemans L, van der Geest R, El Mahdiui M, Schalij MJ, Ajmone Marsan N, Bax JJ, Delgado V. Left ventricular mechanical dispersion in ischaemic cardiomyopathy: association with myocardial scar burden and prognostic implications. Eur Heart J Cardiovasc Imaging 2020;21:1227-34. [PMID: 32734280 DOI: 10.1093/ehjci/jeaa187] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
56 Robles MC, Corches CL, Bradford M, Rice TS, Sukul D, Springer MV, Bailey S, Oliver A, Skolarus LE. Understanding and Informing Community Emergency Cardiovascular Disease Preparedness during the COVID-19 Pandemic: Stroke Ready. J Stroke Cerebrovasc Dis 2021;30:105479. [PMID: 33246207 DOI: 10.1016/j.jstrokecerebrovasdis.2020.105479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Roldan LP, Rowan C, Sheldon M, Roldan CA. Three-vessel coronary artery aneurysmal disease complicated by multivessel thrombosis and cardiogenic shock: the saving role of intracoronary thrombolysis. BMJ Case Rep 2017;2017:bcr-2017-222038. [PMID: 29248881 DOI: 10.1136/bcr-2017-222038] [Reference Citation Analysis]
58 Kim W, Cho HY, Kim BK, Huh C, Chung KH, Ahn C, Kim YJ, Kim A. Highly sensitive detection of cardiac troponin I in human serum using gold nanoparticle-based enhanced sandwich immunoassay. Sensors and Actuators B: Chemical 2015;221:537-43. [DOI: 10.1016/j.snb.2015.06.128] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
59 Valente S, Lazzeri C, Mattesini A, Chiostri M, Giglioli C, Meucci F, Baldereschi G, Gensini GF. Thrombus aspiration in elderly STEMI patients: a single center experience. Int J Cardiol. 2013;168:3097-3099. [PMID: 23642592 DOI: 10.1016/j.ijcard.2013.04.077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
60 Zhang Y, Tian Y, Dong P, Xu Y, Yu B, Li H, Li J, Ge J, Sun Y, Wang J, Wang L, Chen J, Yan H, Chen Y, Han Y, Huo Y; CSCAP-1 Investigators. Treatment delay and reperfusion management of acute ST-segment elevation myocardial infarction: analysis of the China STEMI Care Project Phase 1. QJM 2021;114:299-305. [PMID: 32569364 DOI: 10.1093/qjmed/hcaa186] [Reference Citation Analysis]
61 Mensah GA. Embracing dissemination and implementation research in cardiac critical care. Glob Heart 2014;9:363-6. [PMID: 25592788 DOI: 10.1016/j.gheart.2014.10.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
62 Nallamothu BK, Tommaso CL, Anderson HV, Anderson JL, Cleveland JC, Dudley RA, Duffy PL, Faxon DP, Gurm HS, Hamilton LA, Jensen NC, Josephson RA, Malenka DJ, Maniu CV, Mccabe KW, Mortimer JD, Patel MR, Persell SD, Rumsfeld JS, Shunk KA, Smith SC, Stanko SJ, Watts B. ACC/AHA/SCAI/AMA–Convened PCPI/NCQA 2013 Performance Measures for Adults Undergoing Percutaneous Coronary Intervention. Journal of the American College of Cardiology 2014;63:722-45. [DOI: 10.1016/j.jacc.2013.12.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
63 Askandar S, Bob-manuel T, Singh P, Khouzam RN. Shorter Door-To-Balloon ST-Elevation Myocardial Infarction Time: Should There Be a Minimum Limit? Current Problems in Cardiology 2017;42:175-87. [DOI: 10.1016/j.cpcardiol.2017.02.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
64 Shacham Y, Gal-Oz A, Flint N, Keren G, Arbel Y. Serum Uric Acid Levels and Renal Impairment among ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Intervention. Cardiorenal Med 2016;6:191-7. [PMID: 27275155 DOI: 10.1159/000444100] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
65 Kızıltunç E, Gök M, Topçuoğlu C, Kundi H, Çetin M, Turhan T, Örnek E. Serum Sphingosine 1 Phosphate Levels in Patients with and without Coronary Collateral Circulation. Acta Cardiol Sin 2018;34:379-85. [PMID: 30271087 DOI: 10.6515/ACS.201809_34(5).20180405A] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
66 Govea A, Lipinksi J, Patel MP. Prehospital Evaluation, ED Management, Transfers, and Management of Inpatient STEMI. Interv Cardiol Clin 2021;10:293-306. [PMID: 34053616 DOI: 10.1016/j.iccl.2021.03.002] [Reference Citation Analysis]
67 Rossello X, Pocock SJ, Julian DG. Long-Term Use of Cardiovascular Drugs: Challenges for Research and for Patient Care. J Am Coll Cardiol 2015;66:1273-85. [PMID: 26361160 DOI: 10.1016/j.jacc.2015.07.018] [Cited by in Crossref: 70] [Cited by in F6Publishing: 56] [Article Influence: 10.0] [Reference Citation Analysis]
68 Liu Y, Hong D, Wang AY, Guo R, Smyth B, Liu J, Sun G, Chen S, Tan N, Jardine M, Brieger D, Shaman A, Islam S, Chen J, Gallagher M. Effects of intravenous hydration on risk of contrast induced nephropathy and in-hospital mortality in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials. BMC Cardiovasc Disord 2019;19:87. [PMID: 30961544 DOI: 10.1186/s12872-019-1054-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
69 Yu KM, Kern MJ. Physiological Lesion Assessment in STEMI and Other Acute Coronary Syndromes. In: Watson TJ, Ong PJ, Tcheng JE, editors. Primary Angioplasty. Singapore: Springer; 2018. pp. 197-210. [DOI: 10.1007/978-981-13-1114-7_15] [Reference Citation Analysis]
70 Wang J, Zhang Y, Li H, Hu X, Li M, Song P, Ma Q, Peng L, Chen X. CRISPLD1 rs12115090 polymorphisms alters antiplatelet potency of clopidogrel in coronary artery disease patients in Chinese Han. Gene 2018;678:226-32. [DOI: 10.1016/j.gene.2018.08.027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
71 de Waha S, Thiele H, Richardt G. [Antiplatelet therapy and anticoagulation in acute coronary syndrome: current evidence]. Herz 2014;39:692-701. [PMID: 25081127 DOI: 10.1007/s00059-014-4132-z] [Reference Citation Analysis]
72 Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR, Hohnloser SH, Indik J, Lee R, Mehra MR, Menon V, Page RL, Shen W, Slotwiner DJ, Stevenson LW, Varosy PD, Welikovitch L. HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials. Journal of the American College of Cardiology 2014;64:1143-77. [DOI: 10.1016/j.jacc.2014.04.008] [Cited by in Crossref: 61] [Cited by in F6Publishing: 45] [Article Influence: 7.6] [Reference Citation Analysis]
73 Chen HY, Gore JM, Lapane KL, Yarzebski J, Person SD, Kiefe CI, Goldberg RJ. Decade-long trends in the timeliness of receipt of a primary percutaneous coronary intervention. Clin Epidemiol 2016;8:141-9. [PMID: 27350759 DOI: 10.2147/CLEP.S102225] [Reference Citation Analysis]
74 Romeo F, Acconcia MC, Sergi D, Romeo A, Francioni S, Chiarotti F, Caretta Q. Percutaneous assist devices in acute myocardial infarction with cardiogenic shock: Review, meta-analysis. World J Cardiol 2016; 8(1): 98-111 [PMID: 26839661 DOI: 10.4330/wjc.v8.i1.98] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
75 Rodrigues G, de Araújo Gonçalves P, Madeira S, Rodrigues R, Borges Santos M, Brito J, Raposo L, Mesquita Gabriel H, Campante Teles R, Almeida M, Mendes M. Impact of complete revascularization in patients with ST-elevation myocardial infarction: analysis of a 10-year all-comers prospective registry. Coronary Artery Disease 2016;27:122-7. [DOI: 10.1097/mca.0000000000000334] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
76 Dahl Aarvik M, Sandven I, Dondo TB, Gale CP, Ruddox V, Munkhaugen J, Atar D, Otterstad JE. Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother 2019;5:12-20. [PMID: 30192930 DOI: 10.1093/ehjcvp/pvy034] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
77 Hyde EK, Martin DE, Rieger KL, Malone R. "Just think of it as sexercise" - healthcare providers' perceptions about sexual health education in cardiac rehabilitation programs. Disabil Rehabil 2021;:1-7. [PMID: 34779688 DOI: 10.1080/09638288.2021.2001052] [Reference Citation Analysis]
78 Sra S, Tan MK, Mehta SR, Fisher HN, Déry J, Welsh RC, Eisenberg MJ, Overgaard CB, Rose BF, Siega AJD, Cheema AN, Wong BY, Henderson MA, Lutchmedial S, Lavi S, Goodman SG, Yan AT. Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy. American Heart Journal 2016;180:82-9. [DOI: 10.1016/j.ahj.2016.07.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
79 Yeh CF, Wang CH, Tsai PR, Wu CK, Lin YH, Chen YS. Use of Extracorporeal Membrane Oxygenation to Rescue Patients With Refractory Ventricular Arrhythmia in Acute Myocardial Infarction. Medicine (Baltimore) 2015;94:e1241. [PMID: 26222862 DOI: 10.1097/MD.0000000000001241] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
80 Savchenko AS, Borissoff JI, Martinod K, De Meyer SF, Gallant M, Erpenbeck L, Brill A, Wang Y, Wagner DD. VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia/reperfusion injury in mice. Blood 2014;123:141-8. [PMID: 24200682 DOI: 10.1182/blood-2013-07-514992] [Cited by in Crossref: 142] [Cited by in F6Publishing: 144] [Article Influence: 15.8] [Reference Citation Analysis]
81 Villablanca PA, Olmedo W, Weinreich M, Gupta T, Mohananey D, Albuquerque FN, Kassas I, Briceño D, Sanina C, Brevik TA, Ong E, Ramakrishna H, Attubato M, Menegus M, Wiley J, Kalra A. Staged Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With ST-Segment-Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis. J Am Heart Assoc 2018;7:e008415. [PMID: 29654206 DOI: 10.1161/JAHA.117.008415] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Jang JH, Lee MJ, Ko KY, Park JH, Baek YS, Sung-Woo K, Shin SH, Woo SI, Kim DH, Suh YJ, Kwan J, Park SD. Mechanical and Pharmacological Revascularization Strategies for Prevention of Microvascular Dysfunction in ST-Segment Elevation Myocardial Infarction: Analysis from Index of Microcirculatory Resistance Registry Data. J Interv Cardiol 2020;2020:5036396. [PMID: 32728350 DOI: 10.1155/2020/5036396] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
83 Muhlestein JB, Le V, Albert D, Moreno FL, Anderson JL, Yanowitz F, Vranian RB, Barsness GW, Bethea CF, Severance HW, Ramo B, Pierce J, Barbagelata A, Muhlestein JB. Smartphone ECG for evaluation of STEMI: Results of the ST LEUIS Pilot Study. Journal of Electrocardiology 2015;48:249-59. [DOI: 10.1016/j.jelectrocard.2014.11.005] [Cited by in Crossref: 55] [Cited by in F6Publishing: 42] [Article Influence: 7.9] [Reference Citation Analysis]
84 Christopoulos C, Farag M, Sullivan K, Wellsted D, Gorog DA. Impaired thrombolytic status predicts adverse cardiac events in patients undergoing primary percutaneous coronary intervention. Thromb Haemost 2017;117:457-70. [DOI: 10.1160/th16-09-0712] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
85 Tian M, Zhu L, Lin H, Lin Q, Huang P, Yu X, Jing Y. Hsp-27 levels and thrombus burden relate to clinical outcomes in patients with ST-segment elevation myocardial infarction. Oncotarget 2017;8:73733-44. [PMID: 29088740 DOI: 10.18632/oncotarget.17852] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
86 Eijsvogels TM, Molossi S, Lee D, Emery MS, Thompson PD. Exercise at the Extremes. Journal of the American College of Cardiology 2016;67:316-29. [DOI: 10.1016/j.jacc.2015.11.034] [Cited by in Crossref: 141] [Cited by in F6Publishing: 123] [Article Influence: 23.5] [Reference Citation Analysis]
87 Morais J, De Caterina R. Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral Anticoagulants. Cardiovasc Drugs Ther 2016;30:201-14. [PMID: 26780749 DOI: 10.1007/s10557-015-6632-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
88 Foëx P. Innovations in management of cardiac disease: drugs, treatment strategies and technology. British Journal of Anaesthesia 2017;119:i23-33. [DOI: 10.1093/bja/aex327] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
89 Li L, Wu MY, Zhang F, Li SF, Cui YX, Hu D, Chen H. Perspective of delay in door-to-balloon time among Asian population. J Geriatr Cardiol 2018;15:732-7. [PMID: 30675145 DOI: 10.11909/j.issn.1671-5411.2018.12.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
90 de Waha S, Eitel I, Desch S, Fuernau G, Lurz P, Schuler G, Thiele H. Association of upstream clopidogrel administration and myocardial reperfusion assessed by cardiac magnetic resonance imaging in patients with ST-elevation myocardial infarction. European Heart Journal: Acute Cardiovascular Care 2013;3:110-7. [DOI: 10.1177/2048872614520752] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
91 Garcia-Retamero R, Petrova D, Arrebola-Moreno A, Catena A, Ramírez-Hernández JA. Type D personality is related to severity of acute coronary syndrome in patients with recurrent cardiovascular disease. Br J Health Psychol 2016;21:694-711. [PMID: 27222488 DOI: 10.1111/bjhp.12196] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
92 del Val Martin D, Sanmartín Fernández M, Zamorano Gómez JL. Biomarkers in acute coronary syndrome. IJC Metabolic & Endocrine 2015;8:20-3. [DOI: 10.1016/j.ijcme.2015.04.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
93 Xu J, Hee L, Hopkins A, Juergens CP, Lo S, French JK, Mussap CJ. Clinical and Angiographic Predictors of Mortality in Sudden Cardiac Arrest Patients Having Cardiac Catheterisation: A Single Centre Registry. Heart Lung Circ 2019;28:370-8. [PMID: 29459218 DOI: 10.1016/j.hlc.2018.01.005] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
94 Rob D, Bělohlávek J. The mechanical support of cardiogenic shock. Curr Opin Crit Care 2021;27:440-6. [PMID: 33929344 DOI: 10.1097/MCC.0000000000000837] [Reference Citation Analysis]
95 Eliet J, Gaudard P, Zeroual N, Rouvière P, Albat B, Mourad M, Colson PH. Effect of Impella During Veno-Arterial Extracorporeal Membrane Oxygenation on Pulmonary Artery Flow as Assessed by End-Tidal Carbon Dioxide. ASAIO J 2018;64:502-7. [PMID: 28953197 DOI: 10.1097/MAT.0000000000000662] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 4.7] [Reference Citation Analysis]
96 Chew DS, Heikki H, Schmidt G, Kavanagh KM, Dommasch M, Bloch Thomsen PE, Sinnecker D, Raatikainen P, Exner DV. Change in Left Ventricular Ejection Fraction Following First Myocardial Infarction and Outcome. JACC: Clinical Electrophysiology 2018;4:672-82. [DOI: 10.1016/j.jacep.2017.12.015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
97 Paoli G, Notarangelo MF, Mattioli M, La Sala R, Foà C, Solinas E, Fusco S, Fava C, Caminiti C, Artioli G, Pelà G, Dall'Aglio E, Manari A, Tondi S, Rizzo A, Trapolin G, Patrizi G, Cappelli S, Villani GQ, Piepoli M, Zobbi G, Nicosia E, Ardissino D. ALLiance for sEcondary PREvention after an acute coronary syndrome. The ALLEPRE trial: A multicenter fully nurse-coordinated intensive intervention program. Am Heart J 2018;203:12-6. [PMID: 29966801 DOI: 10.1016/j.ahj.2018.06.001] [Reference Citation Analysis]
98 Amier RP, Smulders MW, van der Flier WM, Bekkers SC, Zweerink A, Allaart CP, Demirkiran A, Roos ST, Teunissen PF, Appelman Y, van Royen N, Kim RJ, van Rossum AC, Nijveldt R. Long-Term Prognostic Implications of Previous Silent Myocardial Infarction in Patients Presenting With Acute Myocardial Infarction. JACC: Cardiovascular Imaging 2018;11:1773-81. [DOI: 10.1016/j.jcmg.2018.02.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
99 Mourad M, Gaudard P, De La Arena P, Eliet J, Zeroual N, Rouvière P, Roubille F, Albat B, Colson PH. Circulatory Support with Extracorporeal Membrane Oxygenation and/or Impella for Cardiogenic Shock During Myocardial Infarction. ASAIO J 2018;64:708-14. [PMID: 29240628 DOI: 10.1097/MAT.0000000000000704] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
100 Basir MB, Lemor A, Gorgis S, Taylor AM, Tehrani B, Truesdell AG, Bharadwaj A, Kolski B, Patel K, Gelormini J, Todd J, Lasorda D, Smith C, Riley R, Marso S, Federici R, Kapur NK, O'Neill WW; National Cardiogenic Shock Initiative Investigators. Vasopressors independently associated with mortality in acute myocardial infarction and cardiogenic shock. Catheter Cardiovasc Interv 2021. [PMID: 34343409 DOI: 10.1002/ccd.29895] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Cole J, Beare R, Phan T, Srikanth V, Stub D, Smith K, Murdoch K, Layland J. Modelling STEMI service delivery: a proof of concept study. Emerg Med J 2021:emermed-2020-210334. [PMID: 34937708 DOI: 10.1136/emermed-2020-210334] [Reference Citation Analysis]
102 Romanenko AV, Solovyeva EY. [Pathogenetic and therapeutic aspects of cardioembolic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:165-72. [PMID: 33834736 DOI: 10.17116/jnevro2021121031165] [Reference Citation Analysis]
103 Hu W, Tong J, Kuang X, Chen W, Liu Z. Influence of proton pump inhibitors on clinical outcomes in coronary heart disease patients receiving aspirin and clopidogrel: A meta-analysis. Medicine (Baltimore) 2018;97:e9638. [PMID: 29504996 DOI: 10.1097/MD.0000000000009638] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
104 Gajulapalli RD, Kanmanthareddy A, Balakumaran K, Hong H, Bolen S, Kondapaneni M, Pasala TKR. Aspiration thrombectomy in ST-Elevation myocardial infarction: Further insights from a network meta-analysis of randomized trials. Indian Heart J 2021;73:161-8. [PMID: 33865512 DOI: 10.1016/j.ihj.2021.01.006] [Reference Citation Analysis]
105 Zheng B, Huo Y, Lee SW, Sawhney JPS, Kim HS, Krittayaphong R, Pocock SJ, Nhan VT, Alonso Garcia A, Chin CT, Jiang J, Jan S, Vega AM, Hayashi N, Ong TK. Long-term antithrombotic management patterns in Asian patients with acute coronary syndrome: 2-year observations from the EPICOR Asia study. Clin Cardiol 2020;43:999-1008. [PMID: 32618009 DOI: 10.1002/clc.23400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
106 Chung JH, Lee JM, Her AY, Cho H, Doh JH, Nam CW, Kim HI, Koo BK, Shin ES. Plaque Characteristics and Ruptured Plaque Location according to Lesion Geometry in Culprit Lesions of ST-Segment Elevation Myocardial Infarction. Korean Circ J 2017;47:907-17. [PMID: 29171212 DOI: 10.4070/kcj.2017.0108] [Reference Citation Analysis]
107 Margolis G, Gal-Oz A, Letourneau-Shesaf S, Khoury S, Keren G, Shacham Y. Acute kidney injury based on the KDIGO criteria among ST elevation myocardial infarction patients treated by primary percutaneous intervention. J Nephrol 2018;31:423-8. [PMID: 29185210 DOI: 10.1007/s40620-017-0461-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
108 Jentzer JC, Ternus B, Eleid M, Rihal C. Structural Heart Disease Emergencies. J Intensive Care Med 2021;36:975-88. [PMID: 32314662 DOI: 10.1177/0885066620918776] [Reference Citation Analysis]
109 Buja L, Schoen F. The Pathology of Cardiovascular Interventions and Devices for Coronary Artery Disease, Vascular Disease, Heart Failure, and Arrhythmias. Cardiovascular Pathology. Elsevier; 2016. pp. 577-610. [DOI: 10.1016/b978-0-12-420219-1.00032-x] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
110 Tsai KL, Hsieh PL, Chou WC, Cheng HC, Huang YT, Chan SH. Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK. Cell Biosci 2021;11:44. [PMID: 33637129 DOI: 10.1186/s13578-021-00547-y] [Reference Citation Analysis]
111 Shacham Y, Leshem-Rubinow E, Ben Assa E, Rogowski O, Topilsky Y, Roth A, Steinvil A. Comparison of C-reactive protein and fibrinogen levels in patients having anterior wall ST-Segment elevation myocardial infarction with versus without left ventricular thrombus (from a primary percutaneous coronary intervention cohort). Am J Cardiol 2013;112:57-60. [PMID: 23562384 DOI: 10.1016/j.amjcard.2013.02.052] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
112 Asada S, Sakakura K, Taniguchi Y, Yamamoto K, Tsukui T, Seguchi M, Wada H, Momomura SI, Fujita H. Association of the long fluoroscopy time with factors in contemporary primary percutaneous coronary interventions. PLoS One 2020;15:e0237362. [PMID: 32776989 DOI: 10.1371/journal.pone.0237362] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
113 Gong W, Feng S, Wang X, Fan J, Li A, Nie SP. Beta-blockers reduced the risk of cardiac rupture in patients with acute myocardial infarction: A meta-analysis of randomized control trials. Int J Cardiol 2017;232:171-5. [PMID: 28109576 DOI: 10.1016/j.ijcard.2017.01.035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
114 Lee S, Hizoh I, Kovacs A, Horvath Z, Kiss N, Toth-Zsamboki E, Kiss RG. Predictors of high on-clopidogrel platelet reactivity in patients with acute coronary syndrome. Platelets 2016;27:159-67. [PMID: 26247099 DOI: 10.3109/09537104.2015.1054799] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
115 Arps K, Pallazola VA, Cardoso R, Meyer J, Jones R, Latina J, Gluckman TJ, Stone NJ, Blumenthal RS, Mcevoy JW. Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention: A Review Part 1. The American Journal of Medicine 2019;132:e569-80. [DOI: 10.1016/j.amjmed.2019.01.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
116 Çırakoğlu ÖF, Aslan AO, Yilmaz AS, Kul S, Dursun İ. Usefulness of whole blood viscosity estimated by de Simeone's formula to predict left ventricular thrombus formation within one year following acute anterior myocardial infarction. Biorheology 2020;57:37-51. [PMID: 32444531 DOI: 10.3233/BIR-200240] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
117 Darwesh AM, Bassiouni W, Adebesin AM, Mohammad AS, Falck JR, Seubert JM. A Synthetic Epoxydocosapentaenoic Acid Analogue Ameliorates Cardiac Ischemia/Reperfusion Injury: The Involvement of the Sirtuin 3-NLRP3 Pathway. Int J Mol Sci 2020;21:E5261. [PMID: 32722183 DOI: 10.3390/ijms21155261] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
118 Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127-e248. [PMID: 29146535 DOI: 10.1016/j.jacc.2017.11.006] [Cited by in Crossref: 1578] [Cited by in F6Publishing: 1526] [Article Influence: 315.6] [Reference Citation Analysis]
119 Priti K, Ranwa BL, Gokhroo RK, Kishore K, Bisht DS, Gupta S. Ivabradine vs metoprolol in patients with acute inferior wall myocardial infarction-“Expanding arena for ivabradine”. Cardiovasc Ther 2017;35:e12266. [DOI: 10.1111/1755-5922.12266] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
120 Shin M, Park SH, Mun S, Lee J, Kang HG. Biomarker Discovery of Acute Coronary Syndrome Using Proteomic Approach. Molecules 2021;26:1136. [PMID: 33672727 DOI: 10.3390/molecules26041136] [Reference Citation Analysis]
121 Pei J, Wang X, Chen P, Zheng K, Hu X. Hb Levels and Sex Differences in Relation to Short-Term Outcomes in Patients With Acute Myocardial Infarction. Front Cardiovasc Med 2021;8:653351. [PMID: 34336941 DOI: 10.3389/fcvm.2021.653351] [Reference Citation Analysis]
122 Iqbal MB, Khamis R, Ilsley C, Mikhail G, Crake T, Firoozi S, Kalra S, Knight C, Archbold A, Lim P, Mathur A, Meier P, Rakhit RD, Redwood S, Whitbread M, Bromage D, Rathod K, Jones DA, Wragg A, Dalby M, MacCarthy P, Malik IS; London Heart Attack Centre Group Investigators. Time-trend analyses of bleeding and mortality after primary percutaneous coronary intervention during out of working hours versus in-working hours: an observational study of 11 466 patients. Circ Cardiovasc Interv 2015;8:e002206. [PMID: 26038482 DOI: 10.1161/CIRCINTERVENTIONS.114.002206] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
123 Moreira JI. Beta-blocker therapy after myocardial infarction or acute coronary syndrome: What we don't know. Rev Port Cardiol (Engl Ed) 2021;40:291-2. [PMID: 33637361 DOI: 10.1016/j.repc.2021.02.005] [Reference Citation Analysis]
124 Lindholm D, Storey RF, Christersson C, Halvorsen S, Grove EL, Braun OÖ, Varenhorst C, James SK. Design and rationale of TROCADERO: A TRial Of Caffeine to Alleviate DyspnEa Related to ticagrelOr. Am Heart J 2015;170:465-70. [PMID: 26385029 DOI: 10.1016/j.ahj.2015.06.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
125 Liu C, Chen G, Liu D, Nie S, Wang X, Huang X, Li H, Li Y, Luo S, Zhao G, Lin F, He H, Li J, Xing Y, Zhang Z, Wang J. Observational Study of the Association between TCM Zheng and Types of Coronary Artery Stenosis: Protocol of a Multicenter Case Series Study. Evid Based Complement Alternat Med 2018;2018:2564914. [PMID: 29967647 DOI: 10.1155/2018/2564914] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
126 Pizarro G, Fernández-friera L, Fuster V, Fernández-jiménez R, García-ruiz JM, García-álvarez A, Mateos A, Barreiro MV, Escalera N, Rodriguez MD, de Miguel A, García-lunar I, Parra-fuertes JJ, Sánchez-gonzález J, Pardillos L, Nieto B, Jiménez A, Abejón R, Bastante T, Martínez de Vega V, Cabrera JA, López-melgar B, Guzman G, García-prieto J, Mirelis JG, Zamorano JL, Albarrán A, Goicolea J, Escaned J, Pocock S, Iñiguez A, Fernández-ortiz A, Sánchez-brunete V, Macaya C, Ibanez B. Long-Term Benefit of Early Pre-Reperfusion Metoprolol Administration in Patients With Acute Myocardial Infarction. Journal of the American College of Cardiology 2014;63:2356-62. [DOI: 10.1016/j.jacc.2014.03.014] [Cited by in Crossref: 130] [Cited by in F6Publishing: 105] [Article Influence: 16.3] [Reference Citation Analysis]
127 Granger CB, Rao MP. Assessing oral beta-blocker therapy after percutaneous coronary intervention for ST-segment elevation myocardial infarction: the role of observational data. JACC Cardiovasc Interv 2014;7:602-3. [PMID: 24947718 DOI: 10.1016/j.jcin.2014.04.002] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
128 Ouweneel DM, Eriksen E, Sjauw KD, van Dongen IM, Hirsch A, Packer EJ, Vis MM, Wykrzykowska JJ, Koch KT, Baan J, de Winter RJ, Piek JJ, Lagrand WK, de Mol BA, Tijssen JG, Henriques JP. Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction. Journal of the American College of Cardiology 2017;69:278-87. [DOI: 10.1016/j.jacc.2016.10.022] [Cited by in Crossref: 348] [Cited by in F6Publishing: 265] [Article Influence: 69.6] [Reference Citation Analysis]
129 Shao C, Wang J, Li P, Yang J, Wang W, Wang Y, Zhao Y, Ni L, Tian J, Zhang K, Gao J, Tang YD, Yang Y. Evaluation of a risk index for predicting short-term and long-term outcomes in patients with ST-elevation myocardial infarction. Catheter Cardiovasc Interv 2020;95 Suppl 1:542-9. [PMID: 31922355 DOI: 10.1002/ccd.28706] [Reference Citation Analysis]
130 Brice AE, Hernandez GA, Sanchez M, Haynick M, Mendoza CE. In-stent thrombosis when switching ticagrelor to clopidogrel after percutaneous coronary intervention. Platelets 2017;28:305-9. [PMID: 27778525 DOI: 10.1080/09537104.2016.1235687] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
131 Fuernau G, Eitel I, Wöhrle J, Kerber S, Lauer B, Pauschinger M, Schwab J, Birkemeyer R, Pfeiffer S, Mende M, Brosteanu O, Neuhaus P, Desch S, de Waha S, Gutberlet M, Schuler G, Thiele H. Impact of Long-Term Statin Pretreatment on Myocardial Damage in ST Elevation Myocardial Infarction (from the AIDA STEMI CMR Substudy). The American Journal of Cardiology 2014;114:503-9. [DOI: 10.1016/j.amjcard.2014.05.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
132 Deharo P, Cuisset T. Monitoring platelet function: what have we learned from randomized clinical trials? Cardiovasc Diagn Ther 2018;8:621-9. [PMID: 30498686 DOI: 10.21037/cdt.2018.10.10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
133 Flam B, Albåge A. Large inferolateral left ventricular aneurysm. Ann Card Anaesth 2018;21:68-70. [PMID: 29336397 DOI: 10.4103/aca.ACA_89_17] [Reference Citation Analysis]
134 Jia Y, Gao Y, Li D, Cao Y, Cheng Y, Li F, Xiao L, Jiang Y, Wan Z, Zeng Z, Zeng R. Geriatric Nutritional Risk Index Score Predicts Clinical Outcome in Patients With Acute ST-Segment Elevation Myocardial Infarction. J Cardiovasc Nurs 2020;35:E44-52. [DOI: 10.1097/jcn.0000000000000674] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
135 Safi S, Sethi NJ, Nielsen EE, Feinberg J, Jakobsen JC, Gluud C. Beta-blockers for suspected or diagnosed acute myocardial infarction. Cochrane Database Syst Rev 2019;12:CD012484. [PMID: 31845756 DOI: 10.1002/14651858.CD012484.pub2] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
136 Soeda T, Okura H, Saito Y, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Hirata K, Tanabe K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Toubaru T, Saku K, Oshima S, Miyamoto Y, Ogawa H, Ishihara M; J-MINUET investigators. Clinical characteristics and in-hospital outcomes in patients aged 80 years or over with cardiac troponin-positive acute myocardial infarction -J-MINUET study. J Cardiol 2021;77:139-46. [PMID: 32938566 DOI: 10.1016/j.jjcc.2020.08.006] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
137 Grune J, Yamazoe M, Nahrendorf M. Electroimmunology and cardiac arrhythmia. Nat Rev Cardiol 2021;18:547-64. [PMID: 33654273 DOI: 10.1038/s41569-021-00520-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
138 Chatterjee S, Giri J. Intravenous fibrinolytics in STEMI: a 25-year perspective. Lancet 2017;390:718-20. [PMID: 28831981 DOI: 10.1016/S0140-6736(17)32214-6] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
139 Birnbaum Y, Birnbaum GD, Birnbaum I, Nylander S, Ye Y. Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine. Cardiovasc Drugs Ther 2016;30:539-50. [PMID: 27830382 DOI: 10.1007/s10557-016-6701-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 5.4] [Reference Citation Analysis]
140 Xuan H, Chen YM, Dai YL, Zhou J, Jiang YF, Zhou YF. Safety and Efficacy of Vitamin K Antagonists vs. Novel Oral Anticoagulants in Patients With Left Ventricular Thrombus: A Meta-Analysis. Front Cardiovasc Med 2021;8:636491. [PMID: 33996936 DOI: 10.3389/fcvm.2021.636491] [Reference Citation Analysis]
141 Liu YH, Liu Y, Tan N, Chen J, Chen J, Chen S, He Y, Ran P, Ye P, Li Y. Predictive value of GRACE risk scores for contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction before undergoing primary percutaneous coronary intervention. Int Urol Nephrol 2014;46:417-26. [DOI: 10.1007/s11255-013-0598-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
142 Kytö V, Sipilä J, Rautava P. Gender, age and risk of ST segment elevation myocardial infarction. Eur J Clin Invest 2014;44:902-9. [PMID: 25175007 DOI: 10.1111/eci.12321] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
143 Abram S, Arruda-Olson AM, Scott CG, Pellikka PA, Nkomo VT, Oh JK, Milan A, Abidian MM, McCully RB. Frequency, Predictors, and Implications of Abnormal Blood Pressure Responses During Dobutamine Stress Echocardiography. Circ Cardiovasc Imaging 2017;10:e005444. [PMID: 28351907 DOI: 10.1161/CIRCIMAGING.116.005444] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
144 De Luca L, Danchin N, Valgimigli M, Goldstein P. Effectiveness of Pretreatment With Dual Oral Antiplatelet Therapy. The American Journal of Cardiology 2015;116:660-8. [DOI: 10.1016/j.amjcard.2015.05.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
145 Scirica BM, Bergmark BA, Morrow DA, Antman EM, Bonaca MP, Murphy SA, Sabatine MS, Braunwald E, Wiviott SD. Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome. Journal of the American College of Cardiology 2020;75:1095-106. [DOI: 10.1016/j.jacc.2019.12.067] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
146 Weeks P, Sieg A, Vahdat K, Raissi F, Nathan S. Improved ticagrelor antiplatelet effect on discontinuation of phenytoin. Ann Pharmacother 2014;48:644-7. [PMID: 24477376 DOI: 10.1177/1060028013520140] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
147 Cho KH, Jeong MH, Park KW, Kim HS, Lee SR, Chae JK, Hong YJ, Kim JH, Ahn Y, Cho JG, Park JC; KAMIR (Korea Acute Myocardial Infarction Registry) Investigators. Comparison of the effects of two low-density lipoprotein cholesterol goals for secondary prevention after acute myocardial infarction in real-world practice: ≥ 50% reduction from baseline versus <70 mg/dL. Int J Cardiol 2015;187:478-85. [PMID: 25846658 DOI: 10.1016/j.ijcard.2015.03.386] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
148 Gao L, Cao Z, Zhang H. Efficacy and Safety of Thrombectomy Combined with Intracoronary Administration of Tirofiban in ST-segment Elevation Myocardial Infarction (STEMI). Med Sci Monit 2016;22:2699-705. [PMID: 27475844 DOI: 10.12659/msm.896703] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
149 Bliden KP, Tantry US, Chaudhary R, Byun S, Gurbel PA. Extended-release acetylsalicylic acid for secondary prevention of stroke and cardiovascular events. Expert Review of Cardiovascular Therapy 2016;14:779-91. [DOI: 10.1080/14779072.2016.1188005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
150 Feldman DN, Wang TY, Chen AY, Swaminathan RV, Kim LK, Wong SC, Minutello RM, Bergman G, Singh HS, Madias C. In-Hospital Bleeding Outcomes of Myocardial Infarction in the Era of Warfarin and Direct Oral Anticoagulants for Atrial Fibrillation in the United States: A Report From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry. J Am Heart Assoc. 2019;8:e011606. [PMID: 30955406 DOI: 10.1161/jaha.118.011606] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
151 Khan SU, Lone AN, Asad ZUA, Rahman H, Khan MS, Saleem MA, Arshad A, Nawaz N, Sattur S, Kaluski E. Meta-Analysis of Efficacy and Safety of Proton Pump Inhibitors with Dual Antiplatelet Therapy for Coronary Artery Disease. Cardiovasc Revasc Med 2019;20:1125-33. [PMID: 30773427 DOI: 10.1016/j.carrev.2019.02.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
152 Yang L, Wang H, Zhang Y, Han T, Wang W. The Prognostic Value of Lipoprotein-Associated Phospholipase A2 in the Long-Term Care of Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Clin Appl Thromb Hemost 2018;24:822-7. [PMID: 29121808 DOI: 10.1177/1076029617737837] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
153 Doll JA, Hellkamp A, Thomas L, Ho PM, Kontos MC, Whooley MA, Boyden TF, Peterson ED, Wang TY. Effectiveness of cardiac rehabilitation among older patients after acute myocardial infarction. American Heart Journal 2015;170:855-64. [DOI: 10.1016/j.ahj.2015.08.001] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 6.1] [Reference Citation Analysis]
154 Rihal CS, Naidu SS, Givertz MM, Szeto WY, Burke JA, Kapur NK, Kern M, Garratt KN, Goldstein JA, Dimas V, Tu T; Society for Cardiovascular Angiography and Interventions (SCAI)., Heart Failure Society of America (HFSA)., Society for Thoracic Surgeons (STS)., American Heart Association (AHA)., American College of Cardiology (ACC). 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care (Endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention). J Card Fail 2015;21:499-518. [PMID: 26036425 DOI: 10.1016/j.cardfail.2015.03.002] [Cited by in Crossref: 75] [Cited by in F6Publishing: 60] [Article Influence: 12.5] [Reference Citation Analysis]
155 Li PW, Yu DS. A modeling-based narrative intervention to promote timely care-seeking in patients with acute myocardial infarction: A pilot randomized controlled trial and feasibility analysis. Eur J Cardiovasc Nurs 2019;18:215-23. [PMID: 30371101 DOI: 10.1177/1474515118810126] [Reference Citation Analysis]
156 Fanaroff AC, Fudim M, Califf RM, Windecker S, Smith SC, Lopes RD. Levels of evidence supporting drug, device, and other recommendations in the American Heart Association/American College of Cardiology guidelines. American Heart Journal 2020;226:4-12. [DOI: 10.1016/j.ahj.2020.05.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
157 Pradhan A, Jain N, Cassese S, Vishwakarma P, Sethi R, Chandra S, Chaudhary G, Dwivedi SK, Narain VS. Incidence and predictors of 30-day mortality in patients with ventricular septal rupture complicating acute myocardial infarction. Heart Asia 2018;10:e011062. [PMID: 30166998 DOI: 10.1136/heartasia-2018-011062] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
158 Margolis G, Gal-Oz A, Khoury S, Keren G, Shacham Y. Relation of subclinical serum creatinine elevation to adverse in-hospital outcomes among myocardial infarction patients. Eur Heart J Acute Cardiovasc Care 2018;7:732-8. [PMID: 28617038 DOI: 10.1177/2048872617716389] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
159 Crawshaw J, Bartoli-Abdou JK, Weinman J, McRobbie D, Stebbins M, Brock T, Auyeung V. The transition from hospital to home following acute coronary syndrome: an exploratory qualitative study of patient perceptions and early experiences in two countries. Int J Pharm Pract 2021;29:61-9. [PMID: 33793821 DOI: 10.1093/ijpp/riaa009] [Reference Citation Analysis]
160 Mayfield JJ, Goldschlager N. Woman With Sharp Chest Discomfort. Ann Emerg Med 2019;74:777-81. [PMID: 31779953 DOI: 10.1016/j.annemergmed.2019.04.017] [Reference Citation Analysis]
161 Kutcher MA. Door-to-Balloon Time as a Process Metric for Treatment of ST-Segment Elevation Myocardial Infarction: Time to "Tap Out"? JACC Cardiovasc Interv 2015;8:1975-7. [PMID: 26738668 DOI: 10.1016/j.jcin.2015.10.007] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
162 Huang WP, Zheng X, He L, Su X, Liu CW, Wu MX. Role of Soluble ST2 Levels and Beta-Blockers Dosage on Cardiovascular Events of Patients with Unselected ST-Segment Elevation Myocardial Infarction. Chin Med J (Engl) 2018;131:1282-8. [PMID: 29786039 DOI: 10.4103/0366-6999.232819] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
163 Taglieri N, Bacchi Reggiani ML, Ghetti G, Saia F, Compagnone M, Lanati G, Di Dio MT, Bruno A, Bruno M, Della Riva D, Corsini A, Narducci R, Rapezzi C. Efficacy and safety of thrombus aspiration in ST-segment elevation myocardial infarction: an updated systematic review and meta-analysis of randomised clinical trials. Eur Heart J Acute Cardiovasc Care 2019;8:24-38. [PMID: 30160519 DOI: 10.1177/2048872618795512] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
164 Allon M. Evidence-based cardiology in hemodialysis patients. J Am Soc Nephrol 2013;24:1934-43. [PMID: 24136920 DOI: 10.1681/ASN.2013060632] [Cited by in Crossref: 32] [Cited by in F6Publishing: 7] [Article Influence: 3.6] [Reference Citation Analysis]
165 Cediel G, Rueda F, García C, Oliveras T, Labata C, Serra J, Núñez J, Bodí V, Ferrer M, Lupón J, Bayes-Genis A. Prognostic Value of New-Generation Troponins in ST-Segment-Elevation Myocardial Infarction in the Modern Era: The RUTI-STEMI Study. J Am Heart Assoc 2017;6:e007252. [PMID: 29275366 DOI: 10.1161/JAHA.117.007252] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
166 Neri M, Riezzo I, Pascale N, Pomara C, Turillazzi E. Ischemia/Reperfusion Injury following Acute Myocardial Infarction: A Critical Issue for Clinicians and Forensic Pathologists. Mediators Inflamm 2017;2017:7018393. [PMID: 28286377 DOI: 10.1155/2017/7018393] [Cited by in Crossref: 120] [Cited by in F6Publishing: 118] [Article Influence: 24.0] [Reference Citation Analysis]
167 Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, Blankstein R, Boyd J, Bullock-Palmer RP, Conejo T, Diercks DB, Gentile F, Greenwood JP, Hess EP, Hollenberg SM, Jaber WA, Jneid H, Joglar JA, Morrow DA, O'Connor RE, Ross MA, Shaw LJ; Writing Committee Members. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2021;78:e187-285. [PMID: 34756653 DOI: 10.1016/j.jacc.2021.07.053] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
168 Weeks PA, Sieg A, Paruthi C, Rajapreyar I. Antiplatelet Therapy Considerations in Ischemic Cardiogenic Shock: Implications of Metabolic Bioactivation. J Cardiovasc Pharmacol Ther 2015;20:370-7. [DOI: 10.1177/1074248415571456] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
169 Wang J, Yao Y, Zhang J, Tang X, Meng X, Wang M, Song L, Yuan J. Platelet microRNA-15b protects against high platelet reactivity in patients undergoing percutaneous coronary intervention through Bcl-2-mediated platelet apoptosis. Ann Transl Med 2020;8:364. [PMID: 32355808 DOI: 10.21037/atm.2020.02.88] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
170 Wang JJ, Fan Y, Zhu Y, Zhang JD, Zhang SM, Wan ZF, Su HL, Jiang N. Biomarkers enhance the long-term predictive ability of the KAMIR risk score in Chinese patients with ST-elevation myocardial infarction. Chin Med J (Engl) 2019;132:30-41. [PMID: 30628957 DOI: 10.1097/CM9.0000000000000015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
171 Srivastava AB, Ramsey AT, McIntosh LD, Bailey TC, Fisher SL, Fox L, Castro M, Ma Y, Baker TB, Chen LS, Bierut LJ. Tobacco Use Prevalence and Smoking Cessation Pharmacotherapy Prescription Patterns Among Hospitalized Patients by Medical Specialty. Nicotine Tob Res 2019;21:631-7. [PMID: 29481616 DOI: 10.1093/ntr/nty031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
172 Velders MA, Wallentin L, Becker RC, van Boven AJ, Himmelmann A, Husted S, Katus HA, Lindholm D, Morais J, Siegbahn A, Storey RF, Wernroth L, James SK. Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trial. American Heart Journal 2015;169:879-889.e7. [DOI: 10.1016/j.ahj.2015.02.019] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
173 Baran DA, Grines CL, Bailey S, Burkhoff D, Hall SA, Henry TD, Hollenberg SM, Kapur NK, O'Neill W, Ornato JP, Stelling K, Thiele H, van Diepen S, Naidu SS. SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovasc Interv 2019;94:29-37. [PMID: 31104355 DOI: 10.1002/ccd.28329] [Cited by in Crossref: 70] [Cited by in F6Publishing: 87] [Article Influence: 23.3] [Reference Citation Analysis]
174 Ginwalla M, Tofovic DS. Current Status of Inotropes in Heart Failure. Heart Fail Clin 2018;14:601-16. [PMID: 30266368 DOI: 10.1016/j.hfc.2018.06.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
175 Mckavanagh P, Zawadowski G, Cantor WJ. Utilization of PCI After Fibrinolysis. In: Watson TJ, Ong PJ, Tcheng JE, editors. Primary Angioplasty. Singapore: Springer; 2018. pp. 53-67. [DOI: 10.1007/978-981-13-1114-7_5] [Reference Citation Analysis]
176 Ahn MJ, Kim MC, Ahn Y, Sim DS, Hong YJ, Kim JH, Jeong MH, Cho JG, Park JC. Impact of Complete Revascularization on Six-Year Clinical Outcomes and Incidence of Acute Decompensated Heart Failure in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease. Am J Cardiol 2018;121:544-51. [PMID: 29325904 DOI: 10.1016/j.amjcard.2017.11.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
177 Yudi MB, Clark DJ, Farouque O, Eccleston D, Andrianopoulos N, Duffy SJ, Brennan A, Lefkovits J, Ramchand J, Yip T, Oqueli E, Reid CM, Ajani AE; Melbourne Interventional Group. Clopidogrel, prasugrel or ticagrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention. Intern Med J 2016;46:559-65. [PMID: 26909472 DOI: 10.1111/imj.13041] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
178 Kaji DA, Zech JR, Kim JS, Cho SK, Dangayach NS, Costa AB, Oermann EK. An attention based deep learning model of clinical events in the intensive care unit. PLoS One. 2019;14:e0211057. [PMID: 30759094 DOI: 10.1371/journal.pone.0211057] [Cited by in Crossref: 41] [Cited by in F6Publishing: 25] [Article Influence: 13.7] [Reference Citation Analysis]
179 Bannon L, Merdler I, Bar N, Lupu L, Banai S, Jacob G, Shacham Y. The Cardio-Hepatic Relation in STEMI. J Pers Med 2021;11:1241. [PMID: 34945713 DOI: 10.3390/jpm11121241] [Reference Citation Analysis]
180 Sanchis J, Avanzas P, Bayes-genis A, Pérez de Isla L, Heras M. Síndromes coronarios agudos: nuevas estrategias de diagnóstico y tratamiento. Revista Española de Cardiología 2014;67:138. [DOI: 10.1016/j.recesp.2013.09.013] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
181 Yoshihara HA, Bastiaansen JA, Berthonneche C, Comment A, Schwitter J. An intact small animal model of myocardial ischemia-reperfusion: Characterization of metabolic changes by hyperpolarized 13C MR spectroscopy. Am J Physiol Heart Circ Physiol 2015;309:H2058-66. [PMID: 26453328 DOI: 10.1152/ajpheart.00376.2015] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
182 Hammad TA, Parikh M, Tashtish N, Lowry CM, Gorbey D, Forouzandeh F, Filby SJ, Wolf WM, Costa MA, Simon DI, Shishehbor MH. Impact of COVID-19 pandemic on ST-elevation myocardial infarction in a non-COVID-19 epicenter. Catheter Cardiovasc Interv 2021;97:208-14. [PMID: 32478961 DOI: 10.1002/ccd.28997] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 15.0] [Reference Citation Analysis]
183 De Marzo V, D'amario D, Galli M, Vergallo R, Porto I. High-risk percutaneous coronary intervention: how to define it today? Minerva Cardioangiol 2018;66. [DOI: 10.23736/s0026-4725.18.04679-0] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
184 Loh JP, Poh KK. Changes in the practice of cardiology: therapies at the forefront of science. Singapore Med J 2016;57:344-6. [PMID: 27440236 DOI: 10.11622/smedj.2016115] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
185 Jang JS, Spertus JA, Arnold SV, Shafiq A, Grodzinsky A, Fendler TJ, Salisbury AC, Tang F, McNulty EJ, Grantham JA, Cohen DJ, Amin AP. Impact of multivessel revascularization on health status outcomes in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease. J Am Coll Cardiol 2015;66:2104-13. [PMID: 26541921 DOI: 10.1016/j.jacc.2015.08.873] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
186 Pickworth KK, Blais D; Cardiology Pharmacy Collaborative. COVID-19 Pandemic: Challenges and Solutions from the Cardiology Pharmacist's Perspective. J Am Coll Clin Pharm 2020. [PMID: 32838223 DOI: 10.1002/jac5.1307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
187 Marquis-Gravel G, Thiele H, Jones WS, Smalling RW, Cohen M, Perera D, Pijls N, Fanaroff A, Brucker A, Chiswell K, Patel MR, Ohman EM. Size of Anterior Wall Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention in United States Versus Europe/Australia Versus India (from the CRISP-AMI Randomized Controlled Trial). Am J Cardiol 2019;123:1026-34. [PMID: 30642606 DOI: 10.1016/j.amjcard.2018.12.027] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
188 Bazemore TC, Nanna MG, Rao SV. Benefits and risks of P2Y12 inhibitor preloading in patients with acute coronary syndrome and stable angina. J Thromb Thrombolysis 2017;44:303-15. [DOI: 10.1007/s11239-017-1529-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
189 Patel MR, Calhoon JH, Dehmer GJ, Grantham JA, Maddox TM, Maron DJ, Smith PK. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes. Journal of the American College of Cardiology 2017;69:570-91. [DOI: 10.1016/j.jacc.2016.10.034] [Cited by in Crossref: 103] [Cited by in F6Publishing: 75] [Article Influence: 20.6] [Reference Citation Analysis]
190 Doshi R, Vadher A, Mithawala P, Shah P. Oral antiplatelets in primary and secondary prevention of myocardial infarction: a review. Ir J Med Sci 2019;188:453-67. [PMID: 30178075 DOI: 10.1007/s11845-018-1897-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
191 Kusumoto FM, Schoenfeld MH, Barrett C, Edgerton JR, Ellenbogen KA, Gold MR, Goldschlager NF, Hamilton RM, Joglar JA, Kim RJ, Lee R, Marine JE, Mcleod CJ, Oken KR, Patton KK, Pellegrini CN, Selzman KA, Thompson A, Varosy PD. 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay. Heart Rhythm 2019;16:e128-226. [DOI: 10.1016/j.hrthm.2018.10.037] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 7.3] [Reference Citation Analysis]
192 Wang F, Gulati R, Lennon RJ, Lewis BR, Park J, Sandhu GS, Wright RS, Lerman A, Herrmann J. Cancer History Portends Worse Acute and Long-term Noncardiac (but Not Cardiac) Mortality After Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction. Mayo Clinic Proceedings 2016;91:1680-92. [DOI: 10.1016/j.mayocp.2016.06.029] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 6.3] [Reference Citation Analysis]
193 Montero-Pérez FJ, Quero-Espinosa FB, Clemente-Millán MJ, Castro-Giménez JA, de Burgos-Marín J, Romero-Moreno MÁ. Diagnostic validity of hand gestures in chest pain of coronary origin. Rev Clin Esp (Barc) 2017;217:252-9. [PMID: 28410822 DOI: 10.1016/j.rce.2017.02.019] [Cited by in Crossref: 7] [Article Influence: 1.4] [Reference Citation Analysis]
194 Liu C, Liu M, Chen D, Liu H, Jiang Q, Lu J, Zuo L. Effectiveness of prolonged clopidogrel-based dual antiplatelet therapy after drug-eluting stent implantation: Evidence-based meta-analysis. Herz 2015;40:795-802. [PMID: 25911050 DOI: 10.1007/s00059-015-4304-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
195 Orenes-Piñero E, Ruiz-Nodar JM, Esteve-Pastor MA, Quintana-Giner M, Rivera-Caravaca JM, Veliz A, Valdés M, Macías M, Pernias-Escrig V, Vicente-Ibarra N, Carrillo L, Sandín-Rollán M, Candela E, Lozano T, Marín F. Therapeutic management and one-year outcomes in elderly patients with acute coronary syndrome. Oncotarget 2017;8:80182-91. [PMID: 29113294 DOI: 10.18632/oncotarget.21260] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
196 Liu Y, Li CP, Lu PJ, Wang XY, Xiao JY, Gao MD, Wang JX, Li XW, Zhang N, Li CJ, Ma J, Gao J. Percutaneous coronary intervention assisted by invasive mechanical ventilation and intra-aortic balloon pump for acute myocardial infarction with cardiogenic shock: Retrospective cohort study and meta-analyses. Bosn J Basic Med Sci 2020;20:514-23. [PMID: 31782697 DOI: 10.17305/bjbms.2019.4500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
197 Ialongo C, Bernardini S. Timeliness “at a glance”: assessing the turnaround time through the six sigma metrics. Biochem Med (Zagreb) 2016;26:98-102. [PMID: 27019886 DOI: 10.11613/bm.2016.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
198 Davis A, Chiu J, Lau SK, Kok YJ, Wu JYH. Efficacy of Implementation of a Chest Pain Center at a Community Hospital. Crit Pathw Cardiol 2017;16:135-41. [PMID: 29135621 DOI: 10.1097/HPC.0000000000000133] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
199 Mateos A, García-Lunar I, García-Ruiz JM, Pizarro G, Fernández-Jiménez R, Huertas P, García-Álvarez A, Fernández-Friera L, Bravo J, Flores-Arias J, Barreiro MV, Chayán-Zas L, Corral E, Fuster V, Sánchez-Brunete V, Ibáñez B; METOCARD-CNIC Investigators. Efficacy and safety of out-of-hospital intravenous metoprolol administration in anterior ST-segment elevation acute myocardial infarction: insights from the METOCARD-CNIC trial. Ann Emerg Med 2015;65:318-24. [PMID: 25129820 DOI: 10.1016/j.annemergmed.2014.07.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
200 Kim YH, Her AY, Jeong MH, Kim BK, Hong SJ, Kim S, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y. Impacts of renin-angiotensin system inhibitors on two-year clinical outcomes in diabetic and dyslipidemic acute myocardial infarction patients after a successful percutaneous coronary intervention using newer-generation drug-eluting stents. Medicine (Baltimore) 2020;99:e21289. [PMID: 32791710 DOI: 10.1097/MD.0000000000021289] [Reference Citation Analysis]
201 Jneid H, Addison D, Bhatt DL, Fonarow GC, Gokak S, Grady KL, Green LA, Heidenreich PA, Ho PM, Jurgens CY, King ML, Kumbhani DJ, Pancholy S. 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol. 2017;70:2048-2090. [PMID: 28943066 DOI: 10.1016/j.jacc.2017.06.032] [Cited by in Crossref: 81] [Cited by in F6Publishing: 75] [Article Influence: 16.2] [Reference Citation Analysis]
202 Goins AE, Rayson R, Caughey MC, Sola M, Venkatesh K, Dai X, Yeung M, Stouffer GA. Correlation of infarct size with invasive hemodynamics in patients with ST-elevation myocardial infarction. Catheter Cardiovasc Interv 2018;92:E333-40. [PMID: 29577589 DOI: 10.1002/ccd.27625] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
203 Szarpak L, Michalski TA, Smereka J, Gasecka A, Pruc M, Jaguszewski MJ. Efficacy and safety of ticagrelor use in pre-hospital setting. Am J Emerg Med 2021:S0735-6757(21)00317-X. [PMID: 33966923 DOI: 10.1016/j.ajem.2021.04.031] [Reference Citation Analysis]
204 Yallapragada S, Siddiqui S, Gindi R, Shroff A. Adherence to dual antiplatelet therapy: can we do better? Expert Rev Cardiovasc Ther 2013;11:1417-24. [PMID: 24138527 DOI: 10.1586/14779072.2013.839268] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
205 Nakahashi H, Kosuge M, Sakamaki K, Kiyokuni M, Ebina T, Hibi K, Tsukahara K, Iwahashi N, Kuji S, Oba MS, Umemura S, Kimura K. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention. Heart Vessels 2017;32:22-9. [PMID: 27106917 DOI: 10.1007/s00380-016-0836-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
206 Heydari B, Abdullah S, Pottala JV, Shah R, Abbasi S, Mandry D, Francis SA, Lumish H, Ghoshhajra BB, Hoffmann U, Appelbaum E, Feng JH, Blankstein R, Steigner M, McConnell JP, Harris W, Antman EM, Jerosch-Herold M, Kwong RY. Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial. Circulation 2016;134:378-91. [PMID: 27482002 DOI: 10.1161/CIRCULATIONAHA.115.019949] [Cited by in Crossref: 105] [Cited by in F6Publishing: 53] [Article Influence: 17.5] [Reference Citation Analysis]
207 Fernández-jiménez R, Ibanez B. CAESAR: One Step Beyond in the Construction of a Translational Bridge for Cardioprotection. Circ Res 2015;116:554-6. [DOI: 10.1161/circresaha.115.305841] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
208 Abdel-Qadir H, Roifman I, Wijeysundera HC. Cost-effectiveness of clopidogrel, prasugrel and ticagrelor for dual antiplatelet therapy after acute coronary syndrome: a decision-analytic model. CMAJ Open 2015;3:E438-46. [PMID: 26770967 DOI: 10.9778/cmajo.20150056] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
209 Gupta T, Weinreich M, Kolte D, Khera S, Villablanca PA, Bortnick AE, Wiley JM, Menegus MA, Kirtane AJ, Bhatt DL, Garcia MJ, Latib A, Weisz G. Comparison of Incidence and Outcomes of Cardiogenic Shock Complicating Posterior (Inferior) Versus Anterior ST-Elevation Myocardial Infarction. Am J Cardiol 2020;125:1013-9. [PMID: 31955831 DOI: 10.1016/j.amjcard.2019.12.052] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
210 Vora AN, Peterson ED, McCoy LA, Effron MB, Anstrom KJ, Faries DE, Zettler ME, Fonarow GC, Baker BA, Stone GW, Wang TY. Factors Associated With Initial Prasugrel Versus Clopidogrel Selection for Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From the Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study. J Am Heart Assoc 2016;5:e003946. [PMID: 27663414 DOI: 10.1161/JAHA.116.003946] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
211 Hartopo AB, Sukmasari I, Puspitawati I. The Utility of Point of Care Test for Soluble ST2 in Predicting Adverse Cardiac Events during Acute Care of ST-Segment Elevation Myocardial Infarction. Cardiol Res Pract 2018;2018:3048941. [PMID: 30046467 DOI: 10.1155/2018/3048941] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
212 Strauss BH, Shuvy M. Stent thrombosis following drug-eluting stents in STEMI: "Much ado about nothing?". J Am Coll Cardiol 2014;64:25-7. [PMID: 24998124 DOI: 10.1016/j.jacc.2014.04.026] [Reference Citation Analysis]
213 Schulman-marcus J, Goyal P, Swaminathan RV, Feldman DN, Wong S, Singh HS, Minutello RM, Bergman G, Kim LK. Comparison of Trends in Incidence, Revascularization, and In-Hospital Mortality in ST-Elevation Myocardial Infarction in Patients With Versus Without Severe Mental Illness. The American Journal of Cardiology 2016;117:1405-10. [DOI: 10.1016/j.amjcard.2016.02.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
214 Diao K, Wang D, Chen Z, Wu X, Ma M, Zhu Y, Zhang L, Wang H, Wang M, He S, Li C, Deng Q, Yan T, Wu T, Tang L, Huang B, Sun J, He Y. Rationale and design of a multi-center, prospective randomized controlled trial on the effects of sacubitril-valsartan versus enalapril on left ventricular remodeling in ST-elevation myocardial infarction: The PERI-STEMI study. Clin Cardiol 2021. [PMID: 34668596 DOI: 10.1002/clc.23744] [Reference Citation Analysis]
215 Wilkinson SE, Berkompas DC, Fanning JS, Park HS. Supporting High-Risk Percutaneous Coronary Interventions With Mechanical Devices. JACC Case Rep 2020;2:702-4. [PMID: 34317328 DOI: 10.1016/j.jaccas.2020.01.033] [Reference Citation Analysis]
216 Montalescot G, Angiolillo DJ. Anticoagulation, the Unknown of the Antithrombotic Equation After Stenting of an Acute Coronary Syndrome. Journal of the American College of Cardiology 2019;73:775-8. [DOI: 10.1016/j.jacc.2018.12.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
217 Ranjbar A, Sohrabi B, Sadat-Ebrahimi SR, Ghaffari S, Kazemi B, Aslanabadi N, Seyvani B, Hajizadeh R. The association between T wave inversion in leads with ST-elevation and patency of the infarct-related artery. BMC Cardiovasc Disord 2021;21:27. [PMID: 33435890 DOI: 10.1186/s12872-021-01851-8] [Reference Citation Analysis]
218 Ahmed I, Pancholy SB. Operator's procedure volume and not years of experience, determine needle to balloon time in primary percutaneous coronary intervention: Predictors of Needle to Balloon Time. Cathet Cardiovasc Intervent 2014;84:943-7. [DOI: 10.1002/ccd.25428] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
219 Malebranche D, Hasan S, Fung M, Har B, Champagne P, Schnell G, Wilton SB, Anderson TJ. Patterns of Left-Ventricular Function Assessment in Patients With Acute Coronary Syndromes. CJC Open 2021;3:733-40. [PMID: 34169252 DOI: 10.1016/j.cjco.2020.12.028] [Reference Citation Analysis]
220 Baysal E, Çetin M, Yaylak B, Altntaş B, Altndağ R, Adyaman Ş, Altaş Y, Kaya İ, Sevuk U. Roles of the red cell distribution width and neutrophil/lymphocyte ratio in predicting thrombolysis failure in patients with an ST-segment elevation myocardial infarction. Blood Coagulation & Fibrinolysis 2015;26:274-8. [DOI: 10.1097/mbc.0000000000000227] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
221 Sharma T, Bliden K, Chaudhary R, Tantry U, Gurbel PA. Efficacy of aspirin (325 mg) + omeprazole (40 mg) in treating coronary artery disease. Expert Opinion on Pharmacotherapy 2017;18:123-31. [DOI: 10.1080/14656566.2016.1269747] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
222 Engberding N, Wenger NK. Acute Coronary Syndromes in the Elderly. F1000Res 2017;6:1791. [PMID: 29043079 DOI: 10.12688/f1000research.11064.1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
223 Coons JC, Miller T. Strategies to Reduce Bleeding Risk in Acute Coronary Syndromes and Percutaneous Coronary Intervention: New and Emerging Pharmacotherapeutic Considerations. Pharmacotherapy 2014;34:973-90. [DOI: 10.1002/phar.1447] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
224 Fuernau G, Thiele H. Intra-Aortic Balloon Pump (IABP) in cardiogenic shock: . Current Opinion in Critical Care 2013;19:404-9. [DOI: 10.1097/mcc.0b013e328364d78d] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
225 Wang Y, Wang W, Peng W, Liu W, Cai W, Xia Z, Zhang H, Xing AZ. CARDIOPROTECTIVE ROLES OF THE CHINESE MEDICINAL FORMULA BAO-XIN-TANG ON ACUTE MYOCARDIAL INFARCTION IN RATS. Afr J Tradit Complement Altern Med 2017;14:65-74. [PMID: 28573223 DOI: 10.21010/ajtcam.v14i2.8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
226 Rybicki FJ, Udelson JE, Peacock WF, Goldhaber SZ, Isselbacher EM, Kazerooni E, Kontos MC, Litt H, Woodard PK. 2015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS Appropriate Utilization of Cardiovascular Imaging in Emergency Department Patients With Chest Pain: A Joint Document of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Appropriate Use Criteria Task Force. J Am Coll Cardiol 2016;67:853-79. [PMID: 26809772 DOI: 10.1016/j.jacc.2015.09.011] [Cited by in Crossref: 72] [Cited by in F6Publishing: 41] [Article Influence: 12.0] [Reference Citation Analysis]
227 Lee JM, Kim HK, Lim KS, Park JK, Choi KH, Park J, Hwang D, Rhee TM, Yang JH, Shin ES, Nam CW, Doh JH, Hahn JY, Koo BK, Jeong MH. Influence of Local Myocardial Damage on Index of Microcirculatory Resistance and Fractional Flow Reserve in Target and Nontarget Vascular Territories in a Porcine Microvascular Injury Model. JACC Cardiovasc Interv 2018;11:717-24. [PMID: 29605246 DOI: 10.1016/j.jcin.2017.11.028] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
228 Dilsizian V, Gewirtz H, Paivanas N, Kitsiou AN, Hage FG, Crone NE, Schwartz RG. Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies. J Nucl Cardiol 2015;22:1198-213. [DOI: 10.1007/s12350-015-0141-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 4.1] [Reference Citation Analysis]
229 Rech MA, Day SA, Kast JM, Donahey EE, Pajoumand M, Kram SJ, Erdman MJ, Peitz GJ, Allen JM, Palmer A, Kram B, Harris SA, Turck CJ; Critical Care Pharmacotherapy Literature Update Group. Major publications in the critical care pharmacotherapy literature: January-December 2013. Am J Health Syst Pharm 2015;72:224-36. [PMID: 25596607 DOI: 10.2146/ajhp140241] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
230 Shah R, Matin K, Rogers KC, Rao SV. Effect of post-primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta-analysis of randomized controlled trials: Bivalirudin versus Unfractionated Heparin use in PCI. Cathet Cardiovasc Intervent 2017;90:196-204. [DOI: 10.1002/ccd.26859] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
231 Brewster LM. Creatine kinase, energy reserve, and hypertension: from bench to bedside. Ann Transl Med 2018;6:292. [PMID: 30211180 DOI: 10.21037/atm.2018.07.15] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
232 Al-Shaar L, Li Y, Rimm EB, Manson JE, Rosner B, Hu FB, Stampfer MJ, Willett WC. Physical Activity and Mortality among Male Survivors of Myocardial Infarction. Med Sci Sports Exerc 2020;52:1729-36. [PMID: 32079915 DOI: 10.1249/MSS.0000000000002309] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
233 Shacham Y, Leshem-rubinow E, Gal-oz A, Topilsky Y, Steinvil A, Keren G, Roth A, Arbel Y. Association of Left Ventricular Function and Acute Kidney Injury Among ST-Elevation Myocardial Infarction Patients Treated by Primary Percutaneous Intervention. The American Journal of Cardiology 2015;115:293-7. [DOI: 10.1016/j.amjcard.2014.11.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
234 Shacham Y, Leshem-Rubinow E, Gal-Oz A, Ben-Assa E, Steinvil A, Keren G, Roth A, Arbel Y. Relation of in-hospital serum creatinine change patterns and outcomes among ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. Clin Cardiol 2015;38:274-9. [PMID: 25639761 DOI: 10.1002/clc.22384] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
235 Capodanno D, Angiolillo DJ. Pretreatment With Antiplatelet Drugs in Invasively Managed Patients With Coronary Artery Disease in the Contemporary Era: Review of the Evidence and Practice Guidelines. Circ: Cardiovascular Interventions 2015;8. [DOI: 10.1161/circinterventions.114.002301] [Cited by in Crossref: 48] [Cited by in F6Publishing: 15] [Article Influence: 6.9] [Reference Citation Analysis]
236 Lattuca B, Bouziri N, Kerneis M, Portal JJ, Zhou J, Hauguel-Moreau M, Mameri A, Zeitouni M, Guedeney P, Hammoudi N, Isnard R, Pousset F, Collet JP, Vicaut E, Montalescot G, Silvain J; ACTION Study Group. Antithrombotic Therapy for Patients With Left Ventricular Mural Thrombus. J Am Coll Cardiol 2020;75:1676-85. [PMID: 32273033 DOI: 10.1016/j.jacc.2020.01.057] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 18.5] [Reference Citation Analysis]
237 Yiadom MYAB, Mumma BE, Baugh CW, Patterson BW, Mills AM, Salazar G, Tanski M, Jenkins CA, Vogus TJ, Miller KF, Jackson BE, Lehmann CU, Dorner SC, West JL, Wang TJ, Collins SP, Dittus RS, Bernard GR, Storrow AB, Liu D. Measuring outcome differences associated with STEMI screening and diagnostic performance: a multicentred retrospective cohort study protocol. BMJ Open 2018;8:e022453. [PMID: 29724744 DOI: 10.1136/bmjopen-2018-022453] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
238 Valle JA, Ho PM. Excluding the Elephant in the Room: Cardiac Arrest. J Am Heart Assoc 2019;8:e011381. [PMID: 30595066 DOI: 10.1161/JAHA.118.011381] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
239 Sharma A, Sun J, Lokhnygina Y, Roe MT, Ahmad T, Desai NR, Blazing MA. Patient Phenotypes, Cardiovascular Risk, and Ezetimibe Treatment in Patients After Acute Coronary Syndromes (from IMPROVE-IT). The American Journal of Cardiology 2019;123:1193-201. [DOI: 10.1016/j.amjcard.2019.01.034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
240 Itzahki Ben Zadok O, Ben-Gal T, Abelow A, Shechter A, Zusman O, Iakobishvili Z, Cohen T, Shlomo N, Kornowski R, Eisen A. Temporal Trends in the Characteristics, Management and Outcomes of Patients With Acute Coronary Syndrome According to Their Killip Class. Am J Cardiol 2019;124:1862-8. [PMID: 31685211 DOI: 10.1016/j.amjcard.2019.09.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
241 Rosell-ortiz F, Mellado-vergel FJ, Fernández-valle P, González-lobato I, Martínez-lara M, Ruiz-montero MM, Romero-morales F, Vivar Díaz I, García-alcántara Á, García del Águila J. Initial complications and factors related to prehospital mortality in acute myocardial infarction with ST segment elevation. Emerg Med J 2015;32:559-63. [DOI: 10.1136/emermed-2014-203780] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
242 Nicolau JC, Franci A, Barbosa CJD, Baracioli LM, Franken M, Furtado RH, Giraldez RR, Ganem F, Lima FG, Menezes FR, Arantes FB, Ramires JA, Filho RK, Giugliano RP. Influence of proven oral therapies in the very old with acute coronary syndromes: A 15year experience. International Journal of Cardiology 2015;198:213-5. [DOI: 10.1016/j.ijcard.2015.06.119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
243 Kim LK, Looser P, Swaminathan RV, Horowitz J, Friedman O, Shin JH, Minutello RM, Bergman G, Singh H, Wong SC, Feldman DN. Sex-Based Disparities in Incidence, Treatment, and Outcomes of Cardiac Arrest in the United States, 2003-2012. J Am Heart Assoc 2016;5:e003704. [PMID: 27333880 DOI: 10.1161/JAHA.116.003704] [Cited by in Crossref: 41] [Cited by in F6Publishing: 14] [Article Influence: 6.8] [Reference Citation Analysis]
244 Kahlon TS, Barn K, Akram MMA, Blankenship JC, Bower-stout C, Carey DJ, Sun H, Tompkins Weber K, Skelding KA, Scott TD, Green SM, Berger PB. Impact of pre-hospital electrocardiograms on time to treatment and one year outcome in a rural regional ST-segment elevation myocardial infarction network: Impact of Pre-Hospital Electrocardiograms. Cathet Cardiovasc Intervent 2017;89:245-51. [DOI: 10.1002/ccd.26567] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
245 Cooper HA, Panza JA. Cardiogenic Shock. Cardiology Clinics 2013;31:567-80. [DOI: 10.1016/j.ccl.2013.07.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
246 Nakano M, Yahagi K, Otsuka F, Sakakura K, Finn AV, Kutys R, Ladich E, Fowler DR, Joner M, Virmani R. Causes of Early Stent Thrombosis in Patients Presenting With Acute Coronary Syndrome. Journal of the American College of Cardiology 2014;63:2510-20. [DOI: 10.1016/j.jacc.2014.02.607] [Cited by in Crossref: 78] [Cited by in F6Publishing: 57] [Article Influence: 9.8] [Reference Citation Analysis]
247 Ruiz Pizarro V, Palacios-Rubio J, Cruz-Utrilla A, García-Arribas D, Pérez-Vizcayno MJ, Fernández-Ortiz A, Núñez-Gil IJ. ST-Elevation Myocardial Infarction in Patients ≤35 Years of Age. Am J Cardiol 2019;123:889-93. [PMID: 30600083 DOI: 10.1016/j.amjcard.2018.12.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
248 Wang XB, Han YD, Sabina S, Cui NH, Zhang S, Liu ZJ, Li C, Zheng F. HDAC9 Variant Rs2107595 Modifies Susceptibility to Coronary Artery Disease and the Severity of Coronary Atherosclerosis in a Chinese Han Population. PLoS One 2016;11:e0160449. [PMID: 27494404 DOI: 10.1371/journal.pone.0160449] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
249 Lee SN, Hwang YM, Kim GH, Kim JH, Yoo KD, Kim CM, Moon KW. Primary percutaneous coronary intervention ameliorates complete atrioventricular block complicating acute inferior myocardial infarction. Clin Interv Aging 2014;9:2027-31. [PMID: 25473274 DOI: 10.2147/CIA.S74088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
250 Lux A, Vainer J, Theunissen RALJ, Veenstra LF, Kasperski I, Gho BCG, Stein M, Ilhan M, Ruiters AW, Winkler PJC, van Beurden A, Dohmen W, Rasoul S, van 't Hof AWJ; South Limburg Interventional Cardiology Group, the Netherlands. Sharing primary percutaneous coronary intervention care: first experiences with South Limburg ST-elevation myocardial infarction network. Neth Heart J 2021;29:348-53. [PMID: 33534114 DOI: 10.1007/s12471-021-01541-2] [Reference Citation Analysis]
251 Cheng YT, Liu TJ, Lai HC, Lee WL, Ho HY, Su CS, Liu CN, Wang KY. Lower serum triglyceride level is a risk factor for in-hospital and late major adverse events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention- a cohort study. BMC Cardiovasc Disord 2014;14:143. [PMID: 25303974 DOI: 10.1186/1471-2261-14-143] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
252 Fahrni G, Wolfrum M, De Maria GL, Banning AP, Benedetto U, Kharbanda RK. Prolonged High-Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary Percutaneous Coronary Intervention: Novel Insights From an Updated Meta-Analysis. J Am Heart Assoc 2016;5:e003515. [PMID: 27451466 DOI: 10.1161/JAHA.116.003515] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
253 Vasanthan V, Fatehi Hassanabad A, Pattar S, Niklewski P, Wagner K, Fedak PWM. Promoting Cardiac Regeneration and Repair Using Acellular Biomaterials. Front Bioeng Biotechnol 2020;8:291. [PMID: 32363184 DOI: 10.3389/fbioe.2020.00291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
254 Munkhaugen J, Ruddox V, Halvorsen S, Dammen T, Fagerland MW, Hernæs KH, Vethe NT, Prescott E, Jensen SE, Rødevand O, Jortveit J, Bendz B, Schirmer H, Køber L, Bøtker HE, Larsen AI, Vikenes K, Steigen T, Wiseth R, Pedersen T, Edvardsen T, Otterstad JE, Atar D. BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study. American Heart Journal 2019;208:37-46. [DOI: 10.1016/j.ahj.2018.10.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
255 Udell JA, Braunwald E, Antman EM, Murphy SA, Montalescot G, Wiviott SD. Prasugrel Versus Clopidogrel in Patients With ST-Segment Elevation Myocardial Infarction According to Timing of Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions 2014;7:604-12. [DOI: 10.1016/j.jcin.2014.01.160] [Cited by in Crossref: 34] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
256 Montone RA, Niccoli G, Fracassi F, Russo M, Gurgoglione F, Cammà G, Lanza GA, Crea F. Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests. Eur Heart J 2018;39:91-8. [PMID: 29228159 DOI: 10.1093/eurheartj/ehx667] [Cited by in Crossref: 22] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
257 Baker WE, Solano JJ. Quality Assurance in the Emergency Department. Emerg Med Clin North Am 2020;38:663-80. [PMID: 32616286 DOI: 10.1016/j.emc.2020.05.002] [Reference Citation Analysis]
258 Silveira-Filho LM, Coyan GN, Adamo A, Luketich SK, Menallo G, D'Amore A, Wagner WR. Can a Biohybrid Patch Salvage Ventricular Function at a Late Time Point in the Post-Infarction Remodeling Process? JACC Basic Transl Sci 2021;6:447-63. [PMID: 34095634 DOI: 10.1016/j.jacbts.2021.01.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
259 Madder RD, Reynolds JC. Multidisciplinary Management of the Post–Cardiac Arrest Patient. Cardiology Clinics 2018;36:85-101. [DOI: 10.1016/j.ccl.2017.08.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
260 Gómez-huelgas R, Martínez-sellés M, Formiga F, Alemán Sánchez JJ, Camafort M, Galve E, Gil P, Lobos JM. Tratamiento de los factores de riesgo vascular en el paciente mayor de 80 años. Medicina Clínica 2014;143:134.e1-134.e11. [DOI: 10.1016/j.medcli.2014.04.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
261 Doll JA, Ohman EM, Patel MR, Milano CA, Rogers JG, Wohns DH, Kapur NK, Rao SV. A team-based approach to patients in cardiogenic shock: Team-Based Cardiogenic Shock Management. Cathet Cardiovasc Intervent 2016;88:424-33. [DOI: 10.1002/ccd.26297] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 6.3] [Reference Citation Analysis]
262 White HD, Stewart RAH, Dalby AJ, Stebbins A, Cannon CP, Budaj A, Linhart A, Pais P, Diaz R, Steg PG, Krug-Gourley S, Granger CB, Hochman JS, Koenig W, Harrington RA, Held C, Wallentin L; STABILITY Investigators. In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events. Am Heart J 2020;225:97-107. [PMID: 32480059 DOI: 10.1016/j.ahj.2020.04.004] [Reference Citation Analysis]
263 Kumar R, Batra MK, Khowaja S, Ammar A, Kumar A, Shah JA, Sial JA, Saghir T, Karim M. CHA2DS2-VASc, a Simple Clinical Score Expanding Its Boundaries to Predict Contrast-Induced Acute Kidney Injury After Primary Percutaneous Coronary Interventions. Int J Nephrol Renovasc Dis 2021;14:495-504. [PMID: 35002286 DOI: 10.2147/IJNRD.S347303] [Reference Citation Analysis]
264 Ramakrishnan S, Jabir A, Jayagopal PB, Mohanan PP, Nair VK, Das MK, Mandal M, Roy D, Reddy SS, Malviya A, Singh BP, Bharti BB, Majumder B, Karunadas CP, Meena CB, Girish MP, Ezhilan J, Tummala K, Katyal VK, Subramanyam K, Goyal KK, Kenchappa K, Gupta MD, Hanumanthappa NB, Bardoloi N, Modi N, Bhattacharyya PJ, Gadkari P, Patil RR, Murty RS, Baruah R, Krishnappa S, Kumar S, Routray S, Tewari S, Gupta SB, Maduramuthu S, Yerram S, Kumar S, Jadhav U, Manjunath CN, Prabhakaran D, Kerker P, Yadav R, Guha S, Deb PK, Zachariah G. Pattern of acute MI admissions in India during COVID-19 era: A Cardiological Society of India study - Rationale and design. Indian Heart J 2020;72:541-6. [PMID: 33357642 DOI: 10.1016/j.ihj.2020.09.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
265 Chao CJ, Shanbhag A, Chiang CC, Girardo ME, Seri AR, Khalid MU, Rayfield C, O'Shea MP, Fatunde O, Fortuin FD. Baseline thrombocytopenia in acute coronary syndrome: The lower, the worse. Int J Cardiol 2021;332:1-7. [PMID: 33785391 DOI: 10.1016/j.ijcard.2021.03.059] [Reference Citation Analysis]
266 Marschke CR, Olaf MF, Makowski DJ. ST elevation in massive pulmonary embolism: thrombolysis vs percutaneous catheter intervention. Am J Emerg Med 2016;34:2466.e3-4. [PMID: 27334839 DOI: 10.1016/j.ajem.2016.06.036] [Reference Citation Analysis]
267 Ghantous AE, Ferneini EM. Aspirin, Plavix, and Other Antiplatelet Medications: What the Oral and Maxillofacial Surgeon Needs to Know. Oral Maxillofac Surg Clin North Am. 2016;28:497-506. [PMID: 27595478 DOI: 10.1016/j.coms.2016.06.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
268 Plazak ME, Mouradjian MT, Watson K, Reed BN, Noel ZR, Devabhakthuni S, Gale SE. An aspirin a day? Clinical utility of aspirin therapy for the primary prevention of cardiovascular disease. Expert Rev Cardiovasc Ther 2019;17:561-73. [PMID: 31305180 DOI: 10.1080/14779072.2019.1642108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
269 Russo JJ, Goodman SG, Cantor WJ, Ko DT, Bagai A, Tan MK, Di Mario C, Halvorsen S, Le May M, Fernandez-Avilés F, Scheller B, Armstrong PW, Borgia F, Piscione F, Sanchez PL, Yan AT. Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis. Am Heart J 2017;193:46-54. [PMID: 29129254 DOI: 10.1016/j.ahj.2017.07.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
270 Rao M, Granger C. Improving Integrated Care in Low- and Middle-Income Countries: The Final STEMI Frontier?: EDITORIAL. J Int Cardiol 2014;27:167-70. [DOI: 10.1111/joic.12116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
271 Rob D, Špunda R, Lindner J, Rohn V, Kunstýř J, Balík M, Rulíšek J, Kopecký P, Lipš M, Šmíd O, Kovárník T, Mlejnský F, Linhart A, Bělohlávek J. A rationale for early extracorporeal membrane oxygenation in patients with postinfarction ventricular septal rupture complicated by cardiogenic shock: ECMO in patients with ventricular septal rupture. Eur J Heart Fail 2017;19:97-103. [DOI: 10.1002/ejhf.852] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
272 Hoschar S, Pan J, Wang Z, Fang X, Tang X, Shi W, Tu R, Xi P, Che W, Wang H, Li Y, Fritzsche K, Liu X, Ladwig KH, Ma W. The MEDEA FAR-EAST Study: Conceptual framework, methods and first findings of a multicenter cross-sectional observational study. BMC Emerg Med 2019;19:31. [PMID: 31046724 DOI: 10.1186/s12873-019-0240-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
273 Rahman H, Khan SU, Lone AN, Kaluski E. Revascularization strategies in cardiogenic shock complicating acute myocardial infarction: A systematic review and meta-analysis. Cardiovasc Revasc Med 2018;19:647-54. [PMID: 29909948 DOI: 10.1016/j.carrev.2018.06.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
274 Kubo S, Ohya M, Kuwayama A, Shimada T, Miura K, Amano H, Hyodo Y, Otsuru S, Habara S, Tada T, Tanaka H, Fuku Y, Goto T, Kadota K. Difference in clinical presentations and related angiographic findings among early, late, and very late sirolimus-eluting stent failures requiring target lesion revascularization. Int J Cardiol 2017;243:116-20. [PMID: 28545849 DOI: 10.1016/j.ijcard.2017.05.052] [Reference Citation Analysis]
275 Margolis G, Kofman N, Gal-Oz A, Arbel Y, Khoury S, Keren G, Shacham Y. Relation of positive fluid balance to the severity of renal impairment and recovery among ST elevation myocardial infarction complicated by cardiogenic shock. J Crit Care 2017;40:184-8. [PMID: 28414982 DOI: 10.1016/j.jcrc.2017.04.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
276 Clark MG, Beavers C, Osborne J. Managing the acute coronary syndrome patient: Evidence based recommendations for anti-platelet therapy. Heart & Lung 2015;44:141-9. [DOI: 10.1016/j.hrtlng.2014.11.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
277 Cavallari I, Nusca A, Ricottini E, Di Sciascio G. Prognostic Role of Platelet Reactivity in Patients With Acute Coronary Syndromes. Cardiology in Review 2014;22:313-8. [DOI: 10.1097/crd.0000000000000034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
278 Fernando H, Dinh D, Duffy SJ, Brennan A, Sharma A, Clark D, Ajani A, Freeman M, Peter K, Stub D, Hiew C, Reid CM, Oqueli E. Rescue PCI in the management of STEMI: Contemporary results from the Melbourne Interventional Group registry. Int J Cardiol Heart Vasc 2021;33:100745. [PMID: 33786363 DOI: 10.1016/j.ijcha.2021.100745] [Reference Citation Analysis]
279 Kim YH, Her A, Jeong MH, Kim B, Lee S, Hong S, Shin D, Kim J, Ko Y, Choi D, Hong M, Jang Y. Impact of renin-angiotensin system inhibitors on long-term clinical outcomes in patients with acute myocardial infarction treated with successful percutaneous coronary intervention with drug-eluting stents: Comparison between STEMI and NSTEMI. Atherosclerosis 2019;280:166-73. [DOI: 10.1016/j.atherosclerosis.2018.11.030] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
280 Khoury S, Soleman M, Margolis G, Barashi R, Rozenbaum Z, Keren G, Shacham Y. Incidence, characteristics and outcomes in very young patients with ST segment elevation myocardial infarction. Coron Artery Dis 2020;31:103-8. [PMID: 31524668 DOI: 10.1097/MCA.0000000000000779] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
281 Egan G, Hughes CA, Ackman ML. Drug Interactions Between Antiplatelet or Novel Oral Anticoagulant Medications and Antiretroviral Medications. Ann Pharmacother 2014;48:734-40. [DOI: 10.1177/1060028014523115] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 6.6] [Reference Citation Analysis]
282 Lee JM, Rhee T, Hahn J, Kim HK, Park J, Hwang D, Choi KH, Kim J, Park TK, Yang JH, Song YB, Choi J, Choi S, Koo B, Kim YJ, Chae SC, Cho MC, Kim CJ, Gwon H, Kim JH, Kim H, Jeong MH. Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock. Journal of the American College of Cardiology 2018;71:844-56. [DOI: 10.1016/j.jacc.2017.12.028] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 11.3] [Reference Citation Analysis]
283 Vyas A, El Accaoui R, Blevins A, Karrowni W. Outcome comparison of 600 mg versus 300 mg loading dose of clopidogrel for patients with ST-elevation myocardial infarction: a meta-analysis. Postgrad Med 2014;126:176-86. [PMID: 25295662 DOI: 10.3810/pgm.2014.09.2812] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
284 Thim T, Götberg M, Fröbert O, Nijveldt R, van Royen N, Baptista SB, Koul S, Kellerth T, Bøtker HE, Terkelsen CJ, Christiansen EH, Jakobsen L, Kristensen SD, Maeng M. Nonculprit Stenosis Evaluation Using Instantaneous Wave-Free Ratio in Patients With ST-Segment Elevation Myocardial Infarction. JACC: Cardiovascular Interventions 2017;10:2528-35. [DOI: 10.1016/j.jcin.2017.07.021] [Cited by in Crossref: 37] [Cited by in F6Publishing: 23] [Article Influence: 7.4] [Reference Citation Analysis]
285 Knudtson ML. In Search of the Optimal Strategy for Multivessel Disease Revascularization. JACC Cardiovasc Interv 2017;10:24-6. [PMID: 28057283 DOI: 10.1016/j.jcin.2016.11.035] [Reference Citation Analysis]
286 Abubakar H, Yassin AS, Shokr M. Rivaroxaban Used for Treatment of a Left Ventricular Thrombus in a Patient With Nonischemic Cardiomyopathy. Am J Ther 2018;25:e706-9. [PMID: 29324466 DOI: 10.1097/MJT.0000000000000722] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
287 Khawaja M, Thakker J, Kherallah R, Ye Y, Smith SW, Birnbaum Y. Diagnosis of Occlusion Myocardial Infarction in Patients with Left Bundle Branch Block and Paced Rhythms. Curr Cardiol Rep 2021;23:187. [PMID: 34791609 DOI: 10.1007/s11886-021-01613-0] [Reference Citation Analysis]
288 Habash F, Vallurupalli S. Challenges in management of left ventricular thrombus. Ther Adv Cardiovasc Dis 2017;11:203-13. [PMID: 28589748 DOI: 10.1177/1753944717711139] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 10.0] [Reference Citation Analysis]
289 Jiang YX, Jing LD, Jia YH. Clinical Characteristics and Risk Factors of Left Ventricular Thrombus after Acute Myocardial Infarction: A Matched Case-control Study. Chin Med J (Engl) 2015;128:2415-9. [PMID: 26365955 DOI: 10.4103/0366-6999.164869] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
290 Kastrati A, Coughlan JJ, Ndrepepa G. Primary PCI, Late Presenting STEMI, and the Limits of Time. J Am Coll Cardiol 2021;78:1306-8. [PMID: 34556315 DOI: 10.1016/j.jacc.2021.08.001] [Reference Citation Analysis]
291 Zullo AR, Riester MR, Erqou S, Wu WC, Rudolph JL, Steinman MA. Comparative Effectiveness of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in Older Nursing Home Residents After Myocardial Infarction: A Retrospective Cohort Study. Drugs Aging 2020;37:755-66. [PMID: 32808250 DOI: 10.1007/s40266-020-00791-w] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
292 Cui K, Lyu S, Song X, Liu H, Yuan F, Xu F, Zhang M, Wang W, Zhang M, Zhang D, Tian J. Long-Term Safety and Efficacy of Staged Percutaneous Coronary Intervention for Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease. Am J Cardiol 2019;124:334-42. [PMID: 31174834 DOI: 10.1016/j.amjcard.2019.04.048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
293 Rathod KS, Hamshere SM, Choudhury TR, Jones DA, Mathur A. Use of Thrombectomy Devices in Primary Percutaneous Interventions for ST-elevation Myocardial Infarction - An Update. Interv Cardiol 2014;9:102-7. [PMID: 29588786 DOI: 10.15420/icr.2011.9.2.102] [Reference Citation Analysis]
294 Abreu G, Azevedo P, Galvão Braga C, Vieira C, Álvares Pereira M, Martins J, Arantes C, Rodrigues C, Salgado A, Marques J. Modified shock index: A bedside clinical index for risk assessment of ST-segment elevation myocardial infarction at presentation. Rev Port Cardiol (Engl Ed) 2018;37:481-8. [PMID: 29807676 DOI: 10.1016/j.repc.2017.07.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
295 Perelshtein Brezinov O, Klempfner R, Zekry SB, Goldenberg I, Kuperstein R. Prognostic value of ejection fraction in patients admitted with acute coronary syndrome: A real world study. Medicine (Baltimore) 2017;96:e6226. [PMID: 28248882 DOI: 10.1097/MD.0000000000006226] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 4.4] [Reference Citation Analysis]
296 Dixon SR, Safian RD. The Year in Interventional Cardiology. Journal of the American College of Cardiology 2013;61:1637-52. [DOI: 10.1016/j.jacc.2013.01.040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
297 Larose E. Guilty as Sin: Revisiting Sutton's Law in ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol 2015;66:2725-7. [PMID: 26700835 DOI: 10.1016/j.jacc.2015.10.039] [Reference Citation Analysis]
298 Parvand M, Rayner-hartley E, Sedlak T. Recent Developments in Sex-Related Differences in Presentation, Prognosis, and Management of Coronary Artery Disease. Canadian Journal of Cardiology 2018;34:390-9. [DOI: 10.1016/j.cjca.2018.01.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
299 Fracassi F, Crea F, Sugiyama T, Yamamoto E, Uemura S, Vergallo R, Porto I, Lee H, Fujimoto J, Fuster V, Jang I. Healed Culprit Plaques in Patients With Acute Coronary Syndromes. Journal of the American College of Cardiology 2019;73:2253-63. [DOI: 10.1016/j.jacc.2018.10.093] [Cited by in Crossref: 50] [Cited by in F6Publishing: 33] [Article Influence: 16.7] [Reference Citation Analysis]
300 Sabaté M, Brugaletta S. Thrombectomy and Stroke: Guilty or Innocent Bystander? J Am Coll Cardiol 2018;72:1597-9. [PMID: 30261960 DOI: 10.1016/j.jacc.2018.07.048] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
301 Wessler JD, Stant J, Duru S, Rabbani L, Kirtane AJ. Updates to the ACCF/AHA and ESC STEMI and NSTEMI guidelines: putting guidelines into clinical practice. Am J Cardiol 2015;115:23A-8A. [PMID: 25728971 DOI: 10.1016/j.amjcard.2015.01.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
302 Parco C, Brockmeyer M, Kosejian L, Quade J, Tröstler J, Bader S, Lin Y, Karathanos A, Krieger T, Heinen Y, Schulze V, Icks A, Jung C, Kelm M, Wolff G. Modern NCDR and ACTION risk models outperform the GRACE model for prediction of in-hospital mortality in acute coronary syndrome in a German cohort. Int J Cardiol 2021;329:28-35. [PMID: 33412182 DOI: 10.1016/j.ijcard.2020.12.085] [Reference Citation Analysis]
303 El Nasasra A, Beigel R, Klempfner R, Alnsasra H, Matetzky S, Iakobishvili Z, Rubinshtein R, Halabi M, Blatt A, Zahger D. Comparison of Outcomes with or without Beta-Blocker Therapy After Acute Myocardial Infarction in Patients Without Heart Failure or Left Ventricular Systolic Dysfunction (from the Acute Coronary Syndromes Israeli Survey [ACSIS]). Am J Cardiol 2021;143:1-6. [PMID: 33359228 DOI: 10.1016/j.amjcard.2020.12.044] [Reference Citation Analysis]
304 Shi H, Li W, Zhou X, Liu X, Liu J, Fan S, Wang H, An L. Sex Differences in Prodromal Symptoms and Individual Responses to Acute Coronary Syndrome. J Cardiovasc Nurs 2020;35:545-9. [PMID: 31977563 DOI: 10.1097/JCN.0000000000000643] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
305 Doll JA, Roe MT. Time to treatment as a quality metric for acute STEMI care. The Lancet 2015;385:1056-7. [DOI: 10.1016/s0140-6736(14)62051-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
306 Di Serafino L, Magliulo F, Esposito G. Functionally Complete Coronary Revascularisation in Patients Presenting with ST-elevation MI and Multivessel Coronary Artery Disease. Interv Cardiol 2021;16:e24. [PMID: 34400971 DOI: 10.15420/icr.2020.28] [Reference Citation Analysis]
307 Kusumoto FM, Schoenfeld MH, Barrett C, Edgerton JR, Ellenbogen KA, Gold MR, Goldschlager NF, Hamilton RM, Joglar JA, Kim RJ, Lee R, Marine JE, Mcleod CJ, Oken KR, Patton KK, Pellegrini CN, Selzman KA, Thompson A, Varosy PD. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay. Journal of the American College of Cardiology 2019;74:e51-e156. [DOI: 10.1016/j.jacc.2018.10.044] [Cited by in Crossref: 87] [Cited by in F6Publishing: 57] [Article Influence: 29.0] [Reference Citation Analysis]
308 Rannan-Eliya RP, Wijemanne N, Liyanage IK, Dalpatadu S, de Alwis S, Amarasinghe S, Shanthikumar S. Quality of inpatient care in public and private hospitals in Sri Lanka. Health Policy Plan 2015;30 Suppl 1:i46-58. [PMID: 25759454 DOI: 10.1093/heapol/czu062] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
309 Shacham Y, Leshem-rubinow E, Ziv-baran T, Gal-oz A, Steinvil A, Ben Assa E, Keren G, Roth A, Arbel Y. Incidence and mortality of acute kidney injury in acute myocardial infarction patients: a comparison between AKIN and RIFLE criteria. Int Urol Nephrol 2014;46:2371-7. [DOI: 10.1007/s11255-014-0827-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
310 Wilson C, Sambandamoorthy G, Holloway P, Ramnarayan P, Inwald DP. Admission Plasma Troponin I Is Associated With Mortality in Pediatric Intensive Care. Pediatr Crit Care Med 2016;17:831-6. [PMID: 27355822 DOI: 10.1097/PCC.0000000000000845] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
311 Conrotto F, D'Ascenzo F, Piroli F, Franzé A, de Luca L, Quadri G, Ryan N, Escaned J, Bo M, De Ferrari GM. Percutaneous coronary intervention of unprotected left main and bifurcation in octogenarians: Subanalysis from RAIN (veRy thin stents for patients with left mAIn or bifurcatioN in real life). Catheter Cardiovasc Interv 2021;97:755-63. [PMID: 32478451 DOI: 10.1002/ccd.29048] [Reference Citation Analysis]
312 Jenkins AT, Kantorovich A, Burman L. Contemporary Use of Oral Antithrombotic Agents: Focus on Dual and Triple Therapeutic Approaches. Pharmacotherapy 2017;37:1545-64. [PMID: 28981961 DOI: 10.1002/phar.2041] [Reference Citation Analysis]
313 Park H, Kim HK, Jeong MH, Cho JY, Lee KH, Sim DS, Yoon NS, Yoon HJ, Hong YJ, Kim KH, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kim YJ, Cho MC, Kim CJ; Korea Acute Myocardial Infarction Registry Investigators. Clinical impacts of inhibition of renin-angiotensin system in patients with acute ST-segment elevation myocardial infarction who underwent successful late percutaneous coronary intervention. J Cardiol 2017;69:216-21. [PMID: 27141820 DOI: 10.1016/j.jjcc.2016.03.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
314 Aykan AÇ, Gül I, Gökdeniz T, Kalaycıoğlu E, Turan T, Boyacı F, Erkan H, Hatem E, Aykan DA, Celik S. Is coronary artery disease complexity valuable in the prediction of contrast induced nephropathy besides Mehran risk score, in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention? Heart Lung Circ 2013;22:836-43. [PMID: 23628329 DOI: 10.1016/j.hlc.2013.03.085] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
315 Khalid U, Jneid H, Deswal A. Higher risk, high yield: renin-angiotensin system blockade after percutaneous coronary intervention in patients with acute coronary syndrome. Rev Esp Cardiol (Engl Ed) 2020;73:104-6. [PMID: 31575483 DOI: 10.1016/j.rec.2019.08.007] [Reference Citation Analysis]
316 Reed GW, Cannon CP. Triple oral antithrombotic therapy in atrial fibrillation and coronary artery stenting. Clin Cardiol 2013;36:585-94. [PMID: 23873635 DOI: 10.1002/clc.22167] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
317 Mixon TA, Colato L. Impact of mode of transportation on time to treatment in patients transferred for primary percutaneous coronary intervention. J Emerg Med 2014;47:247-53. [PMID: 24746909 DOI: 10.1016/j.jemermed.2014.02.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
318 Everaars H, van der Hoeven NW, Janssens GN, van Leeuwen MA, van Loon RB, Schumacher SP, Demirkiran A, Hofman MB, van der Geest RJ, van de Ven PM, Götte MJ, van Rossum AC, van Royen N, Nijveldt R. Cardiac Magnetic Resonance for Evaluating Nonculprit Lesions After Myocardial Infarction. JACC: Cardiovascular Imaging 2020;13:715-28. [DOI: 10.1016/j.jcmg.2019.07.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
319 Hadadi L, Şerban RC, Scridon A, Şuş I, Lakatos ÉK, Demjén Z, Dobreanu D. Clinical risk scores predict procedural complications of primary percutaneous coronary intervention. Anatol J Cardiol 2017;17:276-84. [PMID: 28315564 DOI: 10.14744/AnatolJCardiol.2017.7471] [Reference Citation Analysis]
320 Gelsomino S, Johnson DM, Lorusso R. Intra-aortic balloon pump: is the tide turning? Crit Care 2018;22:345. [PMID: 30563544 DOI: 10.1186/s13054-018-2266-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
321 Basaraba JE, Barry AR. What is the optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent implantation? Am J Health Syst Pharm 2016;73:e229-37. [PMID: 27099329 DOI: 10.2146/ajhp150655] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
322 Le VT, Muhlestein JB. Use of Wearable Technologies for Early Diagnosis and Management of Acute Coronary Syndromes and Arrhythmias. Curr Cardiovasc Risk Rep 2018;12. [DOI: 10.1007/s12170-018-0588-3] [Reference Citation Analysis]
323 Rab T, Wilson H. Public Reporting of Mortality After PCI in Cardiac Arrest and Cardiogenic Shock. JACC: Cardiovascular Interventions 2016;9:496-8. [DOI: 10.1016/j.jcin.2015.12.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
324 Aeyels D, Van Vugt S, Sinnaeve PR, Panella M, Van Zelm R, Sermeus W, Vanhaecht K. Lack of evidence and standardization in care pathway documents for patients with ST-elevated myocardial infarction. European Journal of Cardiovascular Nursing 2015;15:e45-51. [DOI: 10.1177/1474515115580237] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
325 Hu MJ, Yang YJ, Yang JG. Immediate Versus Staged Multivessel PCI Strategies in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Systematic Review and Meta-analysis. Am J Med Sci 2021:S0002-9629(21)00254-8. [PMID: 34274323 DOI: 10.1016/j.amjms.2021.06.017] [Reference Citation Analysis]
326 Prodanov P, Widimsky P. Acute Revascularization in ST-Segment-Elevation Myocardial Infarction. Curr Atheroscler Rep 2014;16. [DOI: 10.1007/s11883-014-0412-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
327 Leonardi S, Montalto C, Casella G, Grosseto D, Repetto A, Portolan M, Fortuni F, Ottani F, Galvani M, Cardelli LS, De Servi S, Rubboli A, De Ferrari GM, Oltrona Visconti L, Campo G. Clinical governance programme in patients with acute coronary syndrome: design and methodology of a quality improvement initiative. Open Heart 2020;7:e001415. [PMID: 33372102 DOI: 10.1136/openhrt-2020-001415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
328 Hu B, Zhou Q, Chen J, Tan T, Yao X, Song H, Guo R. Prediction for Improvement and Remodeling in First-Onset Myocardial Infarction by Speckle Tracking Echocardiography: Is Global or Regional Selection Better? Ultrasound Med Biol 2017;43:2452-60. [PMID: 28673476 DOI: 10.1016/j.ultrasmedbio.2017.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
329 Ohman EM, Roe MT, Steg PG, James SK, Povsic TJ, White J, Rockhold F, Plotnikov A, Mundl H, Strony J, Sun X, Husted S, Tendera M, Montalescot G, Bahit MC, Ardissino D, Bueno H, Claeys MJ, Nicolau JC, Cornel JH, Goto S, Kiss RG, Güray Ü, Park D, Bode C, Welsh RC, Gibson CM. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. The Lancet 2017;389:1799-808. [DOI: 10.1016/s0140-6736(17)30751-1] [Cited by in Crossref: 124] [Cited by in F6Publishing: 40] [Article Influence: 24.8] [Reference Citation Analysis]
330 Franchi F, Rollini F, Muñiz-Lozano A, Cho JR, Angiolillo DJ. Cangrelor: a review on pharmacology and clinical trial development. Expert Rev Cardiovasc Ther 2013;11:1279-91. [PMID: 24138516 DOI: 10.1586/14779072.2013.837701] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
331 Karamasis GV, Russhard P, Al Janabi F, Parker M, Davies JR, Keeble TR, Clesham GJ. Peri-procedural ST segment resolution during Primary Percutaneous Coronary Intervention (PPCI) for acute myocardial infarction: predictors and clinical consequences. J Electrocardiol 2018;51:224-9. [PMID: 29108788 DOI: 10.1016/j.jelectrocard.2017.09.011] [Reference Citation Analysis]
332 Lim HCS, Salandanan EA, Phillips R, Tan JG, Hezan MA. Inter-rater reliability of J-point location and measurement of the magnitude of ST segment elevation at the J-point on ECGs of STEMI patients by emergency department doctors. Emerg Med J 2015;32:809-12. [DOI: 10.1136/emermed-2014-204102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
333 Motivala AA, Parikh V, Roe M, Dai D, Abbott JD, Prasad A, Mukherjee D. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions 2016;9:1639-48. [DOI: 10.1016/j.jcin.2016.05.048] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
334 Liakos M, Parikh PB. Gender Disparities in Presentation, Management, and Outcomes of Acute Myocardial Infarction. Curr Cardiol Rep 2018;20. [DOI: 10.1007/s11886-018-1006-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
335 Li Y, Wang X, Bao D, Liao Z, Li J, Han X, Wang H, Xu K, Li Z, Stone GW, Han Y. Optimal antiplatelet therapy for prevention of gastrointestinal injury evaluated by ANKON magnetically controlled capsule endoscopy: Rationale and design of the OPT-PEACE trial. Am Heart J 2020;228:8-16. [PMID: 32745734 DOI: 10.1016/j.ahj.2020.06.004] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
336 Dave DM, Ferencic M, Hoffmann U, Udelson JE. Imaging techniques for the assessment of suspected acute coronary syndromes in the emergency department. Curr Probl Cardiol 2014;39:191-247. [PMID: 24952880 DOI: 10.1016/j.cpcardiol.2014.05.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
337 Pereira H, Caldeira D, Teles RC, Costa M, da Silva PC, da Gama Ribeiro V, Brandão V, Martins D, Matias F, Pereira-Machado F, Baptista J, Abreu PFE, Santos R, Drummond A, de Carvalho HC, Calisto J, Silva JC, Pipa JL, Marques J, Sousa P, Fernandes R, Ferreira RC, Ramos S, Oliveira EI, de Sousa Almeida M; investigators of Portuguese Registry on Interventional Cardiology (Registo Nacional de Cardiologia de Intervenção). Thrombus aspiration in patients with ST-elevation myocardial infarction: results of a national registry of interventional cardiology. BMC Cardiovasc Disord 2018;18:69. [PMID: 29699478 DOI: 10.1186/s12872-018-0794-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
338 Goldman JD, Harte FM. Transition of care to prevent recurrence after acute coronary syndrome: the critical role of the primary care provider and pharmacist. Postgrad Med 2020;132:426-32. [PMID: 32207352 DOI: 10.1080/00325481.2020.1740512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
339 Bittl JA. Abciximab during percutaneous coronary intervention for ST-segment elevation myocardial infarction: intracoronary, intravenous, or not at all? J Am Coll Cardiol 2013;61:1455-7. [PMID: 23466079 DOI: 10.1016/j.jacc.2013.01.042] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
340 Guimarães PO, Tricoci P. Ticagrelor, prasugrel, or clopidogrel in ST-segment elevation myocardial infarction: which one to choose? Expert Opin Pharmacother 2015;16:1983-95. [PMID: 26224244 DOI: 10.1517/14656566.2015.1074180] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
341 Park JJ, Kim SH, Oh IY, Choi DJ, Park HA, Cho HJ, Lee HY, Cho JY, Kim KH, Son JW, Yoo BS, Oh J, Kang SM, Baek SH, Lee GY, Choi JO, Jeon ES, Lee SE, Kim JJ, Lee JH, Cho MC, Jang SY, Chae SC, Oh BH. The Effect of Door-to-Diuretic Time on Clinical Outcomes in Patients With Acute Heart Failure. JACC Heart Fail 2018;6:286-94. [PMID: 29598933 DOI: 10.1016/j.jchf.2017.12.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
342 Zhang K, Yang W, Zhang M, Sun Y, Zhang T, Liu J, Zhang J. Pretreatment with antiplatelet drugs improves the cardiac function after myocardial infarction without reperfusion in a mouse model. Cardiol J 2021;28:118-28. [PMID: 31106840 DOI: 10.5603/CJ.a2019.0051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
343 Xiao L, Jia Y, Wang X, Huang H. The impact of preoperative fibrinogen-albumin ratio on mortality in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Clinica Chimica Acta 2019;493:8-13. [DOI: 10.1016/j.cca.2019.02.018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
344 Sgueglia GA, D'Errico F, Gioffrè G, De Santis A, Summaria F, Piccioni F, Gaspardone A. Angiographic and clinical performance of polymer-free biolimus-eluting stent in patients with ST-segment elevation acute myocardial infarction in a metropolitan public hospital: The BESAMI MUCHO study. Catheter Cardiovasc Interv 2018;91:851-8. [PMID: 28766881 DOI: 10.1002/ccd.27206] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
345 Thompson PL. Should β-blockers still be routine after myocardial infarction? Current Opinion in Cardiology 2013;28:399-404. [DOI: 10.1097/hco.0b013e328361e97a] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
346 Bellandi B, Zocchi C, Xanthopoulou I, Scudiero F, Valenti R, Migliorini A, Antoniucci D, Marchionni N, Alexopoulos D, Parodi G. Morphine use and myocardial reperfusion in patients with acute myocardial infarction treated with primary PCI. International Journal of Cardiology 2016;221:567-71. [DOI: 10.1016/j.ijcard.2016.06.204] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
347 Masoumi A, Rosenblum HR, Garan AR. Cardiogenic Shock in Older Adults. Curr Cardiovasc Risk Rep 2016;10. [DOI: 10.1007/s12170-016-0522-5] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
348 van Es N, Bleker SM, Büller HR, Coppens M. New developments in parenteral anticoagulation for arterial and venous thromboembolism. Best Practice & Research Clinical Haematology 2013;26:203-13. [DOI: 10.1016/j.beha.2013.07.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
349 Dondo TB, Hall M, Timmis AD, Yan AT, Batin PD, Oliver G, Alabas OA, Norman P, Deanfield JE, Bloor K, Hemingway H, Gale CP. Geographic variation in the treatment of non-ST-segment myocardial infarction in the English National Health Service: a cohort study. BMJ Open 2016;6:e011600. [PMID: 27406646 DOI: 10.1136/bmjopen-2016-011600] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
350 Alexander T, Victor SM, Mullasari AS, Veerasekar G, Subramaniam K, Nallamothu BK; TN-STEMI Programme Investigators. Protocol for a prospective, controlled study of assertive and timely reperfusion for patients with ST-segment elevation myocardial infarction in Tamil Nadu: the TN-STEMI programme. BMJ Open 2013;3:e003850. [PMID: 24302505 DOI: 10.1136/bmjopen-2013-003850] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
351 Li D, Dong W, Liu Y, Wang J, Mu Y, Zhou H, Wang J, Zhou S, Chen Y. Impact of metoprolol standard dosing pathway in Chinese patients with acute coronary syndrome: protocol for a multicentre prospective study. BMJ Open 2019;9:e031972. [PMID: 31806613 DOI: 10.1136/bmjopen-2019-031972] [Reference Citation Analysis]
352 Aronow WS. Medical management after myocardial infarction. Future Cardiol 2019;15:135-8. [PMID: 31148480 DOI: 10.2217/fca-2019-0014] [Reference Citation Analysis]
353 Tu D, Holderby A, Coté GL. Aptamer-based surface-enhanced resonance Raman scattering assay on a paper fluidic platform for detection of cardiac troponin I. J Biomed Opt 2020;25. [PMID: 32901465 DOI: 10.1117/1.JBO.25.9.097001] [Reference Citation Analysis]
354 Yoshizaki T, Ishida M, Takagi T, Matsukura G, Yamashita S, Hosoya N, Kageyama S, Watanabe Y, Takeuchi R, Murata K, Nawada R, Onodera T, Nakai M. A case of ventricular septal rupture associated with major septal branch occlusion after percutaneous coronary intervention. J Cardiol Cases 2014;10:140-3. [PMID: 30534226 DOI: 10.1016/j.jccase.2014.06.010] [Reference Citation Analysis]
355 Thukkani AK, Fonarow GC, Cannon CP, Cox M, Hernandez AF, Peterson ED, Peacock WF, Laskey WK, Schwamm LH, Bhatt DL; Get With the Guidelines Steering Committee and Investigators. Quality of care for patients with acute coronary syndromes as a function of hospital revascularization capability: Insights from get with the guidelines-CAD. Clin Cardiol 2014;37:285-92. [PMID: 24452828 DOI: 10.1002/clc.22246] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
356 Serebruany V, Dinicolantonio J. Viewpoint: Mismatch between the European and American guidelines on oral antiplatelet P2Y12 inhibitors after acute coronary syndromes. Thromb Haemost 2017;110:5-10. [DOI: 10.1160/th13-02-0142] [Cited by in Crossref: 7] [Article Influence: 1.4] [Reference Citation Analysis]
357 Sparv D, Hofmann R, Gunnarsson A, James S, Hedberg C, Lauermann J, Torild P, Omerovic E, Bergström K, Haugen E, Bergström C, Linder R, Borg P, Haaga U, Olsson A, Böving E, Östlund O, Rylance R, Witt N, Erlinge D; DETO2X-SWEDEHEART Investigators. The Analgesic Effect of Oxygen in Suspected Acute Myocardial Infarction: A Substudy of the DETO2X-AMI Trial. JACC Cardiovasc Interv 2018;11:1590-7. [PMID: 30139465 DOI: 10.1016/j.jcin.2018.04.043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
358 Krishnan U, Brejt JA, Schulman-marcus J, Swaminathan RV, Feldman DN, Chiu Wong S, Goyal P, Horn EM, Karas M, Sobol I, Minutello RM, Bergman G, Singh H, Kim LK. Characteristics of hospitalizations for cardiogenic shock after acute myocardial infarction in the United States. International Journal of Cardiology 2017;244:213-9. [DOI: 10.1016/j.ijcard.2017.06.088] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
359 Cai X, Wang S, Hong L, Yu S, Li B, Zeng H, Yang X, Zhang P, Shao L. Long Noncoding RNA Taurine-Upregulated Gene 1 Knockdown Protects Cardiomyocytes Against Hypoxia/Reoxygenation-induced Injury Through Regulating miR-532-5p/Sox8 Axis. J Cardiovasc Pharmacol 2020;76:556-63. [PMID: 32833900 DOI: 10.1097/FJC.0000000000000895] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
360 Wongsalap Y, Kengkla K, Poolpun D, Saokaew S. Trends in optimal medical therapy at discharge and clinical outcomes in patients with acute coronary syndrome in Thailand. J Cardiol 2021;77:669-76. [PMID: 33455848 DOI: 10.1016/j.jjcc.2020.12.015] [Reference Citation Analysis]
361 Chakraborty R, Patra S, Banerjee S, Pande A, Khan A, Mandol PC, Ghosh D, De SK, Das SS, Nag R. Outcome of everolimus eluting bioabsorbable vascular scaffold (BVS) compared to non BVS drug eluting stent in the management of ST-segment elevation myocardial infarction (STEMI) — A comparative study. Cardiovascular Revascularization Medicine 2016;17:151-4. [DOI: 10.1016/j.carrev.2016.01.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
362 Zhao B, Peng J, Ren L, Lei L, Wang Z, Ye H. Conservative pharmacotherapy vs. staged percutaneous coronary intervention for non-culprit vessels in patients with ST-segment elevation myocardial infarction. Exp Ther Med 2016;12:4147-53. [PMID: 28105141 DOI: 10.3892/etm.2016.3895] [Reference Citation Analysis]
363 Eijsvogels TM, Maessen MF. Exercise for Coronary Heart Disease Patients. Journal of the American College of Cardiology 2017;70:1701-3. [DOI: 10.1016/j.jacc.2017.08.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
364 Puymirat E, Riant E, Aissaoui N, Soria A, Ducrocq G, Coste P, Cottin Y, Aupetit JF, Bonnefoy E, Blanchard D, Cattan S, Steg G, Schiele F, Ferrières J, Juillière Y, Simon T, Danchin N. β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study. BMJ 2016;354:i4801. [PMID: 27650822 DOI: 10.1136/bmj.i4801] [Cited by in Crossref: 86] [Cited by in F6Publishing: 66] [Article Influence: 14.3] [Reference Citation Analysis]
365 January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary. Journal of the American College of Cardiology 2014;64:2246-80. [DOI: 10.1016/j.jacc.2014.03.021] [Cited by in Crossref: 479] [Cited by in F6Publishing: 206] [Article Influence: 59.9] [Reference Citation Analysis]
366 Nguyen T, Nguyen TH, Pham HT, Nguyen TT, Huynh KM, Vo PT, Pham TT, Taxis K. Physicians' adherence to acute coronary syndrome prescribing guidelines in Vietnamese hospital practice: a cross-sectional study. Trop Med Int Health 2015;20:627-37. [PMID: 25640658 DOI: 10.1111/tmi.12467] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
367 Barkagan M, Steinvil A, Berchenko Y, Finkelstein A, Keren G, Banai S, Halkin A. Impact of routine manual aspiration thrombectomy on outcomes of patients undergoing primary percutaneous coronary intervention for acute myocardial infarction: A meta-analysis. International Journal of Cardiology 2016;204:189-95. [DOI: 10.1016/j.ijcard.2015.11.135] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
368 Promes SB, Glauser JM, Smith MD, Torbati SS, Brown MD; American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Reperfusion Therapy for Acute ST-Segment Elevation Myocardial Infarction. Clinical Policy: Emergency Department Management of Patients Needing Reperfusion Therapy for Acute ST-Segment Elevation Myocardial Infarction. Ann Emerg Med 2017;70:724-39. [PMID: 29056206 DOI: 10.1016/j.annemergmed.2017.09.035] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
369 Barbieri A, Mantovani F, Bursi F, Faggiano A, Boriani G, Faggiano P. Optimal Use of Echocardiography in Management of Thrombosis After Anterior Myocardial Infarction. Echocardiography 2020;37:1287-95. [DOI: 10.1111/echo.14808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
370 Garg P, Underwood SR, Senior R, Greenwood JP, Plein S. Noninvasive cardiac imaging in suspected acute coronary syndrome. Nat Rev Cardiol. 2016;13:266-275. [PMID: 26911331 DOI: 10.1038/nrcardio.2016.18] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
371 Isogai T, Saad AM, Ahuja KR, Gad MM, Shekhar S, Abdelfattah OM, Kaur M, Saw J, Cho L, Kapadia SR. Factors Associated With Revascularization in Women With Spontaneous Coronary Artery Dissection and Acute Myocardial Infarction. Am J Cardiol 2021:S0002-9149(21)01143-7. [PMID: 34949472 DOI: 10.1016/j.amjcard.2021.11.024] [Reference Citation Analysis]
372 Vogel B, Claessen BE, Arnold SV, Chan D, Cohen DJ, Giannitsis E, Gibson CM, Goto S, Katus HA, Kerneis M, Kimura T, Kunadian V, Pinto DS, Shiomi H, Spertus JA, Steg PG, Mehran R. ST-segment elevation myocardial infarction. Nat Rev Dis Primers 2019;5:39. [PMID: 31171787 DOI: 10.1038/s41572-019-0090-3] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 16.7] [Reference Citation Analysis]
373 Wang H, Liang Z, Li Y, Li B, Liu J, Hong X, Lu X, Wu J, Zhao W, Liu Q, An J, Li L, Pu F, Ming Q, Han Y. Effect of postprocedural full-dose infusion of bivalirudin on acute stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Outcomes in a large real-world population. Cardiovasc Ther 2017;35. [PMID: 28083915 DOI: 10.1111/1755-5922.12251] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
374 Padilla López A. Statin adherence and health outcomes after st-elevation myocardial infarction: 1-year follow-up study. Rev Clin Esp (Barc) 2021;221:331-40. [PMID: 34059230 DOI: 10.1016/j.rceng.2020.04.012] [Reference Citation Analysis]
375 Kiron V, George PV. Correlation of cumulative ST elevation with left ventricular ejection fraction and 30-day outcome in patients with ST elevation myocardial infarction. J Postgrad Med 2019;65:146-51. [PMID: 31169133 DOI: 10.4103/jpgm.JPGM_364_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
376 Elbadawi A, Awad O, Raymond R, Badran H, Mostafa AE, Saad M. Impact of Remote Ischemic Postconditioning during Primary Percutaneous Coronary Intervention on Left Ventricular Remodeling after Anterior Wall ST-Segment Elevation Myocardial Infarction: A Single-Center Experience. Int J Angiol 2017;26:241-8. [PMID: 29142491 DOI: 10.1055/s-0037-1601870] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
377 Jawaid O, Stanislawski M, Bricker R, Plomondon ME, Grunwald GK, Valle JA, Armstrong EJ, Waldo SW. Contemporary use of intra-aortic balloon pumps during percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking program. Coron Artery Dis 2019;30:44-50. [PMID: 30358654 DOI: 10.1097/MCA.0000000000000670] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
378 Tu Y, Hu L, Yang C, Nemat A, Xian G, Zhang J, Zeng Q. Optimal Antithrombotic Therapy for Patients with STEMI Undergoing PCI at High Risk of Bleeding. Curr Atheroscler Rep 2019;21. [DOI: 10.1007/s11883-019-0782-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
379 Cirakoglu OF, Aslan AO, Akyuz AR, Kul S, Şahin S, Korkmaz L, Sayın MR. The value of syntax score to predict new-onset atrial fibrillation in patients with acute coronary syndrome. Ann Noninvasive Electrocardiol 2019;24:e12622. [PMID: 30615236 DOI: 10.1111/anec.12622] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
380 Chandrasekhar J, Marley P, Allada C, Mcgill D, O’connor S, Rahman M, Tan R, Hosseiny AD, Shadbolt B, Farshid A. Symptom-to-Balloon Time is a Strong Predictor of Adverse Events Following Primary Percutaneous Coronary Intervention: Results From the Australian Capital Territory PCI Registry. Heart, Lung and Circulation 2017;26:41-8. [DOI: 10.1016/j.hlc.2016.05.114] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
381 Torii S, Fujii T, Murakami T, Nakazawa G, Ijichi T, Nakano M, Ohno Y, Shinozaki N, Yoshimachi F, Ikari Y. Impact of a single universal guiding catheter on door-to-balloon time in primary transradial coronary intervention for ST segment elevation myocardial infarction. Cardiovasc Interv and Ther 2017;32:114-9. [DOI: 10.1007/s12928-016-0395-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
382 Oyetayo OO, Slicker K, De La Rosa L, Lane W, Langsjoen D, Patel C, Brough K, Michel J, Chiles C. Dual antiplatelet compared to triple antithrombotic therapy in anterior wall acute myocardial infarction complicated by depressed left ventricular ejection fraction. Proc (Bayl Univ Med Cent) 2015;28:445-9. [PMID: 26424937 DOI: 10.1080/08998280.2015.11929303] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
383 Calvert PA, Cockburn J, Wynne D, Ludman P, Rana BS, Northridge D, Mullen MJ, Malik I, Turner M, Khogali S, Veldtman GR, Been M, Butler R, Thomson J, Byrne J, Maccarthy P, Morrison L, Shapiro LM, Bridgewater B, de Giovanni J, Hildick-smith D. Percutaneous Closure of Postinfarction Ventricular Septal Defect: In-Hospital Outcomes and Long-Term Follow-Up of UK Experience. Circulation 2014;129:2395-402. [DOI: 10.1161/circulationaha.113.005839] [Cited by in Crossref: 50] [Cited by in F6Publishing: 12] [Article Influence: 6.3] [Reference Citation Analysis]
384 Jiang D, Fu G. A case of de Winter syndrome presenting with chest tightness. J Int Med Res 2021;49:3000605211012198. [PMID: 34256640 DOI: 10.1177/03000605211012198] [Reference Citation Analysis]
385 Zhou JR, Jones P, Guo LR, Dhir A. Heparin Resistance and Intracardiac Thrombosis May Be a Harbinger of Heparin-Induced Thrombocytopenia (HIT). J Cardiothorac Vasc Anesth 2018;32:1386-90. [PMID: 29482938 DOI: 10.1053/j.jvca.2018.01.012] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
386 Levine GN. Editorial commentary: The continuing evolution of primary PCI and clinical guidelines. Trends Cardiovasc Med 2017;27:103-5. [PMID: 27498026 DOI: 10.1016/j.tcm.2016.07.002] [Reference Citation Analysis]
387 Raposeiras-Roubín S, Abu-Assi E, Muñoz-Pousa I, Rossello X, Cespón-Fernández M, Melendo Viu M, Caneiro-Queija B, Cobas-Paz R, Bastos G, Iñíguez-Romo A. Usefulness of Bleeding After Acute Coronary Syndromes for Unmasking Silent Cancer. Am J Cardiol 2020;125:1801-8. [PMID: 32307091 DOI: 10.1016/j.amjcard.2020.03.023] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
388 Liu Y, Chen JY, Huo Y, Ge JB, Xian Y, Duan CY, Chen SQ, Jiang W, Chen PY, Tan N; RESCIND group. Aggressive hydraTion in patients with ST-Elevation Myocardial infarction undergoing Primary percutaneous coronary intervention to prevenT contrast-induced nephropathy (ATTEMPT): Study design and protocol for the randomized, controlled trial, the ATTEMPT, RESCIND 1 (First study for REduction of contraSt-induCed nephropathy followINg carDiac catheterization) trial. Am Heart J 2016;172:88-95. [PMID: 26856220 DOI: 10.1016/j.ahj.2015.10.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
389 Husted S, Boersma E. Case Study: Ticagrelor in PLATO and Prasugrel in TRITON-TIMI 38 and TRILOGY-ACS Trials in Patients With Acute Coronary Syndromes. Am J Ther 2016;23:e1876-89. [PMID: 25830867 DOI: 10.1097/MJT.0000000000000237] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
390 Fakhri Y, Melgaard J, Andersson HB, Schoos MM, Birnbaum Y, Graff C, Sejersten M, Kastrup J, Clemmensen P. Automatic electrocardiographic algorithm for assessing severity of ischemia in ST-segment elevation myocardial infarction. Int J Cardiol 2018;268:18-22. [PMID: 30041784 DOI: 10.1016/j.ijcard.2018.04.057] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
391 Secemsky EA, Ferro EG, Rao SV, Kirtane A, Tamez H, Zakroysky P, Wojdyla D, Bradley SM, Cohen DJ, Yeh RW. Association of Physician Variation in Use of Manual Aspiration Thrombectomy With Outcomes Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: The National Cardiovascular Data Registry CathPCI Registry. JAMA Cardiol 2019;4:110-8. [PMID: 30624549 DOI: 10.1001/jamacardio.2018.4472] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
392 Buntaine AJ, Shah B, Lorin JD, Sedlis SP. Revascularization Strategies in Patients with Diabetes Mellitus and Acute Coronary Syndrome. Curr Cardiol Rep 2016;18. [DOI: 10.1007/s11886-016-0756-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
393 Marcolino MS, Ribeiro ALP. Reperfusion Criteria in Patients Submitted to Fibrinolysis: Is There Room for Improvement? Arq Bras Cardiol 2019;112:30-1. [PMID: 30673013 DOI: 10.5935/abc.20180245] [Reference Citation Analysis]
394 Ishihara M. Distal Protection During Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction. J Atheroscler Thromb 2016;23:1307-8. [PMID: 27319746 DOI: 10.5551/jat.ED051] [Reference Citation Analysis]
395 Burgess SN, French JK, Nguyen TL, Leung M, Richards DA, Thomas L, Mussap C, Lo S, Juergens CP. The impact of incomplete revascularization on early and late outcomes in ST-elevation myocardial infarction. American Heart Journal 2018;205:31-41. [DOI: 10.1016/j.ahj.2018.07.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
396 Gaglia MA Jr. Warfarin Prophylaxis for Anterior Infarction: Another Black Mark for Triple Therapy. Cardiovasc Revasc Med 2017;18:557-8. [PMID: 29246274 DOI: 10.1016/j.carrev.2017.11.006] [Reference Citation Analysis]
397 Hu G, Zhou M, Liu J, Smith SC Jr, Ma C, Ge J, Huo Y, Fonarow GC, Hao Y, Liu J, Taubert KA, Morgan L, Yang N, Zeng Y, Han Y, Zhao D; CCC-ACS Investigators. Smoking and Provision of Smoking Cessation Interventions among Inpatients with Acute Coronary Syndrome in China: Findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project. Glob Heart 2020;15:72. [PMID: 33150137 DOI: 10.5334/gh.784] [Reference Citation Analysis]
398 Bastiany A, Grenier ME, Matteau A, Mansour S, Daneault B, Potter BJ. Prevention of Left Ventricular Thrombus Formation and Systemic Embolism After Anterior Myocardial Infarction: A Systematic Literature Review. Can J Cardiol 2017;33:1229-36. [PMID: 28941605 DOI: 10.1016/j.cjca.2017.07.479] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
399 Grove GL, Pedersen S, Olsen FJ, Skaarup KG, Jørgensen PG, Shah AM, Biering-Sørensen T. Layer-specific global longitudinal strain obtained by speckle tracking echocardiography for predicting heart failure and cardiovascular death following STEMI treated with primary PCI. Int J Cardiovasc Imaging 2021;37:2207-15. [PMID: 33689098 DOI: 10.1007/s10554-021-02202-6] [Reference Citation Analysis]
400 Martínez-Losas P, Fernández-Jiménez R. de Winter syndrome. CMAJ 2016;188:528. [PMID: 26755668 DOI: 10.1503/cmaj.150816] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
401 Lechner I, Reindl M, Tiller C, Holzknecht M, Niederreiter S, Mayr A, Klug G, Brenner C, Bauer A, Metzler B, Reinstadler SJ. Determinants and prognostic relevance of aortic stiffness in patients with recent ST-elevation myocardial infarction. Int J Cardiovasc Imaging 2021. [PMID: 34476665 DOI: 10.1007/s10554-021-02383-0] [Reference Citation Analysis]
402 Le May MR, Acharya S, Wells GA, Burwash I, Chong AY, So DY, Glover CA, Froeschl MP, Hibbert B, Marquis J, Dick A, Blondeau M, Bernick J, Labinaz M. Prophylactic Warfarin Therapy After Primary Percutaneous Coronary Intervention for Anterior ST-Segment Elevation Myocardial Infarction. JACC: Cardiovascular Interventions 2015;8:155-62. [DOI: 10.1016/j.jcin.2014.07.018] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
403 Song C, Fu R, Dou K, Yang J, Xu H, Gao X, Li W, Gao G, Zhao Z, Liu J, Yang Y. The CAMI-score: A Novel Tool derived From CAMI Registry to Predict In-hospital Death among Acute Myocardial Infarction Patients. Sci Rep 2018;8:9082. [PMID: 29899463 DOI: 10.1038/s41598-018-26861-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
404 Bainey KR, Armstrong PW. Transatlantic Comparison of ST-Segment Elevation Myocardial Infarction Guidelines. Journal of the American College of Cardiology 2016;67:216-29. [DOI: 10.1016/j.jacc.2015.11.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
405 Vengoechea F. Management of Acute Coronary Syndrome in the Hospital: A Focus on ACCF/AHA Guideline Updates to Oral Antiplatelet Therapy. Hospital Practice 2015;42:33-47. [DOI: 10.3810/hp.2014.08.1116] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
406 Chen W, Lian XJ, Huang JL, Wei XB, Duan CY, Guo YS, Chen JY, He PC, Liu YH, Tan N. Prognostic value of spot testing urine pH as a novel marker in patients with ST-segment elevation myocardial infarction. Biomark Med 2019;13:821-9. [PMID: 31165633 DOI: 10.2217/bmm-2019-0004] [Reference Citation Analysis]
407 Gambhir DS. First 24 h in the management of non-ST segment elevation myocardial infarction. European Heart Journal Supplements 2018;20:B29-38. [DOI: 10.1093/eurheartj/sux044] [Reference Citation Analysis]
408 Khatib R, Patel N, Laverty U, Mcgawley G, McLenachan J, Shield S, Hall AS. Re-engineering the post-myocardial infarction medicines optimisation pathway: a retrospective analysis of a joint consultant pharmacist and cardiologist clinic model. Open Heart 2018;5:e000921. [PMID: 30613417 DOI: 10.1136/openhrt-2018-000921] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
409 Fatima U, Khan SU, Akanbi O, Girotra S, Opoku-Asare I. Network Meta-Analysis of Percutaneous Intervention-Based Revascularization Strategies for ST-Elevation Myocardial Infarction and Concomitant Multi-Vessel Disease. Cardiovasc Revasc Med 2019;20:603-11. [PMID: 30196030 DOI: 10.1016/j.carrev.2018.08.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
410 Souza Júnior JM, Kulchetscki RM, Linhares Filho JPP, Lima EG, Serrano Junior CV. CULPRIT-SHOCK study. Rev Assoc Med Bras (1992) 2018;64:783-6. [PMID: 30672997 DOI: 10.1590/1806-9282.64.09.783] [Reference Citation Analysis]
411 Nishihira K, Shibata Y, Yamashita A, Kuriyama N, Asada Y. Relationship between thrombus age in aspirated coronary material and mid-term major adverse cardiac and cerebrovascular events in patients with acute myocardial infarction. Atherosclerosis 2018;268:138-44. [PMID: 29223872 DOI: 10.1016/j.atherosclerosis.2017.12.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
412 Jaiswal A, Pollack S, Chichra A, Moustakakis E, Park C, Kerwin T. Manual Aspiration Thrombectomy in Acute Myocardial Infarction: A Clinical Experience. Int J Angiol 2016;25:20-8. [PMID: 26900308 DOI: 10.1055/s-0035-1547515] [Reference Citation Analysis]
413 de Waha S, Jobs A, Eitel I, Pöss J, Stiermaier T, Meyer-saraei R, Fuernau G, Zeymer U, Desch S, Thiele H. Multivessel versus culprit lesion only percutaneous coronary intervention in cardiogenic shock complicating acute myocardial infarction: A systematic review and meta-analysis. European Heart Journal: Acute Cardiovascular Care 2018;7:28-37. [DOI: 10.1177/2048872617719640] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 9.2] [Reference Citation Analysis]
414 Stiermaier T, Eitel I, de Waha S, Pöss J, Fuernau G, Thiele H, Desch S. Myocardial salvage after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction presenting early versus late after symptom onset. Int J Cardiovasc Imaging 2017;33:1571-9. [DOI: 10.1007/s10554-017-1143-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
415 Han H, Chao H, Guerra A, Sosa A, Christopoulos G, Christakopoulos GE, Rangan BV, Maragkoudakis S, Jneid H, Banerjee S, Brilakis ES. Evolution of the American College of Cardiology/American Heart Association Clinical Guidelines. J Am Coll Cardiol 2015;65:2726-34. [PMID: 26112197 DOI: 10.1016/j.jacc.2015.04.050] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
416 Izkhakov E, Rozenbaum Z, Margolis G, Khoury S, Keren G, Shacham Y. Prolonged Hyperglycemia and Renal Failure after Primary Percutaneous Coronary Intervention. Cardiorenal Med 2019;9:92-9. [PMID: 30636246 DOI: 10.1159/000495704] [Reference Citation Analysis]
417 Heinonen I, Sorop O, de Beer VJ, Duncker DJ, Merkus D. What can we learn about treating heart failure from the heart's response to acute exercise? Focus on the coronary microcirculation. J Appl Physiol (1985) 2015;119:934-43. [PMID: 26048972 DOI: 10.1152/japplphysiol.00053.2015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
418 Zhang YS, Davoudi F, Walch P, Manbachi A, Luo X, Dell'Erba V, Miri AK, Albadawi H, Arneri A, Li X, Wang X, Dokmeci MR, Khademhosseini A, Oklu R. Bioprinted thrombosis-on-a-chip. Lab Chip 2016;16:4097-105. [PMID: 27722710 DOI: 10.1039/c6lc00380j] [Cited by in Crossref: 110] [Cited by in F6Publishing: 51] [Article Influence: 27.5] [Reference Citation Analysis]
419 Torosoff MT, Sidhu MS, Desai KP, Fein SA, Boden WE. Revascularization options in stable coronary artery disease: it is not how to revascularize, it is whether and when to revascularize. J Comp Eff Res 2015;4:505-14. [PMID: 26387530 DOI: 10.2217/cer.15.37] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
420 King-Shier K, Quan H, Mather C, Chong E, LeBlanc P, Khan N. Understanding ethno-cultural differences in cardiac medication adherence behavior: a Canadian study. Patient Prefer Adherence 2018;12:1737-47. [PMID: 30233153 DOI: 10.2147/PPA.S169167] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
421 Gershlick AH, Khan JN, Kelly DJ, Greenwood JP, Sasikaran T, Curzen N, Blackman DJ, Dalby M, Fairbrother KL, Banya W, Wang D, Flather M, Hetherington SL, Kelion AD, Talwar S, Gunning M, Hall R, Swanton H, McCann GP. Randomized trial of complete vs lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol. 2015;65:963-972. [PMID: 25766941 DOI: 10.1016/j.jacc.2014.12.038] [Cited by in Crossref: 456] [Cited by in F6Publishing: 319] [Article Influence: 76.0] [Reference Citation Analysis]
422 Akboga MK, Yayla C, Yilmaz S, Sen F, Balci KG, Ozcan F, Aras D. Increased red cell distribution width predicts occlusion of the infarct-related artery in STEMI. Scand Cardiovasc J 2016;50:114-8. [PMID: 26651498 DOI: 10.3109/14017431.2015.1119303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
423 Ferri LA, Morici N, Grosseto D, Tortorella G, Bossi I, Sganzerla P, Cacucci M, Sibilio G, Tondi S, Toso A, Ferrario M, Gandolfo N, Ravera A, Mariani M, Corrada E, Di Ascenzo L, Petronio AS, Cavallini C, Moffa N, De Servi S, Savonitto S. A comparison of reduced-dose prasugrel and standard-dose clopidogrel in elderly patients with acute coronary syndromes undergoing early percutaneous revascularization: Design and rationale of the randomized Elderly-ACS 2 study. American Heart Journal 2016;181:101-6. [DOI: 10.1016/j.ahj.2016.08.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
424 Elyaspour Z, Zibaeenezhad MJ, Razmkhah M, Razeghian-Jahromi I. Is It All About Endothelial Dysfunction and Thrombosis Formation? The Secret of COVID-19. Clin Appl Thromb Hemost 2021;27:10760296211042940. [PMID: 34693754 DOI: 10.1177/10760296211042940] [Reference Citation Analysis]
425 Shacham Y, Leshem-Rubinow E, Gal-Oz A, Arbel Y, Keren G, Roth A, Steinvil A. Acute Cardio-Renal Syndrome as a Cause for Renal Deterioration Among Myocardial Infarction Patients Treated With Primary Percutaneous Intervention. Can J Cardiol 2015;31:1240-4. [PMID: 26163472 DOI: 10.1016/j.cjca.2015.03.031] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
426 Goto K, Zhao Z, Matsumura M, Dohi T, Kobayashi N, Kirtane AJ, Rabbani LE, Collins MB, Parikh MA, Kodali SK, Leon MB, Moses JW, Mintz GS, Maehara A. Mechanisms and Patterns of Intravascular Ultrasound In-Stent Restenosis Among Bare Metal Stents and First- and Second-Generation Drug-Eluting Stents. The American Journal of Cardiology 2015;116:1351-7. [DOI: 10.1016/j.amjcard.2015.07.058] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
427 Liu R, Xu F, Zhou Y, Liu T. The characteristics of risk factors in Chinese young women with acute coronary syndrome. BMC Cardiovasc Disord 2020;20:290. [PMID: 32532208 DOI: 10.1186/s12872-020-01577-z] [Reference Citation Analysis]
428 Knowles JW, Sarraju A. Is ACS in Young Patients a "Canary in the Coal Mine" for Familial Hypercholesterolemia? J Am Coll Cardiol 2017;70:1741-3. [PMID: 28958331 DOI: 10.1016/j.jacc.2017.08.019] [Reference Citation Analysis]
429 Qamar A, Bhatt DL. Current status of data on cangrelor. Pharmacol Ther 2016;159:102-9. [PMID: 26802900 DOI: 10.1016/j.pharmthera.2016.01.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
430 Pufulete M, Brierley RC, Bucciarelli-Ducci C, Greenwood JP, Dorman S, Anderson RA, Harris J, McAlindon E, Rogers CA, Reeves BC. Formal consensus to identify clinically important changes in management resulting from the use of cardiovascular magnetic resonance (CMR) in patients who activate the primary percutaneous coronary intervention (PPCI) pathway. BMJ Open 2017;7:e014627. [PMID: 28645959 DOI: 10.1136/bmjopen-2016-014627] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
431 Yong CM, Ang L, Welt FGP, Gummidipundi S, Henry TD, Pinto DS, Cox D, Wang P, Asch S, Mahmud E, Fearon WF; Society for Cardiovascular Angiography and Interventions (SCAI) and the American College of Cardiology (ACC) Interventional Council. Cardiac procedural deferral during the coronavirus ( COVID ‐19) pandemic. Catheter Cardiovasc Interv 2020;96:1080-6. [DOI: 10.1002/ccd.29262] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
432 Teng R, Muldowney S, Zhao Y, Berg JK, Lu J, Khan ND. Pharmacokinetics and pharmacodynamics of ticagrelor in subjects on hemodialysis and subjects with normal renal function. Eur J Clin Pharmacol 2018;74:1141-8. [PMID: 29850937 DOI: 10.1007/s00228-018-2484-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
433 Meyer C, Bowers A, Jaiswal D, Checketts J, Engheta M, Severns C, Cook S, Walters C, Vassar M. An analysis of randomized controlled trials underpinning ST-elevation myocardial infarction management guidelines. Am J Emerg Med 2019;37:2229-38. [PMID: 30940409 DOI: 10.1016/j.ajem.2019.03.038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
434 Li M, Li S, Du X, Wu T, Li X, Ma C, Huo Y, Hu D, Gao R, Wu Y. Factors attributed to the higher in-hospital mortality of ST elevation myocardial infarction patients admitted during off-hour in comparison with those during regular hour. PLoS One 2017;12:e0175485. [PMID: 28388683 DOI: 10.1371/journal.pone.0175485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
435 Davis P, Howie GJ, Dicker B, Garrett NK. Paramedic-initiated helivac to tertiary hospital for primary percutaneous coronary intervention: a strategy for improving treatment delivery times. J Thorac Dis 2019;11:1819-30. [PMID: 31285874 DOI: 10.21037/jtd.2019.05.45] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
436 Bian J, Morid MA, Jonnalagadda S, Luo G, Del Fiol G. Automatic identification of high impact articles in PubMed to support clinical decision making. J Biomed Inform 2017;73:95-103. [PMID: 28756159 DOI: 10.1016/j.jbi.2017.07.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
437 Dehmer GJ, Blankenship JC, Cilingiroglu M, Dwyer JG, Feldman DN, Gardner TJ, Grines CL, Singh M. SCAI/ACC/AHA Expert Consensus Document: 2014 update on percutaneous coronary intervention without on-site surgical backup. J Am Coll Cardiol. 2014;63:2624-2641. [PMID: 24651052 DOI: 10.1016/j.jacc.2014.03.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
438 Helft G, Georges J, Mouranche X, Loyeau A, Spaulding C, Caussin C, Benamer H, Garot P, Livarek B, Teiger E, Varenne O, Monségu J, Mapouata M, Petroni T, Hammoudi N, Lambert Y, Dupas F, Laborne F, Lapostolle F, Lefort H, Juliard J, Letarnec J, Lamhaut L, Lebail G, Boche T, Jouven X, Bataille S. Outcomes of primary percutaneous coronary interventions in nonagenarians with acute myocardial infarction. International Journal of Cardiology 2015;192:24-9. [DOI: 10.1016/j.ijcard.2015.04.227] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
439 Hannan EL, Wu Y, Cozzens K, Friedrich M, Tamis-Holland J, Jacobs AK, Ling FSK, King SB 3rd, Venditti FJ, Walford G, Berger PB, Kirtane AJ, Kamran M. Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Before and During COVID in New York. Am J Cardiol 2021;142:25-34. [PMID: 33301770 DOI: 10.1016/j.amjcard.2020.11.033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
440 Ferraioli D, Santoro G, Bellino M, Citro R. Ventricular Septal Defect Complicating Inferior Acute Myocardial Infarction: A Case of Percutaneous Closure. J Cardiovasc Echogr 2019;29:17-9. [PMID: 31008033 DOI: 10.4103/jcecho.jcecho_60_18] [Reference Citation Analysis]
441 Abell JE, Laing SM, Barker TC, Norry EC, Starzyk K, Goodman SG, Dellborg M, Steg PG, Giugliano RP. Adjunctive use of anticoagulants at the time of percutaneous coronary intervention in patients with an acute coronary syndrome treated with fondaparinux: a multinational retrospective review. Eur Heart J Cardiovasc Pharmacother 2017;3:214-20. [PMID: 28430984 DOI: 10.1093/ehjcvp/pvx007] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
442 Khoury S, Carmon S, Margolis G, Keren G, Shacham Y. Incidence and outcomes of early left ventricular thrombus following ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Clin Res Cardiol 2017;106:695-701. [DOI: 10.1007/s00392-017-1111-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
443 Brown KA, Lambert LJ, Brophy JM, Nasmith J, Rinfret S, Segal E, Kouz S, Ross D, Harvey R, Maire S, Boothroyd LJ, Bogaty P. Impact of ECG findings and process-of-care characteristics on the likelihood of not receiving reperfusion therapy in patients with ST-elevation myocardial infarction: results of a field evaluation. PLoS One 2014;9:e104874. [PMID: 25144645 DOI: 10.1371/journal.pone.0104874] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
444 Hobl EL, Schmid RW, Stimpfl T, Ebner J, Jilma B. Absorption kinetics of low-dose chewable aspirin--implications for acute coronary syndromes. Eur J Clin Invest 2015;45:13-7. [PMID: 25402445 DOI: 10.1111/eci.12373] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
445 Bell SP, Schnipper JL, Goggins K, Bian A, Shintani A, Roumie CL, Dalal AK, Jacobson TA, Rask KJ, Vaccarino V, Gandhi TK, Labonville SA, Johnson D, Neal EB, Kripalani S; Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) Study Group. Effect of Pharmacist Counseling Intervention on Health Care Utilization Following Hospital Discharge: A Randomized Control Trial. J Gen Intern Med 2016;31:470-7. [PMID: 26883526 DOI: 10.1007/s11606-016-3596-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 6.6] [Reference Citation Analysis]
446 Sharma A, Lavie CJ, Sharma SK, Garg A, Vallakati A, Mukherjee D, Marmur JD. Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With and Without Acute Coronary Syndrome. Mayo Clinic Proceedings 2016;91:1084-93. [DOI: 10.1016/j.mayocp.2016.06.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
447 Jacobs JA, Pickworth K, Boudoulas KD, Hinkley M, Mclaughlin E, Blais D. Outcomes for Cancer Patients with Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Cardiovascular Revascularization Medicine 2019;20:711-5. [DOI: 10.1016/j.carrev.2018.10.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
448 Guzauskas GF, Basu A, Carlson JJ, Veenstra DL. Are There Different Evidence Thresholds for Genomic Versus Clinical Precision Medicine? A Value of Information-Based Framework Applied to Antiplatelet Drug Therapy. Value Health 2019;22:988-94. [PMID: 31511188 DOI: 10.1016/j.jval.2019.03.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
449 Nikolsky E, Mehran R, Dangas GD, Xu K, Parvataneni R, Witzenbichler B, Guagliumi G, Kornowski R, Généreux P, Brener SJ, Stone GW. Cerebrovascular events after a primary percutaneous coronary intervention strategy for acute ST-segment-elevation myocardial infarction: analysis from the HORIZONS-AMI Trial. Circ Cardiovasc Interv 2015;8:e002283. [PMID: 25858976 DOI: 10.1161/CIRCINTERVENTIONS.114.002283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
450 Jang JS, Han KR, Moon KW, Jeon DW, Shin DH, Kim JS, Park DW, Kang HJ, Kim J, Bae JW, Hur SH, Kim BO, Choi D, Gwon HC, Kim HS. The Current Status of Percutaneous Coronary Intervention in Korea: Based on Year 2014 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) Registry. Korean Circ J 2017;47:328-40. [PMID: 28567083 DOI: 10.4070/kcj.2017.0071] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
451 Foussas SG. Acute Coronary Syndromes and Renal Disease. Hellenic J Cardiol 2016;57:210-3. [PMID: 27566931 DOI: 10.1016/j.hjc.2016.07.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
452 Saadat N, Saadatagah S, Aghajani Nargesi A, Alidoosti M, Poorhosseini H, Amirzadegan A, Lashkari R, Mortazavi SH, Jalali A, Ghodsi S, Salarifar M. Short-term safety and long-term benefits of stent postdilation after primary percutaneous coronary intervention: Results of a cohort study. Catheter Cardiovasc Interv 2020;95:1249-56. [PMID: 31318488 DOI: 10.1002/ccd.28396] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
453 Ibanez B, Macaya C, Sánchez-Brunete V, Pizarro G, Fernández-Friera L, Mateos A, Fernández-Ortiz A, García-Ruiz JM, García-Álvarez A, Iñiguez A, Jiménez-Borreguero J, López-Romero P, Fernández-Jiménez R, Goicolea J, Ruiz-Mateos B, Bastante T, Arias M, Iglesias-Vázquez JA, Rodriguez MD, Escalera N, Acebal C, Cabrera JA, Valenciano J, de Prado AP, Fernández-Campos MJ, Casado I, García-Rubira JC, García-Prieto J, Sanz-Rosa D, Cuellas C, Hernández-Antolín R, Albarrán A, Fernández-Vázquez F, de la Torre-Hernández JM, Pocock S, Sanz G, Fuster V. Response to letter regarding article, "effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial". Circulation 2014;130:e19-20. [PMID: 25024129 DOI: 10.1161/CIRCULATIONAHA.114.009352] [Reference Citation Analysis]
454 Massey HT, Choi JH, Maynes EJ, Tchantchaleishvili V. Temporary support strategies for cardiogenic shock: extracorporeal membrane oxygenation, percutaneous ventricular assist devices and surgically placed extracorporeal ventricular assist devices. Ann Cardiothorac Surg 2019;8:32-43. [PMID: 30854310 DOI: 10.21037/acs.2018.11.05] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
455 Shangguan Q, Xu J, Su H, Li J, Wang W, Hong K, Cheng X. Modified Shock Index is a Predictor for 7-Day Outcomes in Patients With STEMI. The American Journal of Emergency Medicine 2015;33:1072-5. [DOI: 10.1016/j.ajem.2015.04.066] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
456 Shacham Y, Topilsky Y, Leshem-rubinow E, Laufer-perl M, Keren G, Roth A, Steinvil A, Arbel Y. Comparison of Left Ventricular Function Following First ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention in Men Versus Women. The American Journal of Cardiology 2014;113:1941-6. [DOI: 10.1016/j.amjcard.2014.03.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
457 Reddy K, Khaliq A, Henning RJ. Recent advances in the diagnosis and treatment of acute myocardial infarction. World J Cardiol 2015; 7(5): 243-276 [PMID: 26015857 DOI: 10.4330/wjc.v7.i5.243] [Cited by in Crossref: 72] [Cited by in F6Publishing: 62] [Article Influence: 10.3] [Reference Citation Analysis]
458 Teng R. Ticagrelor: Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile: An Update. Clin Pharmacokinet 2015;54:1125-38. [PMID: 26063049 DOI: 10.1007/s40262-015-0290-2] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 9.7] [Reference Citation Analysis]
459 Kumbhani DJ, Cannon CP, Beavers CJ, Bhatt DL, Cuker A, Gluckman TJ, Marine JE, Mehran R, Messe SR, Patel NS, Peterson BE, Rosenfield K, Spinler SA, Thourani VH. 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease. Journal of the American College of Cardiology 2021;77:629-58. [DOI: 10.1016/j.jacc.2020.09.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
460 Pi Y, Roe MT, Holmes DN, Chiswell K, Garvey JL, Fonarow GC, de Lemos JA, Garratt KN, Xian Y. Utilization, Characteristics, and In-Hospital Outcomes of Coronary Artery Bypass Grafting in Patients With ST-Segment–Elevation Myocardial Infarction: Results From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry–Get With The Guidelines. Circ: Cardiovascular Quality and Outcomes 2017;10. [DOI: 10.1161/circoutcomes.116.003490] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.4] [Reference Citation Analysis]
461 Mahmoud KD, Hillege HL, Jaffe AS, Lennon RJ, Holmes DR. Biochemical Validation of Patient-Reported Symptom Onset Time in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions 2015;8:778-87. [DOI: 10.1016/j.jcin.2014.12.242] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
462 Wengrofsky P, Lee J, N. Makaryus A. Dyslipidemia and Its Role in the Pathogenesis of Atherosclerotic Cardiovascular Disease: Implications for Evaluation and Targets for Treatment of Dyslipidemia Based on Recent Guidelines. In: I. Mcfarlane S, editor. Dyslipidemia. IntechOpen; 2019. [DOI: 10.5772/intechopen.85772] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
463 Brown TM, Bittner V, Colantonio LD, Deng L, Farkouh ME, Limdi N, Monda KL, Rosenson RS, Serban MC, Somaratne RM, Zhao H, Woodward M, Muntner P. Residual risk for coronary heart disease events and mortality despite intensive medical management after myocardial infarction. J Clin Lipidol 2020;14:260-70. [PMID: 32115398 DOI: 10.1016/j.jacl.2020.01.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
464 Zhong Y, Rao L. Atrioventricular block after reperfusion: A reflection on early beta-blocker therapy for acute myocardial infarction. Anatol J Cardiol 2017;18:438-9. [PMID: 29256884 DOI: 10.14744/AnatolJCardiol.2017.8159] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
465 Sennhauser S, Anand R, Kusumoto F, Goldschlager N. Heart Rhythm Society: expert consensus statements-part 1. Clin Cardiol 2017;40:177-85. [PMID: 28273360 DOI: 10.1002/clc.22666] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
466 Collinson PO, Garrison L, Christenson RH. Cardiac biomarkers - A short biography. Clin Biochem 2015;48:197-200. [PMID: 25464015 DOI: 10.1016/j.clinbiochem.2014.11.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
467 Moayedi Y, Ross HJ. Advances in heart failure: a review of biomarkers, emerging pharmacological therapies, durable mechanical support and telemonitoring. Clin Sci (Lond) 2017;131:553-66. [PMID: 28302916 DOI: 10.1042/CS20160196] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
468 Serbin MA, Guzauskas GF, Veenstra DL. Clopidogrel-Proton Pump Inhibitor Drug-Drug Interaction and Risk of Adverse Clinical Outcomes Among PCI-Treated ACS Patients: A Meta-analysis. J Manag Care Spec Pharm 2016;22:939-47. [PMID: 27459657 DOI: 10.18553/jmcp.2016.22.8.939] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
469 Gebhard CE, Gebhard C, Maafi F, Bertrand M, Stähli BE, Maredziak M, Bengs S, Haider A, Zhang ZW, Smith DC, Ly HQ. Impact of summer season on pre-hospital time delays in women and men undergoing primary percutaneous coronary intervention. Science of The Total Environment 2019;656:322-30. [DOI: 10.1016/j.scitotenv.2018.11.363] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
470 Abe T, Samuel I, Eferoro E, Samuel AO, Monday IT, Olunu E, Fakoya AO. The Diagnostic Challenges Associated with Type 2 Myocardial Infarction. Int J Appl Basic Med Res 2021;11:131-8. [PMID: 34458113 DOI: 10.4103/ijabmr.IJABMR_210_20] [Reference Citation Analysis]
471 Iqbal J, Fay R, Adlam D, Squire I, Parviz Y, Gunn J, Pitt B, Zannad F. Effect of eplerenone in percutaneous coronary intervention-treated post-myocardial infarction patients with left ventricular systolic dysfunction: a subanalysis of the EPHESUS trial. Eur J Heart Fail 2014;16:685-91. [DOI: 10.1002/ejhf.88] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
472 Marwick TH. Ejection Fraction Pros and Cons. Journal of the American College of Cardiology 2018;72:2360-79. [DOI: 10.1016/j.jacc.2018.08.2162] [Cited by in Crossref: 47] [Cited by in F6Publishing: 31] [Article Influence: 11.8] [Reference Citation Analysis]
473 Rashid MK, Guron N, Bernick J, Wells GA, Blondeau M, Chong A, Dick A, Froeschl MP, Glover CA, Hibbert B, Labinaz M, Marquis J, Osborne C, So DY, Le May MR. Safety and Efficacy of a Pharmacoinvasive Strategy in ST-Segment Elevation Myocardial Infarction. JACC: Cardiovascular Interventions 2016;9:2014-20. [DOI: 10.1016/j.jcin.2016.07.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
474 Patel A, Parikh R, Poddar KL, Ellis SG, Tuzcu EM, Kapadia SR. Frequency and factors associated with inappropriate for intervention cardiac catheterization laboratory activation. Cardiovasc Revasc Med 2016;17:219-24. [PMID: 27150501 DOI: 10.1016/j.carrev.2016.03.015] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
475 Deedwania P, Acharya T, Kotak K, Fonarow GC, Cannon CP, Laskey WK, Peacock WF, Pan W, Bhatt DL. Compliance with guideline-directed therapy in diabetic patients admitted with acute coronary syndrome: Findings from the American Heart Association's Get With The Guidelines–Coronary Artery Disease (GWTG-CAD) program. American Heart Journal 2017;187:78-87. [DOI: 10.1016/j.ahj.2017.02.025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
476 Ouweneel DM, Sjauw KD, Wiegerinck EMA, Hirsch A, Baan J, de Mol BAJM, Lagrand WK, Planken RN, Henriques JPS. Assessment of Cardiac Device Position on Supine Chest Radiograph in the ICU: Introduction and Applicability of the Aortic Valve Location Ratio. Critical Care Medicine 2016;44:e957-63. [DOI: 10.1097/ccm.0000000000001858] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
477 Thiele H, de Waha S, Zeymer U, Desch S, Scheller B, Lauer B, Geisler T, Gawaz M, Gunkel O, Bruch L, Klein N, Pfeiffer D, Schuler G, Eitel I. Effect of Aspiration Thrombectomy on Microvascular Obstruction in NSTEMI Patients. Journal of the American College of Cardiology 2014;64:1117-24. [DOI: 10.1016/j.jacc.2014.05.064] [Cited by in Crossref: 54] [Cited by in F6Publishing: 37] [Article Influence: 6.8] [Reference Citation Analysis]
478 Allencherril J, Alam M, Levine G, Jneid H, Atar D, Kloner RA, Birnbaum Y. Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction? J Cardiovasc Pharmacol Ther 2019;24:215-24. [PMID: 30563349 DOI: 10.1177/1074248418812167] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
479 McMaster KS, Chatterjee T, McBrayer D, Brabham D. Thrombolytic use in the region around Amarillo, Texas, in patients with ST elevation myocardial infarction. Proc (Bayl Univ Med Cent) 2018;31:9-11. [PMID: 29686544 DOI: 10.1080/08998280.2017.1400877] [Reference Citation Analysis]
480 Harhash AA, May TL, Hsu CH, Agarwal S, Seder DB, Mooney MR, Patel N, McPherson J, McMullan P, Riker R, Soreide E, Hirsch KG, Stammet P, Dupont A, Rubertsson S, Friberg H, Nielsen N, Rab T, Kern KB. Risk Stratification Among Survivors of Cardiac Arrest Considered for Coronary Angiography. J Am Coll Cardiol 2021;77:360-71. [PMID: 33509392 DOI: 10.1016/j.jacc.2020.11.043] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
481 Cui K, Lyu S, Song X, Liu H, Yuan F, Xu F, Zhang M, Wang W, Zhang M, Zhang D, Dai J, Tian J. Long-term outcomes of in-hospital staged revascularization versus culprit-only intervention for patients with ST-segment elevation myocardial infarction and multivessel disease. Coron Artery Dis 2019;30:188-95. [PMID: 30724818 DOI: 10.1097/MCA.0000000000000701] [Reference Citation Analysis]
482 He PC, Duan CY, Liu YH, Wei XB, Lin SG. N-terminal pro-brain natriuretic peptide improves the C-ACS risk score prediction of clinical outcomes in patients with ST-elevation myocardial infarction. BMC Cardiovasc Disord 2016;16:255. [PMID: 27955618 DOI: 10.1186/s12872-016-0430-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
483 Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, Davila-roman VG, Gerhard-herman MD, Holly TA, Kane GC, Marine JE, Nelson MT, Spencer CC, Thompson A, Ting HH, Uretsky BF, Wijeysundera DN. 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: Executive Summary. Journal of the American College of Cardiology 2014;64:2373-405. [DOI: 10.1016/j.jacc.2014.07.945] [Cited by in Crossref: 66] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
484 Ezekowitz MD, Kurz D, Kent A. Left Ventricular Thrombi. Journal of the American College of Cardiology 2020;75:1686-8. [DOI: 10.1016/j.jacc.2020.02.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
485 Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR, Jaffe AS, Jneid H, Kelly RF, Kontos MC. 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64:e139-e228. [PMID: 25260718 DOI: 10.1016/j.jacc.2014.09.017] [Cited by in Crossref: 1538] [Cited by in F6Publishing: 1248] [Article Influence: 192.3] [Reference Citation Analysis]
486 Yang JQ, Guo XS, Ran P, Hu XM, Tan N. The relationship between pre-procedural elevated arterial lactate and contrast-induced nephropathy following primary percutaneous coronary intervention. J Thorac Dis 2021;13:5467-76. [PMID: 34659813 DOI: 10.21037/jtd-21-1153] [Reference Citation Analysis]
487 Yang Y, Han X, Chen Y, Gao L, Yin X, Li H, Qiu J, Wang Y, Zhou Y, Xia Y. Association between modifiable lifestyle and the prevalence of atrial fibrillation in a Chinese population: Based on the cardiovascular health score. Clin Cardiol 2017;40:1061-7. [PMID: 28833291 DOI: 10.1002/clc.22771] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
488 Hua K, Peng Z, Yang X. Long-Term Survival and Risk Factors for Post-Infarction Ventricular Septal Rupture. Heart Lung Circ 2021;30:978-85. [PMID: 33495129 DOI: 10.1016/j.hlc.2020.11.013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
489 Jang H, Oh PC, Moon J, Suh J, Park HW, Park S, Lee K, Kim JS, Lee HJ, Choi RK, Choi Y, Kang WC, Kwon SW, Kim T. Prognostic Impact of Combined Dysglycemia and Hypoxic Liver Injury on Admission in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention (from the INTERSTELLAR Cohort). The American Journal of Cardiology 2017;119:1179-85. [DOI: 10.1016/j.amjcard.2017.01.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
490 Heckle MR, McCoy CW, Akinseye OA, Khouzam RN. Stress-induced thrombus: prevalence of thromboembolic events and the role of anticoagulation in Takotsubo cardiomyopathy. Ann Transl Med 2018;6:4. [PMID: 29404350 DOI: 10.21037/atm.2017.11.01] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
491 Gao H, Aderhold A, Mangion K, Luo X, Husmeier D, Berry C. Changes and classification in myocardial contractile function in the left ventricle following acute myocardial infarction. J R Soc Interface 2017;14:20170203. [PMID: 28747397 DOI: 10.1098/rsif.2017.0203] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
492 Weissler-Snir A, Gurevitz C, Assali A, Vaknin-Assa H, Bental T, Lador A, Yavin H, Perl L, Kornowski R, Lev E. Prognosis of STEMI Patients with Multi-Vessel Disease Undergoing Culprit-Only PCI without Significant Residual Ischemia on Non-Invasive Stress Testing. PLoS One. 2015;10:e0138474. [PMID: 26406235 DOI: 10.1371/journal.pone.0138474] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
493 Dark C, Xu Y, Kao E. Comparative throughput at freestanding emergency departments versus hospital-based emergency departments: A pilot study. The American Journal of Emergency Medicine 2018;36:1508-9. [DOI: 10.1016/j.ajem.2017.12.048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
494 Kones R, Rumana U. Cardiometabolic diseases of civilization: history and maturation of an evolving global threat. An update and call to action. Ann Med 2017;49:260-74. [PMID: 27936950 DOI: 10.1080/07853890.2016.1271957] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
495 Choi IJ, Lim S, Choo EH, Hwang BH, Kim CJ, Park MW, Lee JM, Park CS, Kim HY, Yoo KD, Jeon DS, Youn HJ, Chung WS, Kim MC, Jeong MH, Ahn Y, Chang K. Impact of Intravascular Ultrasound on Long-Term Clinical Outcomes in Patients With Acute Myocardial Infarction. JACC Cardiovasc Interv 2021;14:2431-43. [PMID: 34756537 DOI: 10.1016/j.jcin.2021.08.021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
496 Gerbaud E, Bouisset F, Ferrières J. Late is not always too late for revascularization in late-presenting patients with ST-segment elevation myocardial infarction. Arch Cardiovasc Dis 2021;114:691-3. [PMID: 34772645 DOI: 10.1016/j.acvd.2021.10.001] [Reference Citation Analysis]
497 Zhang Q, Wang CM, Shi ST, Chen H, Zhou YJ. Relationship of left ventricular thrombus formation and adverse outcomes in acute anterior myocardial infarction in patients treated with primary percutaneous coronary intervention. Clin Cardiol 2019;42:69-75. [PMID: 30367476 DOI: 10.1002/clc.23106] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
498 Ryngach ЕА, Treshkur TV, Tatarinova AA, Shlyakhto EV. [Algorithm for the management of patients with stable coronary artery disease and high-grade ventricular arrhythmias]. Ter Arkh 2017;89:94-102. [PMID: 28635905 DOI: 10.17116/terarkh201789194-102] [Cited by in Crossref: 7] [Article Influence: 1.4] [Reference Citation Analysis]
499 Sribhutorn A, Phrommintikul A, Wongcharoen W, Chaikledkaew U, Eakanunkul S, Sukonthasarn A. The Modification Effect of Influenza Vaccine on Prognostic Indicators for Cardiovascular Events after Acute Coronary Syndrome: Observations from an Influenza Vaccination Trial. Cardiol Res Pract 2016;2016:4097471. [PMID: 27200206 DOI: 10.1155/2016/4097471] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
500 Qamar A, Bhatt DL. Optimizing the Use of Cangrelor in the Real World. Am J Cardiovasc Drugs 2017;17:5-16. [PMID: 27677505 DOI: 10.1007/s40256-016-0192-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
501 Vargas KG, Jäger B, Kaufmann CC, Biagioli A, Watremez S, Gatto F, Özbek C, Razouk A, Geppert A, Huber K. Impella in cardiogenic shock following acute myocardial infarction: a systematic review and meta-analysis. Wien Klin Wochenschr 2020;132:716-25. [DOI: 10.1007/s00508-020-01712-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
502 Tatlisu MA, Kaya A, Keskin M, Uzman O, Borklu EB, Cinier G, Hayiroglu MI, Eren M. The association of the coronary thrombus burden with all-cause mortality and major cardiac events in ST-segment elevation myocardial infarction patients treated with tirofiban. Coronary Artery Disease 2016;27:543-50. [DOI: 10.1097/mca.0000000000000399] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
503 Banning AS, Gershlick AH. Management of Multivessel Coronary Disease in ST-segment Elevation Myocardial Infarction. Curr Cardiol Rep 2015;17:632. [PMID: 26238745 DOI: 10.1007/s11886-015-0632-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
504 Kimura K, Nakao K, Shibata Y, Sone T, Takayama T, Fukuzawa S, Nakama Y, Hirayama H, Matsumoto N, Kosuge M, Hiro T, Sakuma H, Ishihara M, Asakura M, Hamada C, Kaneko A, Yokoi T, Hirayama A; AMITY study group. Randomized controlled trial of TY-51924, a novel hydrophilic NHE inhibitor, in acute myocardial infarction. J Cardiol 2016;67:307-13. [PMID: 26359711 DOI: 10.1016/j.jjcc.2015.07.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
505 Roe MT, Sherwood MW. Uncovering the shroud on antiplatelet therapy for patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. JACC Cardiovasc Interv 2014;7:613-4. [PMID: 24947720 DOI: 10.1016/j.jcin.2014.02.008] [Reference Citation Analysis]
506 Cicci JD, Iyer P, Clarke MM, Mazzella AJ. Aspirin for the Primary Prevention of Cardiovascular Disease: A Review of the Literature and Considerations for Clinical Practice. Cardiology in Review 2020;28:98-106. [DOI: 10.1097/crd.0000000000000297] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
507 Esposito A, Gallone G, Palmisano A, Marchitelli L, Catapano F, Francone M. The current landscape of imaging recommendations in cardiovascular clinical guidelines: toward an imaging-guided precision medicine. Radiol Med 2020;125:1013-23. [PMID: 32964326 DOI: 10.1007/s11547-020-01286-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
508 Dakhil ZA, Farhan HA. Non-ST elevation acute coronary syndromes; clinical landscape, management strategy and in-hospital outcomes: an age perspective. Egypt Heart J 2021;73:33. [PMID: 33788051 DOI: 10.1186/s43044-021-00155-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
509 Johnson NP, Gould KL, Di Carli MF, Taqueti VR. Invasive FFR and Noninvasive CFR in the Evaluation of Ischemia: What Is the Future? J Am Coll Cardiol. 2016;67:2772-2788. [PMID: 27282899 DOI: 10.1016/j.jacc.2016.03.584] [Cited by in Crossref: 50] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
510 Kızıltunç E, Ünlü S, Yakıcı İE, Kundi H, Korkmaz A, Çetin M, Örnek E. Clinical characteristics and prognosis of cardiac tamponade patients: 5‑year experience at a tertiary center. Herz 2020;45:676-83. [PMID: 30470911 DOI: 10.1007/s00059-018-4769-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
511 Bennett CE, Anavekar NS, Gulati R, Singh M, Kane GC, Sandoval Y, Foley TA, Jaffe AS, Sandhu GS, Bell MR, Askew JW. ST-segment Elevation, Myocardial Injury, and Suspected or Confirmed COVID-19 Patients: Diagnostic and Treatment Uncertainties. Mayo Clin Proc 2020;95:1107-11. [PMID: 32414550 DOI: 10.1016/j.mayocp.2020.04.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
512 Wong CK. Simplifying electrocardiographic assessment in STEMI reperfusion management: Pros and cons. Int J Cardiol 2017;227:30-6. [PMID: 27846459 DOI: 10.1016/j.ijcard.2016.11.167] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
513 Hemradj VV, Karami M, Sjauw KD, Engström AE, Ouweneel DM, de Brabander J, Vis MM, Wykrzykowska JJ, Beijk MA, Koch KT, Baan J, de Winter RJ, Piek JJ, Driessen AHG, Lagrand WK, Vlaar APJ, Ottervanger JP, Henriques JPS. Pre-PCI versus immediate post-PCI Impella initiation in acute myocardial infarction complicated by cardiogenic shock. PLoS One 2020;15:e0235762. [PMID: 32687502 DOI: 10.1371/journal.pone.0235762] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
514 Tewelde SZ, Mattu A, Brady WJ Jr. Pitfalls in Electrocardiographic Diagnosis of Acute Coronary Syndrome in Low-Risk Chest Pain. West J Emerg Med 2017;18:601-6. [PMID: 28611879 DOI: 10.5811/westjem.2017.1.32699] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
515 Bhogal S, Mukherjee D, Bagai J, Truong HT, Panchal HB, Murtaza G, Zaman M, Sachdeva R, Paul TK. Bivalirudin Versus Heparin During Intervention in Acute Coronary Syndrome: A Systematic Review of Randomized Trials. Cardiovasc Hematol Disord Drug Targets 2020;20:3-15. [PMID: 31241442 DOI: 10.2174/1871529X19666190626124057] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
516 Polgreen LA, Cook EA, Brooks JM, Tang Y, Polgreen PM. Increased statin prescribing does not lower pneumonia risk. Clin Infect Dis 2015;60:1760-6. [PMID: 25759433 DOI: 10.1093/cid/civ190] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
517 Jentzer JC, Herrmann J, Prasad A, Barsness GW, Bell MR. Utility and Challenges of an Early Invasive Strategy in Patients Resuscitated From Out-of-Hospital Cardiac Arrest. JACC Cardiovasc Interv 2019;12:697-708. [PMID: 31000007 DOI: 10.1016/j.jcin.2019.01.245] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
518 Kala P. European Society of Cardiology ST-segment Elevation Myocardial Infarction Guidelines in Perspective - Focused on Primary Percutaneous Coronary Intervention. Interv Cardiol 2014;9:7-10. [PMID: 29588770 DOI: 10.15420/icr.2011.9.1.7] [Reference Citation Analysis]
519 Kim YH, Her AY, Jeong MH, Kim BK, Hong SJ, Park SH, Kim BG, Kim S, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y. Outcomes between prediabetes and type 2 diabetes mellitus in older adults with acute myocardial infarction in the era of newer-generation drug-eluting stents: a retrospective observational study. BMC Geriatr 2021;21:653. [PMID: 34798819 DOI: 10.1186/s12877-021-02601-3] [Reference Citation Analysis]
520 Lüscher TF. Refining the management of acute coronary and aortic syndromes. Eur Heart J 2019;40:1893-7. [PMID: 33215638 DOI: 10.1093/eurheartj/ehz449] [Reference Citation Analysis]
521 Fan L, Liu B, Guo R, Luo J, Li H, Li Z, Xu W. Elevated plasma S100A1 level is a risk factor for ST-segment elevation myocardial infarction and associated with post-infarction cardiac function. Int J Med Sci 2019;16:1171-9. [PMID: 31523180 DOI: 10.7150/ijms.35037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
522 Calderón-sánchez EM, Domínguez-rodríguez A, López-haldón J, Jiménez-navarro MF, Gómez AM, Smani T, Ordóñez A. Efecto cardioprotector de la ranolazina en el proceso de isquemia-reperfusión en cardiomiocitos de rata adultos. Revista Española de Cardiología 2016;69:45-53. [DOI: 10.1016/j.recesp.2015.02.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
523 Mahmood MM, Watt J, Ahmed JM. Thrombus aspiration during primary percutaneous coronary intervention for acute myocardial infarction: A review of clinical evidence and guidelines. World J Cardiol 2015; 7(12): 889-894 [PMID: 26730294 DOI: 10.4330/wjc.v7.i12.889] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
524 de Waha S, Desch S, Eitel I, Fuernau G, Lurz P, Sandri M, Schuler G, Thiele H. Reprint of “Intra-aortic balloon counterpulsation — Basic principles and clinical evidence”. Vascular Pharmacology 2014;61:30-4. [DOI: 10.1016/j.vph.2014.03.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
525 Kocas C, Abaci O, Halil GS, Arslan S, Cetinkal G, Bostan C, Coskun U, Yildiz A, Ersanli M. Admission hyperglycemia is associated with failed reperfusion following fibrinolytic therapy in patients with STEMI: results of a retrospective study. Am J Cardiovasc Drugs 2015;15:35-42. [PMID: 25424148 DOI: 10.1007/s40256-014-0097-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
526 Amraotkar AR, Ghafghazi S, Trainor PJ, Hargis CW, Irfan AB, Rai SN, Bhatnagar A, DeFilippis AP. Presence of multiple coronary angiographic characteristics for the diagnosis of acute coronary thrombus. Cardiol J 2017;24:25-34. [PMID: 28150291 DOI: 10.5603/CJ.a2017.0004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
527 Serón P, Oliveros MJ, Marzuca-Nassr GN, Lanas F, Morales G, Román C, Muñoz SR, Saavedra N, Grace SL. Hybrid cardiac rehabilitation trial (HYCARET): protocol of a randomised, multicentre, non-inferiority trial in South America. BMJ Open 2019;9:e031213. [PMID: 31662385 DOI: 10.1136/bmjopen-2019-031213] [Reference Citation Analysis]
528 Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2017;72:S0735-1097(17)41306-4. [PMID: 29097296 DOI: 10.1016/j.jacc.2017.10.054] [Cited by in Crossref: 286] [Cited by in F6Publishing: 234] [Article Influence: 71.5] [Reference Citation Analysis]
529 Yamada T, Takahashi A, Mizuguchi Y, Hashimoto S, Taniguchi N, Nakajima S, Hata T. Impact of shorter door-to-balloon time on prognosis of patients with STEMI-single-center analysis with a large proportion of the patients treated within 30 min. Cardiovasc Interv Ther 2019;34:97-104. [PMID: 29736670 DOI: 10.1007/s12928-018-0521-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
530 Chen T, Wang Q, Liu G, Jin Q, Liu C, Gao L, Chen Y, Guo J. Safety and efficacy of intracoronary thrombolytic therapy via a new infusion catheter in patients with ST-segment elevation myocardial infarction with large thrombus burden: a pilot study. Coron Artery Dis 2021;32:205-10. [PMID: 32558694 DOI: 10.1097/MCA.0000000000000915] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
531 Goedemans L, Hoogslag GE, Abou R, Schalij MJ, Marsan NA, Bax JJ, Delgado V. ST-Segment Elevation Myocardial Infarction in Patients With Chronic Obstructive Pulmonary Disease: Prognostic Implications of Right Ventricular Systolic Dysfunction as Assessed with Two-Dimensional Speckle-Tracking Echocardiography. J Am Soc Echocardiogr 2019;32:1277-85. [PMID: 31311703 DOI: 10.1016/j.echo.2019.05.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
532 Sappa R, Grillo MT, Cinquetti M, Prati G, Spedicato L, Nucifora G, Perkan A, Zanuttini D, Sinagra G, Proclemer A. Short and long-term outcome in very old patients with ST-elevation myocardial infarction after primary percutaneous coronary intervention. Int J Cardiol 2017;249:112-8. [PMID: 28935461 DOI: 10.1016/j.ijcard.2017.09.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
533 Peck KY, Andrianopoulos N, Dinh D, Roberts L, Duffy SJ, Sebastian M, Clark D, Brennan A, Oqueli E, Ajani AE, Reid CM, Freeman M, Teh AW. Role of beta blockers following percutaneous coronary intervention for acute coronary syndrome. Heart 2021;107:728-33. [PMID: 32887736 DOI: 10.1136/heartjnl-2020-316605] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
534 Galli A, Lombardi F. Postinfarct Left Ventricular Remodelling: A Prevailing Cause of Heart Failure. Cardiol Res Pract 2016;2016:2579832. [PMID: 26989555 DOI: 10.1155/2016/2579832] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 6.3] [Reference Citation Analysis]
535 Sandoval Y, Smith SW, Thordsen SE, Apple FS. Supply/demand type 2 myocardial infarction: should we be paying more attention? J Am Coll Cardiol 2014;63:2079-87. [PMID: 24632278 DOI: 10.1016/j.jacc.2014.02.541] [Cited by in Crossref: 93] [Cited by in F6Publishing: 82] [Article Influence: 11.6] [Reference Citation Analysis]
536 Rosanio S, Keylani AM, D'agostino DC, Delaughter CM, Vitarelli A. Pharmacology, benefits, unaddressed questions, and pragmatic issues of the newer oral anticoagulants for stroke prophylaxis in non-valvular atrial fibrillation and proposal of a management algorithm. International Journal of Cardiology 2014;174:471-83. [DOI: 10.1016/j.ijcard.2014.04.179] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
537 Ferreiro JL, Sánchez-Salado JC, Gracida M, Marcano AL, Roura G, Ariza A, Gómez-Lara J, Lorente V, Romaguera R, Homs S, Sánchez-Elvira G, Teruel L, Rivera K, Sosa SG, Gómez-Hospital JA, Angiolillo DJ, Cequier A. Impact of mild hypothermia on platelet responsiveness to aspirin and clopidogrel: an in vitro pharmacodynamic investigation. J Cardiovasc Transl Res 2014;7:39-46. [PMID: 24362676 DOI: 10.1007/s12265-013-9533-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
538 Al-Hijji MA, Gulati R, Lennon RJ, Bell M, El Sabbagh A, Park JY, Slusser J, Sandhu GS, Reeder GS, Rihal CS, Singh M. Outcomes of Percutaneous Coronary Interventions in Patients With Anemia Presenting With Acute Coronary Syndrome. Mayo Clin Proc 2018;93:1448-61. [PMID: 30286831 DOI: 10.1016/j.mayocp.2018.03.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
539 Gostoli S, Bonomo M, Roncuzzi R, Biffi M, Boriani G, Rafanelli C. Psychological correlates, allostatic overload and clinical course in patients with implantable cardioverter defibrillator (ICD). International Journal of Cardiology 2016;220:360-4. [DOI: 10.1016/j.ijcard.2016.06.246] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
540 Steg PG, Bhatt DL, Hamm CW, Stone GW, Gibson CM, Mahaffey KW, Leonardi S, Liu T, Skerjanec S, Day JR, Iwaoka RS, Stuckey TD, Gogia HS, Gruberg L, French WJ, White HD, Harrington RA; CHAMPION Investigators. Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data. Lancet 2013;382:1981-92. [PMID: 24011551 DOI: 10.1016/S0140-6736(13)61615-3] [Cited by in Crossref: 206] [Cited by in F6Publishing: 30] [Article Influence: 22.9] [Reference Citation Analysis]
541 Choi SY, Choi BG, Rha SW, Byun JK, Shim MS, Li H, Mashaly A, Choi CU, Park CG, Seo HS, Oh DJ, Jeong MH; Other Korea Acute Myocardial Infarction Registry (KAMIR) investigators. Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers in acute ST-segment elevation myocardial infarction patients with diabetes mellitus undergoing percutaneous coronary intervention. Int J Cardiol 2017;249:48-54. [PMID: 28867244 DOI: 10.1016/j.ijcard.2017.08.030] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
542 Sidhu MS, Lyubarova R, Bangalore S, Bonaca MP. Challenges of Long-term Dual Antiplatelet Therapy Use Following Acute Coronary Syndromes: Patient Selection for Long-term DAPT After ACS. Am Heart J 2021:S0002-8703(21)00478-6. [PMID: 34933000 DOI: 10.1016/j.ahj.2021.12.005] [Reference Citation Analysis]
543 Maniwa N, Fujino M, Nakai M, Nishimura K, Miyamoto Y, Kataoka Y, Asaumi Y, Tahara Y, Nakanishi M, Anzai T, Kusano K, Akasaka T, Goto Y, Noguchi T, Yasuda S. Anticoagulation combined with antiplatelet therapy in patients with left ventricular thrombus after first acute myocardial infarction. Eur Heart J 2018;39:201-8. [PMID: 29029233 DOI: 10.1093/eurheartj/ehx551] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 15.3] [Reference Citation Analysis]
544 Taty Zau JF, Costa Zeferino R, Sandrine Mota N, Fernandes Martins G, Manoel Serra S, Bonates da Cunha T, Medeiros Lima D, Bragança Pereira B, Matos do Nascimento E, Filho DW, Curi Pedrosa R, Pedrosa RC. Exercise through a cardiac rehabilitation program attenuates oxidative stress in patients submitted to coronary artery bypass grafting. Redox Rep 2018;23:94-9. [PMID: 29279041 DOI: 10.1080/13510002.2017.1418191] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
545 Dieplinger B, Egger M, Luft C, Hinterreiter F, Pernerstorfer T, Haltmayer M, Mueller T. Comparison between activated clotting time and anti-activated factor X activity for the monitoring of unfractionated heparin therapy in patients with aortic aneurysm undergoing an endovascular procedure. Journal of Vascular Surgery 2018;68:400-7. [DOI: 10.1016/j.jvs.2017.11.079] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
546 Carey MG. Acute Coronary Syndrome and ST Segment Monitoring. Crit Care Nurs Clin North Am 2016;28:347-55. [PMID: 27484662 DOI: 10.1016/j.cnc.2016.04.006] [Reference Citation Analysis]
547 Marbach JA, Chweich H, Miyashita S, Kapur NK. Temporary mechanical circulatory support devices: updates from recent studies. Curr Opin Cardiol 2021;36:375-83. [PMID: 33990478 DOI: 10.1097/HCO.0000000000000880] [Reference Citation Analysis]
548 Bailes J, Soloviev M. Insulin-Like Growth Factor-1 (IGF-1) and Its Monitoring in Medical Diagnostic and in Sports. Biomolecules 2021;11:217. [PMID: 33557137 DOI: 10.3390/biom11020217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
549 Hoogslag GE, Haeck ML, Velders MA, Joyce E, Boden H, Schalij MJ, Bax JJ, Ajmone Marsan N, Delgado V. Determinants of Right Ventricular Remodeling Following ST-Segment Elevation Myocardial Infarction. The American Journal of Cardiology 2014;114:1490-6. [DOI: 10.1016/j.amjcard.2014.08.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
550 Zhang S, Zhou H, Zhuang X, Yang D, Sun X, Zhong X, Lin X, Hu X, Huang Y, Liao X, Du Z. Critical appraisal of guidelines for coronary artery disease on dual antiplatelet therapy: More consensus than controversies. Clin Cardiol 2019;42:1170-80. [PMID: 31609463 DOI: 10.1002/clc.23275] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
551 Doersch KM, Tong CW, Gongora E, Konda S, Sareyyupoglu B. Temporary left ventricular assist device through an axillary access is a promising approach to improve outcomes in refractory cardiogenic shock patients. ASAIO J 2015;61:253-8. [PMID: 25923576 DOI: 10.1097/MAT.0000000000000222] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
552 Shemin RJ. American College of Cardiology/American Heart Association 2016 dual antiplatelet therapy (DAPT) focused update: Implications for surgeons. J Thorac Cardiovasc Surg 2016;152:1276-8. [PMID: 27189892 DOI: 10.1016/j.jtcvs.2016.04.047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
553 Lemkes J, Nijveldt R, Beek AM, Knaapen P, Hirsch A, Meijers J, Allaart CP, van Rossum A, van Royen N. Evaluating the Optimal Timing of Revascularisation in Patients with Transient ST-Segment Elevation Myocardial Infarction: Rationale and Design of the TRANSIENT Trial. J of Cardiovasc Trans Res 2014;7:590-6. [DOI: 10.1007/s12265-014-9572-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
554 Abrich VA, Rokey R, Bhupathi SS, Mesa JE. Variability of door-to-device times at a rural tertiary care center. Clin Med Res 2014;12:138-46. [PMID: 24667220 DOI: 10.3121/cmr.2014.1221] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
555 Samanta R, Narayan A, Kovoor P, Thiagalingam A. Long-term survival in patients presenting with STEMI complicated by out of hospital cardiac arrest. Int J Cardiol Heart Vasc 2019;22:50-4. [PMID: 30603662 DOI: 10.1016/j.ijcha.2018.12.001] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
556 Xiao-Dong Z, Fei-Fei L, Zhan-Peng W, Xin-Xue L, Zhi-Min D. Renin-angiotensin system inhibitors in patients with coronary artery disease who have undergone percutaneous coronary intervention. Ther Adv Cardiovasc Dis 2016;10:172-7. [PMID: 27185017 DOI: 10.1177/1753944716648851] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
557 Sharma A, Hai O, Garg A, Vallakati A, Lavie CJ, Marmur JD. Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Current Problems in Cardiology 2017;42:404-17. [DOI: 10.1016/j.cpcardiol.2017.04.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
558 Li M, Wang H, Xuan L, Shi X, Zhou T, Zhang N, Huang Y. Associations between P2RY12 gene polymorphisms and risks of clopidogrel resistance and adverse cardiovascular events after PCI in patients with acute coronary syndrome. Medicine (Baltimore) 2017;96:e6553. [PMID: 28383427 DOI: 10.1097/MD.0000000000006553] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
559 Lewis EF, Kim HY, Claggett B, Spertus J, Heitner JF, Assmann SF, Kenwood CT, Solomon SD, Desai AS, Fang JC, McKinlay SA, Pitt BA, Pfeffer MA; TOPCAT Investigators. Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial. Circ Heart Fail 2016;9:e001937. [PMID: 26962133 DOI: 10.1161/CIRCHEARTFAILURE.114.001937] [Cited by in Crossref: 48] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
560 Kloner RA, Braunwald E. Intravenous Beta-Blockade for Limiting Myocardial Infarct Size. Journal of the American College of Cardiology 2016;67:2105-7. [DOI: 10.1016/j.jacc.2016.02.061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
561 de Oliveira FA, Shahin MH, Gong Y, McDonough CW, Beitelshees AL, Gums JG, Chapman AB, Boerwinkle E, Turner ST, Frye RF, Fiehn O, Kaddurah-Daouk R, Johnson JA, Cooper-DeHoff RM. Novel plasma biomarker of atenolol-induced hyperglycemia identified through a metabolomics-genomics integrative approach. Metabolomics 2016;12:129. [PMID: 28217400 DOI: 10.1007/s11306-016-1076-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
562 Mazhar J, Mashicharan M, Farshid A. Predictors and outcome of no-reflow post primary percutaneous coronary intervention for ST elevation myocardial infarction. Int J Cardiol Heart Vasc. 2015;10:8-12. [PMID: 28616509 DOI: 10.1016/j.ijcha.2015.11.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
563 Kubo S, Ohya M, Kuwayama A, Shimada T, Miura K, Amano H, Otsuru S, Habara S, Tada T, Tanaka H, Fuku Y, Goto T, Kadota K. Very long-term serial luminal changes after sirolimus-eluting stent implantation and progression process of very late stent failure. Cardiovasc Revasc Med 2018;19:88-94. [PMID: 28778392 DOI: 10.1016/j.carrev.2017.06.017] [Reference Citation Analysis]
564 Meyers HP, Jaffa E, Smith SW, Drake W, Limkakeng AT Jr. Evaluation of T-Wave Morphology in Patients With Left Bundle Branch Block and Suspected Acute Coronary Syndrome. J Emerg Med 2016;51:229-37. [PMID: 27318856 DOI: 10.1016/j.jemermed.2016.05.004] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
565 Bruning R, Dykes H, Jones TW, Wayne NB, Sikora Newsome A. Beta-Adrenergic Blockade in Critical Illness. Front Pharmacol 2021;12:735841. [PMID: 34721025 DOI: 10.3389/fphar.2021.735841] [Reference Citation Analysis]
566 Dahal K, Hendrani A, Sharma SP, Singireddy S, Mina G, Reddy P, Dominic P, Modi K. Aldosterone Antagonist Therapy and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Without Heart Failure: A Systematic Review and Meta-analysis. JAMA Intern Med 2018;178:913-20. [PMID: 29799995 DOI: 10.1001/jamainternmed.2018.0850] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
567 Tsukui T, Sakakura K, Taniguchi Y, Yamamoto K, Seguchi M, Jinnouchi H, Wada H, Fujita H. Factors associated with poor clinical outcomes of ST-elevation myocardial infarction in patients with door-to-balloon time <90 minutes. PLoS One 2020;15:e0241251. [PMID: 33091051 DOI: 10.1371/journal.pone.0241251] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
568 Ongstad EL, Gourdie RG. Can heart function lost to disease be regenerated by therapeutic targeting of cardiac scar tissue? Semin Cell Dev Biol 2016;58:41-54. [PMID: 27234380 DOI: 10.1016/j.semcdb.2016.05.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
569 Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2018;72:1677-749. [PMID: 29097294 DOI: 10.1016/j.jacc.2017.10.053] [Cited by in Crossref: 145] [Cited by in F6Publishing: 127] [Article Influence: 29.0] [Reference Citation Analysis]
570 Gu J, Yin ZF, Xu ZJ, Fan YQ, Wang CQ, Zhang JF. Incident Heart Failure in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention. Front Cardiovasc Med 2021;8:727727. [PMID: 34671653 DOI: 10.3389/fcvm.2021.727727] [Reference Citation Analysis]
571 Nguyen HL, Yarzebski J, Lessard D, Gore JM, McManus DD, Goldberg RJ. Ten-Year (2001-2011) Trends in the Incidence Rates and Short-Term Outcomes of Early Versus Late Onset Cardiogenic Shock After Hospitalization for Acute Myocardial Infarction. J Am Heart Assoc 2017;6:e005566. [PMID: 28592462 DOI: 10.1161/JAHA.117.005566] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
572 Park JJ, Kim SH, Kang SH, Yoon CH, Cho YS, Youn TJ, Chae IH, Choi DJ. Effect of β-Blockers Beyond 3 Years After Acute Myocardial Infarction. J Am Heart Assoc 2018;7:e007567. [PMID: 29502101 DOI: 10.1161/JAHA.117.007567] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
573 Quraishi AU, Lambert LJ, Madan M, Gong Y, Forsey A, Galbraith D, Gill N, Oakes GH, Lavoie A, Carere RG, Welsh RC; PCI Quality Indicator Working Group. Quality of Care for Percutaneous Coronary Intervention: Development of Canadian Cardiovascular Society Quality Indicators. Can J Cardiol 2016;32:1570-3. [PMID: 27743759 DOI: 10.1016/j.cjca.2016.07.511] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
574 Ma M, Diao KY, Yang ZG, Zhu Y, Guo YK, Yang MX, Zhang Y, He Y. Clinical associations of microvascular obstruction and intramyocardial hemorrhage on cardiovascular magnetic resonance in patients with acute ST segment elevation myocardial infarction (STEMI): An observational cohort study. Medicine (Baltimore) 2018;97:e11617. [PMID: 30045300 DOI: 10.1097/MD.0000000000011617] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
575 Elgendy IY, Huo T, Mahmoud A, Bavry AA. Complete versus culprit-only revascularization in patients with multi-vessel disease undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials. Int J Cardiol 2015;186:98-103. [PMID: 25814353 DOI: 10.1016/j.ijcard.2015.03.163] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
576 Doorey A, Garratt KN, Weintraub WW. Coronary Angiography After Out-of-Hospital Cardiac Arrest. JACC Cardiovasc Interv 2017;10:963. [PMID: 28473120 DOI: 10.1016/j.jcin.2017.02.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
577 Kosmidou I, Redfors B, Crowley A, Gersh B, Chen S, Dizon JM, Embacher M, Mehran R, Ben-Yehuda O, Mintz GS, Stone GW. Prognostic implications of Q waves at presentation in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: An analysis of the HORIZONS-AMI study. Clin Cardiol 2017;40:982-7. [PMID: 28696573 DOI: 10.1002/clc.22751] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
578 Arps K, Pallazola VA, Cardoso R, Meyer J, Jones R, Latina J, Gluckman TJ, Stone NJ, Blumenthal RS, Mcevoy JW. Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention: A Review Part 2. The American Journal of Medicine 2019;132:e599-609. [DOI: 10.1016/j.amjmed.2019.01.031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
579 Vallabhajosyula S, Kumar V, Sundaragiri PR, Cheungpasitporn W, Bell MR, Singh M, Jaffe AS, Barsness GW. Influence of primary payer status on the management and outcomes of ST-segment elevation myocardial infarction in the United States. PLoS One 2020;15:e0243810. [PMID: 33338071 DOI: 10.1371/journal.pone.0243810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
580 Kwong JS, Sun X. Development of local clinical practice guidelines in the real world: an evolving scene in China. Heart Asia 2017;9:e010903. [PMID: 29467835 DOI: 10.1136/heartasia-2017-010903] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
581 Carlsen EA, Bang LE, Lønborg J, Ahtarovski KA, Køber L, Kelbæk H, Vejlstrup N, Jørgensen E, Helqvist S, Saunamäki K, Clemmensen P, Holmvang L, Wagner GS, Engstrøm T. A mismatch index based on the difference between measured left ventricular ejection fraction and that estimated by infarct size at three months following reperfused acute myocardial infarction. J Electrocardiol 2014;47:191-6. [PMID: 24373864 DOI: 10.1016/j.jelectrocard.2013.10.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
582 Aradi D, Tornyos A, Pintér T, Vorobcsuk A, Kónyi A, Faluközy J, Veress G, Magyari B, Horváth IG, Komócsi A. Optimizing P2Y12 receptor inhibition in patients with acute coronary syndrome on the basis of platelet function testing: impact of prasugrel and high-dose clopidogrel. J Am Coll Cardiol 2014;63:1061-70. [PMID: 24486281 DOI: 10.1016/j.jacc.2013.12.023] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 8.1] [Reference Citation Analysis]
583 Kastrati A, Colleran R, Ndrepepa G. Cardiogenic Shock: How Long Does the Storm Last? J Am Coll Cardiol 2016;67:748-50. [PMID: 26892408 DOI: 10.1016/j.jacc.2015.12.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
584 Joyce E, Hoogslag GE, Al Amri I, Debonnaire P, Katsanos S, Bax JJ, Delgado V, Marsan NA. Quantitative Dobutamine Stress Echocardiography Using Speckle-Tracking Analysis versus Conventional Visual Analysis for Detection of Significant Coronary Artery Disease after ST-Segment Elevation Myocardial Infarction. Journal of the American Society of Echocardiography 2015;28:1379-1389.e1. [DOI: 10.1016/j.echo.2015.07.023] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
585 Ibáñez B, Raposeiras-roubin S, García-ruiz JM. The Swing of β-Blockers. Journal of the American College of Cardiology 2017;69:2721-4. [DOI: 10.1016/j.jacc.2017.04.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
586 Kim YH, Her A, Jeong MH, Kim B, Lee S, Hong S, Shin D, Kim J, Ko Y, Choi D, Hong M, Jang Y. Comparison Between Beta-Blockers with Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers with Angiotensin II Type I Receptor Blockers in ST-Segment Elevation Myocardial Infarction After Successful Percutaneous Coronary Intervention with Drug-Eluting Stents. Cardiovasc Drugs Ther 2019;33:55-67. [DOI: 10.1007/s10557-018-6841-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
587 McGinty EE, Baller J, Azrin ST, Juliano-Bult D, Daumit GL. Quality of medical care for persons with serious mental illness: A comprehensive review. Schizophr Res 2015;165:227-35. [PMID: 25936686 DOI: 10.1016/j.schres.2015.04.010] [Cited by in Crossref: 78] [Cited by in F6Publishing: 63] [Article Influence: 11.1] [Reference Citation Analysis]
588 Harari R, Bangalore S. Beta-blockers after acute myocardial infarction: an old drug in urgent need of new evidence! European Heart Journal 2020;41:3530-2. [DOI: 10.1093/eurheartj/ehaa436] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
589 Couture EL, Bérubé S, Dalery K, Gervais A, Harvey R, Nguyen M, Parenteau É, Daneault B. Culprit Vessel Revascularization Prior to Diagnostic Angiography as a Strategy to Reduce Delays in Primary Percutaneous Coronary Intervention: A Propensity-Matched Analysis. Circ Cardiovasc Interv 2016;9:e003510. [PMID: 27162215 DOI: 10.1161/CIRCINTERVENTIONS.115.003510] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
590 Levisman J, Price MJ. Update on the guidelines for the management of ST-elevation myocardial infarction. Am J Cardiol 2015;115:3A-9A. [PMID: 25728973 DOI: 10.1016/j.amjcard.2015.01.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
591 Pradhan A, Vishwakarma P, Sethi R. Landmark Trials in Cardiology in 2017-Celebrating 40 Years of Angioplasty. Int J Angiol 2018;27:167-73. [PMID: 30154637 DOI: 10.1055/s-0038-1661376] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
592 Salih M, Ibrahim AM, Al-Akchar M, Bhattarai M, Koester C, Ayan M, Hafiz AM. Complete Versus Culprit-Only Revascularization in Patients Presenting With ST-Segment Elevation Myocardial Infarction: A Meta-Analysis of Randomized Control Trials. Cardiovasc Revasc Med 2020;21:1482-8. [PMID: 32571757 DOI: 10.1016/j.carrev.2020.05.019] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
593 Gill R, Donahey E, Ruland S. Early administration of therapeutic anticoagulation following intravenous thrombolysis for acute cardiogenic embolic stroke caused by left ventricular thrombus: case report and topic review. Front Neurol 2015;6:9. [PMID: 25699011 DOI: 10.3389/fneur.2015.00009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
594 Akyuz S, Yazici S, Bozbeyoglu E, Onuk T, Yildirimturk O, Karacimen D, Hayiroglu MI, Erdogan G, Oner AO, Calik AN, Cagdas M, Cam N. Validity of the updated GRACE risk predictor (version 2.0) in patients with non-ST-elevation acute coronary syndrome. Revista Portuguesa de Cardiologia 2016;35:25-31. [DOI: 10.1016/j.repc.2015.07.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
595 Fan Y, Wang J, Zhang S, Wan Z, Zhou D, Ding Y, He Q, Xie P. Homocysteine enhances the predictive value of the GRACE risk score in patients with ST-elevation myocardial infarction. Anatol J Cardiol 2017;18:182-93. [PMID: 28782750 DOI: 10.14744/AnatolJCardiol.2017.7798] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
596 Seetharam K, Cheema A, Friedman G, Pachulski R. Left Bundle Branch Block Chest Pain Conundrum. Case Rep Cardiol 2020;2020:2724981. [PMID: 32148969 DOI: 10.1155/2020/2724981] [Reference Citation Analysis]
597 Jiang M, You JH. CYP2C19 LOF and GOF-Guided Antiplatelet Therapy in Patients with Acute Coronary Syndrome: A Cost-Effectiveness Analysis. Cardiovasc Drugs Ther 2017;31:39-49. [PMID: 27924429 DOI: 10.1007/s10557-016-6705-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
598 Wegermann ZK, Rao SV. Currently Available Options for Mechanical Circulatory Support for the Management of Cardiogenic Shock. Cardiol Clin 2020;38:527-42. [PMID: 33036715 DOI: 10.1016/j.ccl.2020.06.006] [Reference Citation Analysis]
599 Hodzic E, Perla S, Iglica A, Vucijak M. Seasonal Incidence of Acute Coronary Syndrome and Its Features. Mater Sociomed 2018;30:10-4. [PMID: 29670472 DOI: 10.5455/msm.2018.30.10-14] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
600 Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, Davila-roman VG, Gerhard-herman MD, Holly TA, Kane GC, Marine JE, Nelson MT, Spencer CC, Thompson A, Ting HH, Uretsky BF, Wijeysundera DN. 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. Journal of the American College of Cardiology 2014;64:e77-e137. [DOI: 10.1016/j.jacc.2014.07.944] [Cited by in Crossref: 750] [Cited by in F6Publishing: 473] [Article Influence: 93.8] [Reference Citation Analysis]
601 Kim YH, Her AY, Jeong MH, Kim BK, Hong SJ, Kim S, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y. Effects of stent generation on clinical outcomes after acute myocardial infarction compared between prediabetes and diabetes patients. Sci Rep 2021;11:9364. [PMID: 33931673 DOI: 10.1038/s41598-021-88593-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
602 Cauchy E, Davis CB, Pasquier M, Meyer EF, Hackett PH. A New Proposal for Management of Severe Frostbite in the Austere Environment. Wilderness Environ Med 2016;27:92-9. [PMID: 26948558 DOI: 10.1016/j.wem.2015.11.014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 5.4] [Reference Citation Analysis]
603 Ghauharali-Imami S, Bax M, Haasdijk A, Schotborgh C, Oemrawsingh P, Bech J, van Domburg R, Zijlstra F. The impact of gender on long-term mortality in patients with multivessel disease after primary percutaneous coronary intervention. Neth Heart J 2015;23:592-9. [PMID: 26449240 DOI: 10.1007/s12471-015-0754-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
604 Hu B, Zhou Q, Yao X, Tan T, Lei J, Cao Q, Chen J, Guo R. Layer-Specific Strain for Long-Term Outcome Prediction After First-Onset Myocardial Infarction. Ultrasound Med Biol 2020;46:1435-41. [PMID: 32224078 DOI: 10.1016/j.ultrasmedbio.2020.02.013] [Reference Citation Analysis]
605 Cowper PA, Pan W, Anstrom KJ, Kaul P, Wallentin L, Davidson-ray L, Nikolic E, Janzon M, Levin L, Cannon CP, Harrington RA, Mark DB. Economic Analysis of Ticagrelor Therapy From a U.S. Perspective. Journal of the American College of Cardiology 2015;65:465-76. [DOI: 10.1016/j.jacc.2014.11.034] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
606 Mina GS, Firouzbakht T, Modi K, Dominic P. Gender-based outcomes of bivalirudin versus heparin in patients undergoing percutaneous coronary interventions: Meta-analysis of randomized controlled trials. Catheter Cardiovasc Interv 2017;90:735-42. [PMID: 28339139 DOI: 10.1002/ccd.26985] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
607 Vaidya GN, Khan A, Ghafghazi S. Effect of morphine use on oral P2Y12 platelet inhibitors in acute myocardial infarction: Meta-analysis. Indian Heart J 2019;71:126-35. [PMID: 31280824 DOI: 10.1016/j.ihj.2019.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
608 Wang A, Liu J, Li C, Gao J, Li X, Chen S, Wu S, Ding H, Fan H, Hou S. Cumulative Exposure to High-Sensitivity C-Reactive Protein Predicts the Risk of Cardiovascular Disease. J Am Heart Assoc 2017;6:e005610. [PMID: 29066453 DOI: 10.1161/JAHA.117.005610] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
609 Patel N, Petraco R, Dall'Armellina E, Kassimis G, De Maria GL, Dawkins S, Lee R, Prendergast BD, Choudhury RP, Forfar JC, Channon KM, Davies J, Banning AP, Kharbanda RK. Zero-Flow Pressure Measured Immediately After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Provides the Best Invasive Index for Predicting the Extent of Myocardial Infarction at 6 Months: An OxAMI Study (Oxford Acute Myocardial Infarction). JACC Cardiovasc Interv 2015;8:1410-21. [PMID: 26404192 DOI: 10.1016/j.jcin.2015.04.029] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
610 Choi KH, Lee JM, Kim HK, Kim J, Park J, Hwang D, Rhee TM, Park TK, Yang JH, Song YB, Shin ES, Nam CW, Doh JH, Hahn JY, Choi JH, Choi SH, Koo BK, Gwon HC. Fractional Flow Reserve and Instantaneous Wave-Free Ratio for Nonculprit Stenosis in Patients With Acute Myocardial Infarction. JACC Cardiovasc Interv 2018;11:1848-58. [PMID: 30236358 DOI: 10.1016/j.jcin.2018.06.045] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
611 Caraballo P, Bielinski S, St. Sauver J, Weinshilboum R. Electronic Medical Record-Integrated Pharmacogenomics and Related Clinical Decision Support Concepts. Clin Pharmacol Ther 2017;102:254-64. [DOI: 10.1002/cpt.707] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 7.8] [Reference Citation Analysis]
612 Park S, Kim YG, Ann SH, Park HW, Suh J, Roh JH, Cho YR, Han S, Park GM. Angiotensin-Converting Enzyme Inhibitor-based Versus Angiotensin Receptor Blocker-based Optimal Medical Therapy After Percutaneous Coronary Intervention: A Nationwide Cohort Study. J Cardiovasc Pharmacol 2021;77:61-8. [PMID: 33165139 DOI: 10.1097/FJC.0000000000000930] [Reference Citation Analysis]
613 von Hafe M, Neves JS, Vale C, Borges-Canha M, Leite-Moreira A. The impact of thyroid hormone dysfunction on ischemic heart disease. Endocr Connect 2019;8:R76-90. [PMID: 30959486 DOI: 10.1530/EC-19-0096] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
614 Savonitto S, Morici N, Nozza A, Cosentino F, Perrone Filardi P, Murena E, Morocutti G, Ferri M, Cavallini C, Eijkemans MJ, Stähli BE, Schrieks IC, Toyama T, Lambers Heerspink HJ, Malmberg K, Schwartz GG, Lincoff AM, Ryden L, Tardif JC, Grobbee DE. Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes. Diab Vasc Dis Res 2018;15:14-23. [PMID: 29052439 DOI: 10.1177/1479164117735493] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
615 Green JL, Nallamothu BK. Direct emergency medical services transport in STEMI: breaking the bank for non-PCI capable hospitals? Open Heart 2015;2:e000139. [PMID: 26167289 DOI: 10.1136/openhrt-2014-000139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
616 Day SA, Cucci M, Droege ME, Holzhausen JM, Kram B, Kram S, Pajoumand M, Parker CR, Patel MK, Peitz GJ, Poore A, Turck CJ, Van Berkel MA, Wong A, Zomp A, Rech MA. Major publications in the critical care pharmacotherapy literature: January-December 2014. Am J Health Syst Pharm 2015;72:1974-85. [PMID: 26541953 DOI: 10.2146/ajhp150220] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
617 Mcdaniel M. Pre-Hospital Ticagrelor in ST-Segment Elevation Myocardial Infarction? JACC: Cardiovascular Interventions 2016;9:657-9. [DOI: 10.1016/j.jcin.2016.01.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
618 Pappas C, Lekakis J, Alexopoulos D. Ticagrelor recommended over clopidogrel in STEMI patients. Expert Rev Cardiovasc Ther 2016;14:983-5. [PMID: 27348183 DOI: 10.1080/14779072.2016.1204912] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
619 Milewska A, Minczykowski A, Krauze T, Piskorski J, Heathers J, Szczepanik A, Banaszak A, Guzik P, Wykretowicz A. Prognosis after acute coronary syndrome in relation with ventricular–arterial coupling and left ventricular strain. International Journal of Cardiology 2016;220:343-8. [DOI: 10.1016/j.ijcard.2016.06.173] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
620 Choi IS, Park IB, Lee K, Ahn TH, Kim JH, Ahn Y, Chae SC, Kim HS, Kim YJ, Cho MC, Kim CJ, Jeong MH, Lee DH; Korea Acute Myocardial Infarction Registry-National Institutes of Health (KAMIR-NIH) investigators. Angiotensin-Converting Enzyme Inhibitors Provide Better Long-Term Survival Benefits to Patients With AMI Than Angiotensin II Receptor Blockers After Survival Hospital Discharge. J Cardiovasc Pharmacol Ther 2018;:1074248418795897. [PMID: 30130974 DOI: 10.1177/1074248418795897] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
621 Bob-manuel T, Ifedili I, Reed G, Ibebuogu UN, Khouzam RN. Non-ST Elevation Acute Coronary Syndromes: A Comprehensive Review. Current Problems in Cardiology 2017;42:266-305. [DOI: 10.1016/j.cpcardiol.2017.04.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
622 Wong C. From culprit artery reperfusion to non-culprit revascularization: Will ECG play a bigger role in the evolving STEMI care? International Journal of Cardiology 2015;182:124-5. [DOI: 10.1016/j.ijcard.2014.12.157] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
623 Berga Congost G, Brugaletta S, Valverde Bernal J, Márquez López A, Ruiz Gabalda J, Garcia-Picart J, Puig Campmany M, Martinez Momblan MA. The importance of organizational variables in treatment time for patients with ST-elevation acute myocardial infarction improve delays in STEMI. Australas Emerg Care 2021;24:141-6. [PMID: 33199195 DOI: 10.1016/j.auec.2020.10.001] [Reference Citation Analysis]
624 Dasari TW, Hamilton S, Chen AY, Wang TY, Peterson ED, de Lemos JA, Saucedo JF. Non-eligibility for reperfusion therapy in patients presenting with ST-segment elevation myocardial infarction: Contemporary insights from the National Cardiovascular Data Registry (NCDR). American Heart Journal 2016;172:1-8. [DOI: 10.1016/j.ahj.2015.10.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
625 Gupta T. STEMI care in the elderly: Does under-treatment reflect appropriate clinical judgment or therapeutic nihilism? Indian Heart J 2016;68:753-5. [PMID: 27931539 DOI: 10.1016/j.ihj.2016.03.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
626 Kedev S, Sukmawan R, Kalpak O, Dharma S, Antov S, Kostov J, Pejkov H, Spiroski I. Transradial versus transfemoral access for female patients who underwent primary PCI in STEMI: Two years follow-up data from acute STEMI interventional registry. International Journal of Cardiology 2016;217:S16-20. [DOI: 10.1016/j.ijcard.2016.06.222] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
627 O'Brien EC, Wu J, Schulte PJ, Christian A, Laskey W, Bhatt DL, Peterson ED, Hernandez AF, Fonarow GC. Statin use, intensity, and 3-year clinical outcomes among older patients with coronary artery disease. Am Heart J 2016;173:27-34. [PMID: 26920593 DOI: 10.1016/j.ahj.2015.11.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
628 Garcia S, Albaghdadi MS, Meraj PM, Schmidt C, Garberich R, Jaffer FA, Dixon S, Rade JJ, Tannenbaum M, Chambers J, Huang PP, Henry TD. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic. J Am Coll Cardiol 2020;75:2871-2. [PMID: 32283124 DOI: 10.1016/j.jacc.2020.04.011] [Cited by in Crossref: 563] [Cited by in F6Publishing: 501] [Article Influence: 281.5] [Reference Citation Analysis]
629 Tickoo S, Bhardwaj A, Fonarow GC, Liang L, Bhatt DL, Cannon CP. Relation Between Hospital Length of Stay and Quality of Care in Patients With Acute Coronary Syndromes (from the American Heart Association's Get With the Guidelines—Coronary Artery Disease Data Set). The American Journal of Cardiology 2016;117:201-5. [DOI: 10.1016/j.amjcard.2015.10.027] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
630 Tisminetzky M, Mehawej J, Miozzo R, Gurwitz JH, Gore JM, Lessard D, Abu HO, Bamgbade BA, Yarzebski J, Granillo E, Goldberg RJ. Temporal Trends and Patient Characteristics Associated with 30-Day Hospital Readmission Rates after a First Acute Myocardial Infarction. Am J Med 2021;134:1127-34. [PMID: 33864760 DOI: 10.1016/j.amjmed.2021.03.024] [Reference Citation Analysis]
631 Tsang M, Jolly S. Interventional Strategies in Thrombus Management for ST Elevation Myocardial Infarction. Interv Cardiol 2015;10:35-8. [PMID: 29588672 DOI: 10.15420/icr.2015.10.1.35] [Reference Citation Analysis]
632 Bennin CK, Ibrahim S, Al-Saffar F, Box LC, Strom JA. Achieving timely percutaneous reperfusion for rural ST-elevation myocardial infarction patients by direct transport to an urban PCI-hospital. J Geriatr Cardiol 2016;13:840-5. [PMID: 27928226 DOI: 10.11909/j.issn.1671-5411.2016.10.012] [Reference Citation Analysis]
633 Riddell E, Vader JM. Potential Expanded Indications for Neprilysin Inhibitors. Curr Heart Fail Rep 2017;14:134-45. [PMID: 28281174 DOI: 10.1007/s11897-017-0327-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
634 Solomon R, Nowak R, Hudson M, Moyer M, Jacobsen G, McCord J. Is Duration of Symptoms Predictive of Acute Myocardial Infarction? Curr Probl Cardiol 2021;46:100555. [PMID: 32305256 DOI: 10.1016/j.cpcardiol.2020.100555] [Reference Citation Analysis]
635 Choi AW, Blair JE, Flaherty JD. Abciximab-induced alveolar hemorrhage treated with rescue extracorporeal membranous oxygenation: Alveolar Hemorrhage and rescue ECMO. Cathet Cardiovasc Intervent 2015;85:828-31. [DOI: 10.1002/ccd.25731] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
636 Kim MC, Ahn Y, Cho JY, Lee KH, Sim DS, Yoon NS, Yoon HJ, Kim KH, Hong YJ, Park HW, Kim JH, Jeong MH, Cho JG, Park JC, Chang K, Seung KB. Benefit of Early Statin Initiation within 48 Hours after Admission in Statin-Naïve Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention. Korean Circ J 2019;49:419-33. [PMID: 30808084 DOI: 10.4070/kcj.2018.0341] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
637 Kaul S. Choice of Optimal Anticoagulant to Support Primary PCI. Journal of the American College of Cardiology 2015;65:39-42. [DOI: 10.1016/j.jacc.2014.11.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
638 Guo XY, Li N, Du X, Bai R, Yu RH, Long DY, Tang RB, Sang CH, Jiang CX, Ning M, Li SN, Liu N, Dong JZ, Ma CS. Atrial fibrillation is associated with an increased risk of myocardial infarction: Insights from a meta-analysis. Atherosclerosis 2016;254:1-7. [PMID: 27673698 DOI: 10.1016/j.atherosclerosis.2016.09.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
639 Schultz A, Dahl L, McGibbon E, Brownlie J, Cook C, Elbarouni B, Katz A, Nguyen T, Sawatzky JA, Sinclaire M, Throndson K, Fransoo R. Health Outcome and Follow-up Care Differences Between First Nation and Non-First Nation Coronary Angiogram Patients: A Retrospective Cohort Study. Can J Cardiol 2018;34:1333-40. [PMID: 30269830 DOI: 10.1016/j.cjca.2018.07.418] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
640 Di Vito L, Cattabiani MA, Paoletti G, Yoon JH, Chisari A, Gramegna M, Versaci F, Castriota F, Prati F. Comparison between intermediate and severe coronary stenoses and clinical outcomes of an OCT-guided PCI strategy: . Journal of Cardiovascular Medicine 2016;17:361-7. [DOI: 10.2459/jcm.0000000000000280] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
641 Ueland T, Laugsand LE, Vatten LJ, Janszky I, Platou C, Michelsen AE, Damås JK, Aukrust P, Åsvold BO. Extracellular matrix markers and risk of myocardial infarction: The HUNT Study in Norway. Eur J Prev Cardiol 2017;24:1161-7. [PMID: 28429960 DOI: 10.1177/2047487317703826] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
642 Sharkawi MA, Filippaios A, Dani SS, Shah SP, Riskalla N, Venesy DM, Labib SB, Resnic FS. Identifying patients for safe early hospital discharge following st elevation myocardial infarction: Identifying Patients for Safe Early Hospital Discharge following STEMI. Cathet Cardiovasc Intervent 2017;89:1141-6. [DOI: 10.1002/ccd.26873] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
643 Feher A, Kampaktsis PN, Parameswaran R, Stein EM, Steingart R, Gupta D. Aspirin Is Associated with Improved Survival in Severely Thrombocytopenic Cancer Patients with Acute Myocardial Infarction. Oncologist 2017;22:213-21. [PMID: 28159866 DOI: 10.1634/theoncologist.2016-0110] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
644 Twerenbold R, Boeddinghaus J, Nestelberger T, Wildi K, Rubini Gimenez M, Badertscher P, Mueller C. How to best use high-sensitivity cardiac troponin in patients with suspected myocardial infarction. Clinical Biochemistry 2018;53:143-55. [DOI: 10.1016/j.clinbiochem.2017.12.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
645 Ramakrishnan S, Janssens W, Burgel PR, Contoli M, Franssen FME, Greening NJ, Greulich T, Gyselinck I, Halner A, Huerta A, Morgan RL, Quint JK, Vanfleteren LEGW, Vermeersch K, Watz H, Bafadhel M. Standardisation of Clinical Assessment, Management and Follow-Up of Acute Hospitalised Exacerbation of COPD: A Europe-Wide Consensus. Int J Chron Obstruct Pulmon Dis 2021;16:321-32. [PMID: 33623379 DOI: 10.2147/COPD.S287705] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
646 Pacheco LD, Lozada MJ, Saade GR. The Golden Hour: Early Interventions for Medical Emergencies during Pregnancy. Am J Perinatol 2020. [PMID: 33242907 DOI: 10.1055/s-0040-1721393] [Reference Citation Analysis]
647 Zhang F, Su S, Hou Y, Zhao L, Wang Z, Liu F, Wu F, Zhang L. Effects (MACE and bleeding events) of ticagrelor combined with omeprazole on patients with acute myocardial infarction undergoing primary PCI. Hellenic Journal of Cardiology 2020;61:306-10. [DOI: 10.1016/j.hjc.2019.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
648 Alves M, Prada L, Costa J, Ferreira JJ, Pinto FJ, Caldeira D. Effect of oxygen supply on mortality in acute ST-elevation myocardial infarction: systematic review and meta-analysis. Eur J Emerg Med 2021;28:11-8. [PMID: 33079738 DOI: 10.1097/MEJ.0000000000000764] [Reference Citation Analysis]
649 Monte E, Fischer MA, Vondriska TM. Epigenomic Disruption of Cardiovascular Care: What It Will Take. Circ Res 2017;120:1692-3. [PMID: 28546346 DOI: 10.1161/CIRCRESAHA.117.311072] [Reference Citation Analysis]
650 Vives-Borrás M, Moustafa AH, Álvarez-García J, Ferrero-Gregori A, Balcells J, García-Picart J, Serra-Peñaranda A, Sionis A, Cinca J. Clinical and Prognostic Value of the Electrocardiogram in Patients With Acute Occlusion of the Left Circumflex Coronary Artery. Am J Cardiol 2017;120:1487-94. [PMID: 28842146 DOI: 10.1016/j.amjcard.2017.07.038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
651 Abuzeid W, Bennell M, Qiu F, Kassam S, Overgaard C, Fam N, Wijeysundera HC. Clinical Outcomes of Early Repatriation for Patients With ST-Segment Elevation Myocardial Infarction: A Propensity-Matched Analysis. Can J Cardiol 2015;31:1225-31. [PMID: 26081691 DOI: 10.1016/j.cjca.2015.01.039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
652 Gu L, Jiang W, Qian H, Zheng R, Li W. Elevated serum FGF21 predicts the major adverse cardiovascular events in STEMI patients after emergency percutaneous coronary intervention. PeerJ 2021;9:e12235. [PMID: 34703671 DOI: 10.7717/peerj.12235] [Reference Citation Analysis]
653 Zupec JF, Marrs JC, Saseen JJ. Evaluation of Statin Prescribing for Secondary Prevention in Primary Care Following New Guideline Recommendations. Ann Pharmacother 2016;50:17-21. [DOI: 10.1177/1060028015608199] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
654 Rybicki FJ, Udelson JE, Peacock WF, Goldhaber SZ, Isselbacher EM, Kazerooni E, Kontos MC, Litt H, Woodard PK; Emergency Department Patients With Chest Pain Writing Panel., Emergency Department Patients With Chest Pain Rating Panel., Appropriate Utilization of Cardiovascular Imaging Oversight Committee. 2015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS Appropriate Utilization of Cardiovascular Imaging in Emergency Department Patients With Chest Pain: A Joint Document of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Appropriate Use Criteria Task Force. J Am Coll Radiol 2016;13:e1-e29. [PMID: 26810814 DOI: 10.1016/j.jacr.2015.07.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
655 Rollini F, Franchi F, Tello-Montoliu A, Patel R, Darlington A, Ferreiro JL, Cho JR, Muñiz-Lozano A, Desai B, Zenni MM, Guzman LA, Bass TA, Angiolillo DJ. Pharmacodynamic effects of cangrelor on platelet P2Y12 receptor-mediated signaling in prasugrel-treated patients. JACC Cardiovasc Interv 2014;7:426-34. [PMID: 24630878 DOI: 10.1016/j.jcin.2013.11.019] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
656 Guha S, Sethi R, Ray S, Bahl VK, Shanmugasundaram S, Kerkar P, Ramakrishnan S, Yadav R, Chaudhary G, Kapoor A, Mahajan A, Sinha AK, Mullasari A, Pradhan A, Banerjee AK, Singh BP, Balachander J, Pinto B, Manjunath CN, Makhale C, Roy D, Kahali D, Zachariah G, Wander GS, Kalita HC, Chopra HK, Jabir A, Tharakan J, Paul J, Venogopal K, Baksi KB, Ganguly K, Goswami KC, Somasundaram M, Chhetri MK, Hiremath MS, Ravi MS, Das MK, Khanna NN, Jayagopal PB, Asokan PK, Deb PK, Mohanan PP, Chandra P, Girish CR, Rabindra Nath O, Gupta R, Raghu C, Dani S, Bansal S, Tyagi S, Routray S, Tewari S, Chandra S, Mishra SS, Datta S, Chaterjee SS, Kumar S, Mookerjee S, Victor SM, Mishra S, Alexander T, Samal UC, Trehan V. Cardiological Society of India: Position statement for the management of ST elevation myocardial infarction in India. Indian Heart J 2017;69 Suppl 1:S63-97. [PMID: 28400042 DOI: 10.1016/j.ihj.2017.03.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
657 Azzalini L, Khan R, Al-hawwas M, Hatem R, Fortier A, L’allier PL, Ly HQ. Effect of Radial-to-Femoral Access Crossover on Adverse Outcomes in Primary Percutaneous Coronary Intervention. The American Journal of Cardiology 2014;114:1165-73. [DOI: 10.1016/j.amjcard.2014.07.033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
658 AlFaleh HF, Alsheikh-Ali AA, Ullah A, AlHabib KF, Hersi A, Suwaidi JA, Sulaiman K, Saif SA, Almahmeed W, Asaad N, Amin H, Al-Motarreb A, Kashour T. Validation of the Canada Acute Coronary Syndrome Risk Score for Hospital Mortality in the Gulf Registry of Acute Coronary Events-2. Clin Cardiol 2015;38:542-7. [PMID: 26418408 DOI: 10.1002/clc.22446] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
659 Ben-shoshan J, Segman-rosenstveig Y, Arbel Y, Chorin E, Barkagan M, Rozenbaum Z, Granot Y, Finkelstein A, Banai S, Keren G, Shacham Y. Comparison of Triggering and Nontriggering Factors in ST-Segment Elevation Myocardial Infarction and Extent of Coronary Arterial Narrowing. The American Journal of Cardiology 2016;117:1219-23. [DOI: 10.1016/j.amjcard.2016.01.038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
660 Shacham Y, Gal-Oz A, Leshem-Rubinow E, Arbel Y, Keren G, Roth A, Steinvil A. Admission Glucose Levels and the Risk of Acute Kidney Injury in Nondiabetic ST Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention. Cardiorenal Med 2015;5:191-8. [PMID: 26195971 DOI: 10.1159/000430472] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
661 Teunissen PF, Tijssen R, van Montfoort ML, Robbers LF, de Waard GA, van de Ven PM, Beek AM, Knaapen P, Meijers JC, van Royen N. Kinetics of coagulation in ST-elevation myocardial infarction following successful primary percutaneous coronary intervention. Thrombosis Research 2016;137:64-71. [DOI: 10.1016/j.thromres.2015.11.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
662 Møller-helgestad OK, Poulsen CB, Christiansen EH, Lassen JF, Ravn HB. Support with intra-aortic balloon pump vs. Impella2.5® and blood flow to the heart, brain and kidneys — An experimental porcine model of ischaemic heart failure. International Journal of Cardiology 2015;178:153-8. [DOI: 10.1016/j.ijcard.2014.10.153] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
663 Hernandez JM, Glembocki MM, McCoy MA. Increasing Nursing Knowledge of ST-Elevated Myocardial Infarction Recognition on 12-Lead Electrocardiograms to Improve Patient Outcomes. J Contin Educ Nurs 2019;50:475-80. [PMID: 31556964 DOI: 10.3928/00220124-20190917-10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
664 Saito D, Nakanishi R, Watanabe I, Yabe T, Okubo R, Amano H, Toda M, Ikeda T. Combined assessment of left ventricular end-diastolic pressure and ejection fraction by left ventriculography predicts long-term outcomes of patients with ST-segment elevation myocardial infarction. Heart Vessels 2018;33:453-61. [DOI: 10.1007/s00380-017-1080-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
665 Nairooz R, Valgimigli M, Rochlani Y, Pothineni NV, Raina S, Sardar P, Mukherjee D, Naidu SS, Shavelle DM. Meta-analysis of clopidogrel pretreatment in acute coronary syndrome patients undergoing invasive strategy. International Journal of Cardiology 2017;229:82-9. [DOI: 10.1016/j.ijcard.2016.11.226] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
666 Xu L, Huang X, Ma J, Huang J, Fan Y, Li H, Qiu J, Zhang H, Huang W. Value of three-dimensional strain parameters for predicting left ventricular remodeling after ST-elevation myocardial infarction. Int J Cardiovasc Imaging 2017;33:663-73. [DOI: 10.1007/s10554-016-1053-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 7.2] [Reference Citation Analysis]
667 Secemsky EA, Butala N, Raja A, Khera R, Wang Y, Curtis JP, Maddox TM, Virani SS, Armstrong EJ, Shunk KA, Brindis RG, Bhatt D, Yeh RW. Temporal Changes and Institutional Variation in Use of Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction With Multivessel Coronary Artery Disease in the United States: An NCDR Research to Practice Project. JAMA Cardiol 2021;6:574-80. [PMID: 33146666 DOI: 10.1001/jamacardio.2020.5354] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
668 Shacham Y, Leshem-rubinow E, Steinvil A, Assa EB, Keren G, Roth A, Arbel Y. Renal impairment according to acute kidney injury network criteria among ST elevation myocardial infarction patients undergoing primary percutaneous intervention: a retrospective observational study. Clin Res Cardiol 2014;103:525-32. [DOI: 10.1007/s00392-014-0680-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
669 DeJong C, Redberg RF. Multivessel or Culprit Vessel-Only Percutaneous Coronary Intervention for Patients With Acute Myocardial Infarction and Cardiogenic Shock: Real-World Evidence in Support of CULPRIT-SHOCK. JAMA Intern Med 2020;180:1280-3. [PMID: 32833000 DOI: 10.1001/jamainternmed.2020.3400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
670 Li C, Sun Y, Shen X, Yu T, Li Q, Ruan G, Zhang L, Huang Q, Zhuang H, Huang J, Ni L, Wang L, Jiang J, Wang Y, Wang DW. Relationship Between β-Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. J Am Heart Assoc 2016;5:e004190. [PMID: 27852588 DOI: 10.1161/JAHA.116.004190] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
671 Montero-Balosa MC, Fernández-Urrusuno R, Vilches-Arenas A. The Effect of Monthly Medication on Mortality After a Coronary Event. J Cardiovasc Pharmacol Ther 2018;23:192-9. [PMID: 28978235 DOI: 10.1177/1074248417732833] [Reference Citation Analysis]
672 Liang D, Shi R, Zheng KI, Zhou X, Zhu Q, Chen M, Wang L, Fang Y, Xue C, Huang W, Shan P. Clinical characteristics and outcomes in patients with echocardiographic left ventricular spontaneous echo contrast. Int J Cardiol 2021;330:245-50. [PMID: 33577908 DOI: 10.1016/j.ijcard.2021.02.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
673 Li M, Feng L, Li X, Gao R, Wu Y. Influences of Smoking Status on Effectiveness of Cytochrome P450 Enzyme System Metabolized Medications in Reducing In-Hospital Death in 14 658 Patients With Acute Myocardial Infarction: Data From CPACS-3 Study. J Cardiovasc Pharmacol Ther 2020;25:418-24. [PMID: 32338045 DOI: 10.1177/1074248420921304] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
674 Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, Crumb SR, Dearani JA, Fuller S, Gurvitz M, Khairy P, Landzberg MJ, Saidi A, Valente AM, Van Hare GF. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2019;73:1494-563. [PMID: 30121240 DOI: 10.1016/j.jacc.2018.08.1028] [Cited by in Crossref: 144] [Cited by in F6Publishing: 112] [Article Influence: 36.0] [Reference Citation Analysis]
675 Koza Y. The association between C-reactive protein level and left ventricular diastolic functions in patients with first ST-segment elevation myocardial infarction treated by primary coronary intervention. J Cardiol 2014;64:328. [PMID: 24513448 DOI: 10.1016/j.jjcc.2013.12.011] [Reference Citation Analysis]
676 Villablanca P, Nona P, Lemor A, Qintar M, O'Neill B, Lee J, Frisoli T, Wang DD, Eng MH, O'Neill WW. Mechanical Circulatory Support in Cardiogenic Shock due to Structural Heart Disease. Interv Cardiol Clin 2021;10:221-34. [PMID: 33745671 DOI: 10.1016/j.iccl.2020.12.007] [Reference Citation Analysis]
677 Atti V, Gwon Y, Narayanan MA, Garcia S, Sandoval Y, Brilakis ES, Basir MB, Turagam MK, Khandelwal A, Mena-hurtado C, Mamas MA, Abbott JD, Bhatt DL, Velagapudi P. Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease. JACC: Cardiovascular Interventions 2020;13:1571-82. [DOI: 10.1016/j.jcin.2020.04.055] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
678 Al-khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Heart Rhythm 2018;15:e73-e189. [DOI: 10.1016/j.hrthm.2017.10.036] [Cited by in Crossref: 117] [Cited by in F6Publishing: 82] [Article Influence: 29.3] [Reference Citation Analysis]
679 Levine GN, Jeong YH, Goto S, Anderson JL, Huo Y, Mega JL, Taubert K, Smith SC. Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI. Nat Rev Cardiol. 2014;11:597-606. [PMID: 25154978 DOI: 10.1038/nrcardio.2014.104] [Cited by in Crossref: 160] [Cited by in F6Publishing: 128] [Article Influence: 20.0] [Reference Citation Analysis]
680 Kassaian SE, Fathi Y, Lotfi-Tokaldany M, Salarifar M, Alidoosti M, Haji-Zeinali AM, Aghajani H, Amirzadegan A, Nozari Y, Mortazavi SH, Jalali A, Saroukhani S. Comparison of 1-year Major Adverse Cardiac Events in Patients Undergoing Primary Percutaneous Coronary Intervention Receiving Intracoronary Bolus Only Versus Intracoronary Bolus Plus Infusion of Glycoprotein IIb/IIIa Inhibitors. Crit Pathw Cardiol 2016;15:89-94. [PMID: 27465002 DOI: 10.1097/HPC.0000000000000079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
681 Henry TD, Armstrong PW. The Choice Is Reperfusion Therapy: But Which One? JACC Cardiovasc Interv 2016;9:2021-3. [PMID: 27712738 DOI: 10.1016/j.jcin.2016.08.004] [Cited by in Crossref: 6] [Article Influence: 1.0] [Reference Citation Analysis]
682 Batra G, Lindhagen L, Andell P, Erlinge D, James S, Spaak J, Oldgren J. Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but Do Not Prevent New-Onset Atrial Fibrillation After Acute Myocardial Infarction. J Am Heart Assoc 2017;6:e005165. [PMID: 28320744 DOI: 10.1161/JAHA.116.005165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
683 Guo Z, Liu J, Lei L, Xue Y, Liu L, Huang H, Chen S, Liu Y, Lin Y, Tao J, Xu Q, Wu K, Zhang L, Chen JY. Effect of N-acetylcysteine on prevention of contrast-associated acute kidney injury in patients with STEMI undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomised controlled trials. BMJ Open 2020;10:e039009. [PMID: 33067289 DOI: 10.1136/bmjopen-2020-039009] [Reference Citation Analysis]
684 Hu X, Li H, Zhao X, Zhou R, Liu H, Sun Y, Fan Y, Shi Y, Qiao S, Liu S, Liu H, Zhang S. Multi-omics study reveals that statin therapy is associated with restoration of gut microbiota homeostasis and improvement in outcomes in patients with acute coronary syndrome. Theranostics 2021;11:5778-93. [PMID: 33897881 DOI: 10.7150/thno.55946] [Reference Citation Analysis]
685 Jarrah M, Hammoudeh A, Okkeh O, Khader Y, Gharaibeh S, Nasser L, Rasheed A, Al-Hindi A, Mohealdeen M, Kharabsheh H, Abunimeh H, Hijjih E, Tashman L, Omar D, Kufoof N; First Jordanian PCI Registry Investigators Group. Major bleeding events in Jordanian patients undergoing percutaneous coronary intervention (PCI): Incidence, associated factors, impact on prognosis, and predictability of the CRUSADE bleeding risk score. Results from the First Jordanian PCR (PCR1). Anatol J Cardiol 2017;17:445-51. [PMID: 28344216 DOI: 10.14744/AnatolJCardiol.2017.7530] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
686 Kotwal S, Ranasinghe I, Brieger D, Clayton P, Cass A, Gallagher M. Long-term Outcomes of Patients with Acute Myocardial Infarction Presenting to Regional and Remote Hospitals. Heart, Lung and Circulation 2016;25:124-31. [DOI: 10.1016/j.hlc.2015.07.019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
687 Shacham Y, Gal-Oz A, Ben-Shoshan J, Keren G, Arbel Y. Prognostic Implications of Acute Renal Impairment among ST Elevation Myocardial Infarction Patients with Preserved Left Ventricular Function. Cardiorenal Med 2016;6:143-9. [PMID: 26989399 DOI: 10.1159/000443621] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
688 Dauerman HL, Ibanez B. The Edge of Time in Acute Myocardial Infarction. J Am Coll Cardiol 2021;77:1871-4. [PMID: 33858623 DOI: 10.1016/j.jacc.2021.03.003] [Reference Citation Analysis]
689 Yassin F, Sawh C, Garg P. Chest Pain of Uncertain Aetiology: Role of Contrast Enhanced Computed Tomography in the Emergency Department. Open Cardiovasc Med J 2016;10:205-11. [PMID: 27733870 DOI: 10.2174/1874192401610010205] [Reference Citation Analysis]
690 Smith HS, Criner AJ, Fehrle D, Grabianowski CL, Jacobs MR, Criner GJ. Use of a SmartPhone/Tablet-Based Bidirectional Telemedicine Disease Management Program Facilitates Early Detection and Treatment of COPD Exacerbation Symptoms. Telemed J E Health 2016;22:395-9. [PMID: 26451903 DOI: 10.1089/tmj.2015.0135] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
691 Tran PM, Zhu C, Dreyer R, Lichtman JH. Sex- and Age-Specific Comparisons of Cardiac Rehabilitation Attendance Among Rural Versus Urban Residing Us Myocardial Infarction Survivors. J Cardiopulm Rehabil Prev 2022;42:68-9. [PMID: 34979001 DOI: 10.1097/HCR.0000000000000666] [Reference Citation Analysis]
692 Moyer AM, Caraballo PJ. The challenges of implementing pharmacogenomic testing in the clinic. Expert Rev Pharmacoecon Outcomes Res 2017;17:567-77. [PMID: 28949250 DOI: 10.1080/14737167.2017.1385395] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
693 Ali SM, Rajani AR, Baslaib FO. Intracranial haemorrhage 4 days after receiving thrombolytic therapy in a young woman with myocardial infarction. BMJ Case Rep 2013;2013:bcr2013009816. [PMID: 23704457 DOI: 10.1136/bcr-2013-009816] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
694 Pathan F, Negishi K. Prediction of cardiovascular outcomes by imaging coronary atherosclerosis. Cardiovasc Diagn Ther 2016;6:322-39. [PMID: 27500091 DOI: 10.21037/cdt.2015.12.08] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
695 Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, Bittl JA, Cohen MG, DiMaio JM, Don CW, Fremes SE, Gaudino MF, Goldberger ZD, Grant MC, Jaswal JB, Kurlansky PA, Mehran R, Metkus TS Jr, Nnacheta LC, Rao SV, Sellke FW, Sharma G, Yong CM, Zwischenberger BA; Writing Committee Members. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2021:S0735-1097(21)06158-1. [PMID: 34895950 DOI: 10.1016/j.jacc.2021.09.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
696 Shacham Y, Leshem-Rubinow E, Steinvil A, Keren G, Roth A, Arbel Y. High sensitive C-reactive protein and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention. Clin Exp Nephrol 2015;19:838-43. [PMID: 25492251 DOI: 10.1007/s10157-014-1071-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
697 Coons JC, Schwier N, Harris J, Seybert AL. Pharmacokinetic evaluation of prasugrel for the treatment of myocardial infarction. Expert Opinion on Drug Metabolism & Toxicology 2014;10:609-20. [DOI: 10.1517/17425255.2014.890589] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
698 January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64:e1-76. [PMID: 24685669 DOI: 10.1016/j.jacc.2014.03.022] [Cited by in Crossref: 2154] [Cited by in F6Publishing: 2019] [Article Influence: 269.3] [Reference Citation Analysis]
699 Ludhwani D, Rahaby M, Patel V, Jamil S, Kedzia A, Wu C. Implications of Left Bundle Branch Block in Takotsubo Cardiomyopathy: Propensity Match Analysis from the National Inpatient Sample. Cardiol Ther 2019;8:253-65. [PMID: 31317468 DOI: 10.1007/s40119-019-0141-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
700 Brenes-salazar JA, Forman DE. Advances in Percutaneous Coronary Interventions for Elderly Patients. Progress in Cardiovascular Diseases 2014;57:176-86. [DOI: 10.1016/j.pcad.2014.07.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
701 Gruberg L, Hellkamp AS, Thomas LE, de Lemos JA, Scirica BM, Hilliard A, Enriquez JR, Mohsen A, Wang TY. The Association of Previous Revascularization With In-Hospital Outcomes in Acute Myocardial Infarction Patients. JACC: Cardiovascular Interventions 2015;8:1954-62. [DOI: 10.1016/j.jcin.2015.08.030] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
702 Lee WH, Chen YC, Chen SC, Chen CJ, Hsu PC, Tsai WC, Chu CY, Lee CS, Lin TH, Voon WC, Kuo CH, Su HM. Cardiovascular disease management during the coronavirus disease 2019 pandemic. Int J Med Sci 2020;17:1340-4. [PMID: 32624690 DOI: 10.7150/ijms.46484] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
703 Abou R, Leung M, Goedemans L, Hoogslag GE, Schalij MJ, Marsan NA, Bax JJ, Delgado V. Effect of Guideline-Based Therapy on Left Ventricular Systolic Function Recovery After ST-Segment Elevation Myocardial Infarction. The American Journal of Cardiology 2018;122:1591-7. [DOI: 10.1016/j.amjcard.2018.07.035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
704 Cole J, Beare R, Phan TG, Srikanth V, MacIsaac A, Tan C, Tong D, Yee S, Ho J, Layland J. Staff Recall Travel Time for ST Elevation Myocardial Infarction Impacted by Traffic Congestion and Distance: A Digitally Integrated Map Software Study. Front Cardiovasc Med 2017;4:89. [PMID: 29359134 DOI: 10.3389/fcvm.2017.00089] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]